matchedPattern,context,lineNumber,columnNumber,publicationName
p.Gln209Pro,...able 3). All mutations were present in codon 209 (p.Gln209Pro and p.Gln209Leu) and were somatic muta...,81,162,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,...ations were present in codon 209 (p.Gln209Pro and p.Gln209Leu) and were somatic mutations (Fig. 2). ...,81,178,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,3	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,86,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,7	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,90,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,7	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,90,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,12	MC	c.626 A>T (p.Gln209Leu)	wt	na	na,95,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,12	MC	c.626 A>T (p.Gln209Leu)	wt	na	na,95,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,"... with a BRAF point mutation (case 15; c.1799 T>A, p.V600E) might be a metastasis rather than a prima...",114,857,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Glu5845Glu,....13066delT; p.Tyr4356Thrfs*8 ex110; c.17535G > A; p.Glu5845Glu	exon 86: frameshift mutation leading ...,39,365,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Glu5845Glu,....13066delT; p.Tyr4356Thrfs*8 ex110; c.17535G > A; p.Glu5845Glu	exon 86: frameshift mutation leading ...,39,365,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Gly6976Gly,...acheostomy.	Yes From 1 month	ex139; c.20928G > T; p.Gly6976Gly	RTPCR and Sanger sequencing of cDNA s...,46,389,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Ser8193Ser,"...non-invasive ventilation.	No	ex175; c.24579G > A, p.Ser8193Ser ex119; c.18676C > T, p.Gln6226*	ex175...",50,383,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Ser8193Ser,"...non-invasive ventilation.	No	ex175; c.24579G > A, p.Ser8193Ser ex119; c.18676C > T, p.Gln6226*	ex175...",50,383,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.V600E,"... KIAA1549-BRAF fusions are found in PAs, and BRAF:p.V600E mutations are frequently detected in PXAs ...",17,414,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF: p.V600E,27,7,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF: p.V600E,27,7,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF:p.V600E mutations were detected in 7 of 16 (43%) g...,123,6,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,...ere unable to show a KIAA1549-BRAF fusion or BRAF:p.V600E mutation. Low-grade neuroepithelial tumors...,133,925,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.R132H,...rs presenting in childhood rarely contain an IDH1:p.R132H mutation. This mutation is regarded as a h...,133,1023,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.R132H,...rs presenting in childhood rarely contain an IDH1:p.R132H mutation. This mutation is regarded as a h...,133,1023,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,...not characterized by KIAA1549-BRAF fusion or BRAF:p.V600E mutation [27],133,1448,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,...not characterized by KIAA1549-BRAF fusion or BRAF:p.V600E mutation [27],133,1448,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.Phe93Leu,"...sly reported missense mutation [1, 2], c.279C > G p.Phe93Leu in patient 3s. Patients 1 and 2s had no...",118,117,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.Phe93Leu,"...sly reported missense mutation [1, 2], c.279C > G p.Phe93Leu in patient 3s. Patients 1 and 2s had no...",118,117,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.Phe93Leu,"...sly reported missense mutation [1, 2], c.279C > G p.Phe93Leu in patient 3s. Patients 1 and 2s had no...",118,117,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.Phe91Ile,"...atients 1 and 2s had novel mutations, c.271 T > A p.Phe91Ile, and c.273C > G p.Phe91Leu, respectivel...",118,194,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.K510E,"...gically, including cases with the newly described p.K510E mutation and a case with both a known p.P5...",5,897,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...bed p.K510E mutation and a case with both a known p.P525L mutation in the FUS gene and a truncating ...,5,943,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...p.P525L mutation in the FUS gene and a truncating p.Y374X mutation in the TARDBP gene,5,993,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...red both a p.P525L FUS mutation and also a TARDBP p.Y374X truncation mutation, the latter of which h...",34,666,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...red both a p.P525L FUS mutation and also a TARDBP p.Y374X truncation mutation, the latter of which h...",34,666,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,"...r parent of case 6 to test for segregation of the p.P525L and p.Y374X mutations, however, clinical r...",34,906,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...case 6 to test for segregation of the p.P525L and p.Y374X mutations, however, clinical records descr...",34,918,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,5	15	c.1562G>A	p.R521H	35	F	>36	NA	Yes	L	No,41,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R514G,7	15	c.1540A>G	p.R514G	60	M	>96	NA	Yes	B	No,45,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...l surviving angulated neurons (arrows) in case 5 (p.R521H). H&E. b Well circumscribed basophilic inc...,121,136,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ion (arrow) in an anterior horn neuron in case 6 (p.P525L and p.Y374X TARDBP mutation). This contras...,121,239,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,...sophilic aggregate-like inclusions (inset-case 2 (p.K510E)) which resemble condensed Nissl substance...,121,389,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,...in the anterior horns of the spinal cord. Case 1 (p.R495X). Anti p62. d-f. Reveal the differing shap...,121,582,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ts of FUS immunopositivity. Anti-FUS. b-e Case 6 (p.P525L and p.Y374X TARDBP mutation) also does exh...,124,159,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...munopositivity. Anti-FUS. b-e Case 6 (p.P525L and p.Y374X TARDBP mutation) also does exhibit FUS-imm...,124,171,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...munopositivity. Anti-FUS. b-e Case 6 (p.P525L and p.Y374X TARDBP mutation) also does exhibit FUS-imm...,124,171,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...munopositivity. Anti-FUS. b-e Case 6 (p.P525L and p.Y374X TARDBP mutation) also does exhibit FUS-imm...,124,171,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,... and anti-p62 in (e) inset. f The cord in case 1 (p.R495X) revealing very mild loss of myelin in the...,124,807,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ous basophilic inclusions (including 2 cases with p.P525L mutations) tended to have a more rapid dis...,135,3215,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ous basophilic inclusions (including 2 cases with p.P525L mutations) tended to have a more rapid dis...,135,3215,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,"...t, and slower progression (including 2 cases with p.R521C mutations). Our findings do not fit neatly...",135,3462,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...nto this distinct grouping. Whereas case 5 with a p.R521H mutation would certainly appear to partial...,135,3564,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,"...ed this, in that this patient as well as having a p.P525L mutation also had a truncating p.Y374X TAR...",135,4494,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,...ption of a patient with ALS-FUS associated with a p.K510E mutation. Syriani et al. described the cli...,137,107,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R514G,The p.R514G missense mutation again has been detected ...,139,5,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.A31P,...s that were homozygous for the mutation had fHCM. p.A31P heterozygosity was not associated with a si...,10,360,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ed significance. The clinical significance of the p.A31P cMyBP-C protein mutation was determined by ...,38,185,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,cMyBP-C p.A31P genotype	P-value,107,10,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The significance of the p.A31P cMyBP-C mutatio,139,25,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The significance of the p.A31P cMyBP-C mutatio,139,25,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...zygous. Again, no significant association between p.A31P cMyBP-C and fHCM was found in heterozygous ...",166,314,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...zygous. Again, no significant association between p.A31P cMyBP-C and fHCM was found in heterozygous ...",166,314,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...d in heterozygous cats. This again indicated that p.A31P cMyBP-C associated fHCM was a disease with ...,166,396,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...her yet undiscovered mutation is present with the p.A31P cMyBP-C mutation. Digenic or compound heter...,170,627,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...roduction. That the prevalence of fHCM and of the p.A31P cMyBP-C mutation found in our cohort is sim...,180,885,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...roduction. That the prevalence of fHCM and of the p.A31P cMyBP-C mutation found in our cohort is sim...,180,885,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...to the high probability of developing fHCM in the p.A31P cMyBP-C homozygous cats the 'production' of...,183,556,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...to the high probability of developing fHCM in the p.A31P cMyBP-C homozygous cats the 'production' of...,183,556,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...to the high probability of developing fHCM in the p.A31P cMyBP-C homozygous cats the 'production' of...,183,556,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...ould be avoided. Thus, although genotyping of the p.A31P cMyBP-C mutation can not stand alone in lim...",183,678,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...ould be avoided. Thus, although genotyping of the p.A31P cMyBP-C mutation can not stand alone in lim...",183,678,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A53T,"...triplications [72] or the SNCA missense mutation, p.A53T [73]. A number of other early-onset familie...",59,313,Alzheimers_Res_Ther_2013_Jul_31_5(Suppl_1)_S7.txt
p.T185S,"... [13,14]. A nonsynonymous SNP numbered rs3173615 (p.T185S) located in exon 6 of the TMEM106B gene sh...",18,956,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,...fibrillary degeneration)	pTDP-43 immunoreactivity	p.T185S genotype,28,178,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,p.T185S genotypin,65,1,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,p.T185S genotypin,65,1,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,p.T185S genotypin,65,1,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...able 1. Before starting this, we investigated the p.T185S genotype of rs3173615 in the human TMEM106...",89,243,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...e disequilibrium with the coding rs3173615 SNP of p.T185S, is closely associated with FTLD-TDP in th...",124,115,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...e disequilibrium with the coding rs3173615 SNP of p.T185S, is closely associated with FTLD-TDP in th...",124,115,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.G130A,"...with a heterozygous mutation in SOX2 (c.389G > C, p.G130A) [Kelberman et al., 2006] makes this anoth...",22,103,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.G130A,"...with a heterozygous mutation in SOX2 (c.389G > C, p.G130A) [Kelberman et al., 2006] makes this anoth...",22,103,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.A242T,"Exon 3	Chr9: 125,817,622	n/a	c.724G > A	1/97 (1)	p.A242T, conserveda",123,51,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.D255D,"...	Chr9: 125,823,236	rs61734362	c.765C > T	1/97 (1)	p.D255D",125,58,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.D255D,"...	Chr9: 125,823,236	rs61734362	c.765C > T	1/97 (1)	p.D255D",125,58,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Asn125Ser,"...erozygous missense mutation in HESX1, c.374A > G (p.Asn125Ser). However, since this polymorphism has...",140,161,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Ala172Phe,...al ReportsThe Fibroblast Growth Factor Receptor 2 p.Ala172Phe Mutation in Pfeiffer Syndrome—History ...,3,204,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...anomalies, these are a more severe feature of the p.Ala172Phe mutation than most other FGFR2-associa...",42,1762,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...ype (mild skull/severe limb) correlation with the p.Ala172Phe mutation, both within and across famil...",42,2474,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ile442Met,"...nsin I complex, subunit G (NCAPG) gene encoding a p.Ile442Met variant is associated with an increase...",1143,89,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
p.Arg463Trp,"...s of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin structure, processing ...",51,1458,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg463Trp,"...s of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin structure, processing ...",51,1458,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg438Cys,"...performed and the pathogenic mutation, c.1312C>T (p.Arg438Cys), was identified. Interestingly, this ...",3,1972,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
p.Arg438Cys,"...performed and the pathogenic mutation, c.1312C>T (p.Arg438Cys), was identified. Interestingly, this ...",3,1972,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
p.Glu255Lys,... a missense mutation [ABL1 NM_005157.4: c.763G>A (p.Glu255Lys)] was newly detected in the second eva...,15,772,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
p.Glu255Lys,...e was changed from G to A [NM_005157.4: c.763G>A (p.Glu255Lys)],25,501,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
p.Arg1150X,"... (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were identified in this ...",18,913,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
p.D630Y,...tein is a downstream target of GNA11/GNAQ and the p.D630Y PLCB4 mutation was mutually exclusive with...,41,602,Appl_Clin_Genet_2016_Sep_6_9_147-155.txt
p.His161Arg,...active Crohn's disease and analysis of the IL-17F p.His161Arg polymorphism in IBD Inflamm Bowel Dis ...,141,325,Arthritis_Res_Ther_2008_Apr_18_10(2)_206.txt
p.Gln4154Lys,"...ciation of the APOB gene polymorphism c.12669G>A, p.Gln4154Lys with the risk of CAD varies considera...",3,1299,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...ion in linking APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) with CAD risk in different populatio...",8,1395,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Asp727Glu,"... MNG. We investigated the codon 727 polymorphism (p.Asp727Glu, p.D727E) of the human TSHR gene using...",3,1433,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.Asp727Glu,"... MNG. We investigated the codon 727 polymorphism (p.Asp727Glu, p.D727E) of the human TSHR gene using...",3,1433,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ers in exon 10 of the TSHR gene that contains the p.D727E polymorphism and digested by theNlaIII (Hi...,3,1835,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...e TSH (p = 0.047). These results suggest that the p.D727E polymorphism of the TSHR gene may not cont...,3,2354,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.Asp727Glu,... substitution of glutamic acid for aspartic acid (p.Asp727Glu; p.D727E) in the intracellular portion...,8,1212,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.Asp727Glu,... substitution of glutamic acid for aspartic acid (p.Asp727Glu; p.D727E) in the intracellular portion...,8,1212,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ion in exon 10 of the TSHR gene that contains the p.D727E polymorphism (rs1991517), as previously de...",17,263,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ion in exon 10 of the TSHR gene that contains the p.D727E polymorphism (rs1991517), as previously de...",17,263,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ta did not show a direct relationship between the p.D727E polymorphism and non toxic MNG in our grou...,29,177,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ta did not show a direct relationship between the p.D727E polymorphism and non toxic MNG in our grou...,29,177,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,Gabriel et al.[1] indicated that a p.D727E polymorphism of the human TSHR gene was si...,31,36,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...al.[13] studied the frequency of the polymorphism p.D727E in a large group of patients with non auto...,33,192,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...sion, taking into consideration the fact that the p.D727E TSHR variant is frequently detected in the...",35,60,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...in our population. This is the first study of the p.D727E polymorphism in Turkish patients with MNG....,35,466,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.Leu849Pro,"...utation, where a proline residue replaced Leu860 (p.Leu849Pro in [14,15]). The L860P mutation is loc...",56,73,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.G12S, c.34G>A	p.G12S	1 (0.5),194,10,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	6 (3.2),200,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	8 (4.3),203,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.V600E, c.1799T>A	p.V600E	51,244,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.V600E, c.1799T>A	p.V600E	51,244,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.G12S, c.34G>A	p.G12S	1,248,10,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	29,250,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	4,253,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	3,254,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	3,254,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	2,256,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.180_181TC>AA	p.Q61K,257,17,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.180_181TC>AA	p.Q61K,257,17,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.R1441C,... K.  Rademakers R.  Theuns J.    Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene ...,127,63,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
p.H178D,25	2	+ (80%)	−	Exon 5/p.H178D,60,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.H178D,25	2	+ (80%)	−	Exon 5/p.H178D,60,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R273H,27	2	+ (94%)	−	Exon 8/p.R273H,62,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R248E,28	2	+ (79%)	−	Exon 7/p.R248E,63,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.V272M,31	2	+ (91%)	−	Exon 8/p.V272M,67,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.G12V,...hybridization. A KRAS codon 12 mutation (c.35G>T; p.G12V) was detected in the pyloric gland adenoma ...,7,900,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12V,"...C1, p16), negative: MUC2, CD10, CDX2	KRAS exon 1 (p.G12V; c.35G>T); CGH: gains at 1q, 6p11p22, 7p, 1...",96,152,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12V,"...C1, p16), negative: MUC2, CD10, CDX2	KRAS exon 1 (p.G12V; c.35G>T); CGH: gains at 1q, 6p11p22, 7p, 1...",96,152,BMC_Cancer_2012_Dec_4_12_570.txt
p.G13D,...  Frattini M  Piessevaux H    Association of KRAS p.G13D mutation with outcome in patients with chem...,417,146,BMC_Cancer_2016_Aug_2_16_585.txt
p.Pro200Leu,c.599C>T	p.Pro200Leu	rs1050450,50,11,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Cys130Arg,c.388 T>C	p.Cys130Arg	rs429358,59,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Ala567Thr,"Our results show that the rs1803274 (1699G>A, p.Ala567Thr) polymorphism of BCHE was also signifi...",265,47,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.T972M,"...ction was carried out with the following primers (p.T972M, For: 5’ -catctttggcagcggcaTggtcaccttctcac...",85,183,BMC_Endocr_Disord_2014_Oct_7_14_81.txt
p.R605Q,Exon 17	c.1814G>A	NA	p.R605Q	unknown	1/39 (het: Pt-7) (0.013)	0/100	pre...,37,22,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.D19H,...ed from blood leukocytes. Genotype frequencies of p.D19H were established using MALDI-TOF mass spect...,7,494,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"... Moreover, irrespective of phenotype, carriers of p.D19H displayed a significant lower absorption th...",10,620,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"..., P = 0.0347 and wild type controls to cases with p.D19H 37%, P = 0.0030). Regarding the cholesterol...",160,775,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...s. (GG) = wild type individual; (Gc) = carrier of p.D19H. Controls: (GG) = 80 and (Gc) = 15; gallsto...,166,499,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...erol gallstones [27,29]. In our study carriers of p.D19H were characterised by significantly reduced...",181,503,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.Trp82Arg,...y. We report here a new large family in which the p.Trp82Arg variant (this nomenclature includes the...,16,1003,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,"...ge of the amino acid from tryptophan to arginine (p.Trp82Arg in the new nomenclature, corresponds to...",25,399,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,The families with the p.Trp82Arg variant already reported are either fro...,76,23,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,The families with the p.Trp82Arg variant already reported are either fro...,76,23,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.P18A,p.P18A	c.52 C>G	0	0	0	0	0.08	0	0	0,40,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F45L,p.F45L	c.133 T>C	0	0	0	0	0	0.24	0	0,44,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R67Q,p.R67Q	c.200 G>A	0	0	1.17	0	0	0.06	0	0,48,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R67Q,p.R67Q	c.200 G>A	0	0	1.17	0	0	0.06	0	0,48,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R67Q,p.R67Q	c.200 G>A	0	0	1.17	0	0	0.06	0	0,48,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A81P,p.A81P	c.241 G>C	0	0	0	0	0.08	0	0	0,49,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A81P,p.A81P	c.241 G>C	0	0	0	0	0.08	0	0	0,49,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S83P,p.S83P	c.247 T>C	0	0	0	0	0.15	0.12	0.19	0,50,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S83L,p.S83L	c.248 C>T	0	0	0	0	0	0.06	0	0,51,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S83L,p.S83L	c.248 C>T	0	0	0	0	0	0.06	0	0,51,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T95M,p.T95M	c.284 C>T	0	0	0	0	0.08	0.12	0	0,54,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T95M,p.T95M	c.284 C>T	0	0	0	0	0.08	0.12	0	0,54,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I120T,p.I120T	c.359 T>C	0	0	1.75	0	0	0.06	0	0,60,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V122M,p.V122M	c.364 G>A	0	0	0	0	0	0.24	0	0,61,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V122M,p.V122M	c.364 G>A	0	0	0	0	0	0.24	0	0,61,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R151C,p.R151C	c. 451 C>T	0.03	0	0	0	5.62	3.16	6.42	0,64,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I168I,p.I168I	c.504 C>T	0	0.43	0	0	0	0	0	0,71,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I168I,p.I168I	c.504 C>T	0	0.43	0	0	0	0	0	0,71,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V174I,p.V174I	c.520 G>A	0	0	0	0	0.08	0	0	0,73,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V174I,p.V174I	c.520 G>A	0	0	0	0	0.08	0	0	0,73,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Y182Y,p.Y182Y	c.546 C>T	0	0	0	0	0	0	0.19	0,74,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R213W,p.R213W	c.637 C>T	0	0	0	0	0	0.06	0	0,76,1,BMC_Genet_2008_Apr_10_9_31.txt
p.G220G,p.G220G	c.660 C>T	0	0	0	0	0	0.06	0	0,77,1,BMC_Genet_2008_Apr_10_9_31.txt
p.P230L,p.P230L	c.689 C>T	0	0	0	0	0.31	0	0	0,79,1,BMC_Genet_2008_Apr_10_9_31.txt
p.P230L,p.P230L	c.689 C>T	0	0	0	0	0.31	0	0	0,79,1,BMC_Genet_2008_Apr_10_9_31.txt
p.P230L,p.P230L	c.689 C>T	0	0	0	0	0.31	0	0	0,79,1,BMC_Genet_2008_Apr_10_9_31.txt
p.P230P,p.P230P	c.690 G>A	0	0	0	0	0.08	0	0	0,80,1,BMC_Genet_2008_Apr_10_9_31.txt
p.H260P,p.H260P	c.779 A>C	0	0	0	0	0.23	0	0	0,85,1,BMC_Genet_2008_Apr_10_9_31.txt
p.C273C,p.C273C	c.819 C>T	0	0.43	0	0	0	0	0	0,88,1,BMC_Genet_2008_Apr_10_9_31.txt
p.C273C,p.C273C	c.819 C>T	0	0.43	0	0	0	0	0	0,88,1,BMC_Genet_2008_Apr_10_9_31.txt
p.K278E,p.K278E	c.832 A>G	0	0	0	0	0.23	0.24	0	0,89,1,BMC_Genet_2008_Apr_10_9_31.txt
p.K278E,p.K278E	c.832 A>G	0	0	0	0	0.23	0.24	0	0,89,1,BMC_Genet_2008_Apr_10_9_31.txt
p.N279K,p.N279K	c.837 C>A	0	0	0	0	0	0.06	0	0,90,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F300F,p.F300F	c.900 C>T	0	2.99	0	0	0	0	0	0,92,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R124W, 	 	c.370C > T (p.R124W)	18217	32.3	58	39	1.77	58.36	0.48	39.35	0....,57,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R124W, 	 	c.370C > T (p.R124W)	18217	32.3	58	39	1.77	58.36	0.48	39.35	0....,57,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R124W, 	 	c.370C > T (p.R124W)	18217	32.3	58	39	1.77	58.36	0.48	39.35	0....,57,17,BMC_Genet_2013_Feb_19_14_6.txt
p.V320A,CBS	NM_000071.2	c.959 T > C (p.V320A)	8715	24.4	7	91	0.48	90.82	1.63	7.05	0.00	...,62,30,BMC_Genet_2013_Feb_19_14_6.txt
p.V320A,CBS	NM_000071.2	c.959 T > C (p.V320A)	8715	24.4	7	91	0.48	90.82	1.63	7.05	0.00	...,62,30,BMC_Genet_2013_Feb_19_14_6.txt
p.D882G,DMD	NM_004006.2	c.2645A > G (p.D882G)	2974	19.6	5	93	4.98	0.87	92.67	1.48	0	0,67,30,BMC_Genet_2013_Feb_19_14_6.txt
p.R1745H, 	 	c.5234 G > A (p.R1745H)	4289	23.4	4	93	93.38	1.19	4.13	1.31	0	0,68,19,BMC_Genet_2013_Feb_19_14_6.txt
p.V780I, 	 	c.2338 G > A (p.V780I)	8957	10.2	11	83	82.93	3.74	10.73	2.57	0.0...,90,19,BMC_Genet_2013_Feb_19_14_6.txt
p.V780I, 	 	c.2338 G > A (p.V780I)	8957	10.2	11	83	82.93	3.74	10.73	2.57	0.0...,90,19,BMC_Genet_2013_Feb_19_14_6.txt
p.R184C, 	 	c.550C > T (p.R184C)	9215	19.6	39	54	2.59	38.77	4.75	53.88	0	0...,94,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R184C, 	 	c.550C > T (p.R184C)	9215	19.6	39	54	2.59	38.77	4.75	53.88	0	0...,94,17,BMC_Genet_2013_Feb_19_14_6.txt
p.D248N, 	 	c.742 G > A (p.D248N)	15664	32.8	62	35	35.28	0.5	61.78	2.43	0	0...,96,18,BMC_Genet_2013_Feb_19_14_6.txt
p.T641A, 	 	c.1921A > G (p.T641A)	20556	23.6	2	97	2.13	0.88	96.5	0.49	0	0.0...,103,18,BMC_Genet_2013_Feb_19_14_6.txt
p.D273H, 	 	c.817 G > C (p.D273H)	27824	32.3	61	38	0.68	37.71	60.85	0.73	0....,114,18,BMC_Genet_2013_Feb_19_14_6.txt
p.A495P, 	 	c.1483 G > C (p.A495P)	2569	16.3	53	44	1.01	44.45	53.41	1.05	0	0...,118,19,BMC_Genet_2013_Feb_19_14_6.txt
p.A495P, 	 	c.1483 G > C (p.A495P)	2569	16.3	53	44	1.01	44.45	53.41	1.05	0	0...,118,19,BMC_Genet_2013_Feb_19_14_6.txt
p.N409S, 	 	c.1226 A > G (p.N409S)	3813	22.9	71	23	70.52	1.1	26.86	1.52	0	0,121,19,BMC_Genet_2013_Feb_19_14_6.txt
p.N409S, 	 	c.1226 A > G (p.N409S)	3813	22.9	71	23	70.52	1.1	26.86	1.52	0	0,121,19,BMC_Genet_2013_Feb_19_14_6.txt
p.L62S,HEXB	NM_000521.3	c.185 T > C (p.L62S)	21320	33.2	8	86	3.63	86.44	2.33	7.59	0.00	...,125,31,BMC_Genet_2013_Feb_19_14_6.txt
p.R505W, 	 	c.1513C > T (p.R505W)	8306	30.9	62	37	0.52	61.77	0.92	36.78	0.0...,129,18,BMC_Genet_2013_Feb_19_14_6.txt
p.G549R, 	 	c.1645 G > A (p.G549R)	33259	34.6	84	15	15.46	0.47	83.69	0.36	0....,131,19,BMC_Genet_2013_Feb_19_14_6.txt
p.G549R, 	 	c.1645 G > A (p.G549R)	33259	34.6	84	15	15.46	0.47	83.69	0.36	0....,131,19,BMC_Genet_2013_Feb_19_14_6.txt
p.Q70X, 	 	c.208C > T (p.Q70X)	4106	9.4	49	46	2.65	49.05	1.90	46.40	0.00	...,133,17,BMC_Genet_2013_Feb_19_14_6.txt
p.A361T, 	 	c.1081 G > A (p.A361T)	9486	26.7	60	38	37.50	1.18	59.99	1.33	0.0...,142,19,BMC_Genet_2013_Feb_19_14_6.txt
p.A361T, 	 	c.1081 G > A (p.A361T)	9486	26.7	60	38	37.50	1.18	59.99	1.33	0.0...,142,19,BMC_Genet_2013_Feb_19_14_6.txt
p.S298P, 	 	c.892 T > C (p.S298P)	12564	31.7	60	38	0.93	37.61	1.13	60.31	0	...,164,18,BMC_Genet_2013_Feb_19_14_6.txt
p.L502V,"...les we ran, there is a heterozygous c.1504 C > G (p.L502V) missense mutation in the ACADVL gene. Thi...",310,156,BMC_Genet_2013_Feb_19_14_6.txt
p.L99P,"...gh differentiation, (ii) the fixation of the MC1R p.L99P mutation in (old and new) BBC, BBM and HF, ...",118,724,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.P19S,... retardation and a reduced lifespan in mice [17]. p.P19S is therefore a plausible candidate mutation...,103,277,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.W317R,...he SGT1 protein sequence. The red arrow indicates p.W317R. Protein sequences were obtained from NCBI...,130,719,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.R961W,"...actor receptor (EGFR) inhibitors, however the KDR p.R961W c.2881C>T mutation that was noted as a var...",26,712,Cureus_8(2)_e478.txt
p.G1706A,"...[p.Q23fs], c.330A > G, [p.64-71del], c.5236G > A [p.G1706A], c.5242C > A [p.A1708E], c.589-590delCT ...",20,184,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.S157X,BRCA1 c.589-590delCT (p.S157X)	F ctcttcaggaggaaaagcac,40,23,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.G1706A,BRCA1 c.5236 G > C (p.G1706A,42,21,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.E34V,Si	F	31	1.2	2.1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,45,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,D	F	15	0.9	1.4	34	1.28 (619)	ND	-/-	c.670T>G/p.W224R,69,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,50,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,50,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,So	M	18	1.1	1.2	35	1.15 (619)	ND	-/-	c.503G>A/p.R168H,110,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,Si	F	35	ND	ND	ND	3.15	1281	+/-	c.503G>A/p.R168H,113,42,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.L178V,XXV	P	F	27	3.1	4.0	870	5.40	1592	+/-	c.532T>G/p.L178V,117,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...tamic acid residue to a valine residue in exon 3 (p.E34V). The other was a G to C substitution at nu...,209,303,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...tamic acid residue to a valine residue in exon 3 (p.E34V). The other was a G to C substitution at nu...,209,303,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,... described mutations causing VP: p.W224X [37] and p.W224R [39]. Recently was also suggested that thi...,244,376,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E320Q,"...3. A pathogenic homozygous mutation (c.958G > C, [p.E320Q]) in SLC19A3 was identified in all four pa...",10,201,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...racterization of a disease mutation (c.958G > C, [p.E320Q]). (A) The sequence analyses showed a G to...",99,82,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...racterization of a disease mutation (c.958G > C, [p.E320Q]). (A) The sequence analyses showed a G to...",99,82,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"... were caused by homozygous mutation (c.958G > C, [p.E320Q]) in SLC19A3. Our cases broaden the phenot...",114,330,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E594K,"...partate to glutamate in exon 13; (d) c.1780G > A (p.E594K), a transition from G to A at nucleotide 1...",35,784,BMC_Med_Genet_2010_May_26_11_79.txt
p.E594K,"...partate to glutamate in exon 13; (d) c.1780G > A (p.E594K), a transition from G to A at nucleotide 1...",35,784,BMC_Med_Genet_2010_May_26_11_79.txt
p.E594K,16	c.1780 G > A	p.E594K	Missense	0501768	12	0/184,42,17,BMC_Med_Genet_2010_May_26_11_79.txt
p.E594K,"... A/p.D398E, c.1740delC/p.s581PfsX40 and c.1780G>A/p.E594K. Two columns are sequencing chromatograms ...",52,190,BMC_Med_Genet_2010_May_26_11_79.txt
p.R49W,"...fied, including 4 missense mutations: c.145C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) ...",54,113,BMC_Med_Genet_2010_May_26_11_79.txt
p.A53T,"...sense mutations: c.145C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82...",54,134,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"... c.2975_2978delAG (p.Q994VfsX6), and c.4819C > T (p.R1607W). The frameshift mutation (c.2975_2978del...",69,132,BMC_Med_Genet_2010_May_26_11_79.txt
p.I515T,"...sponsible heterozygous mutation of the OTOF gene, p.I515T, was first found in two affected children ...",76,378,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"...in function[8]. The paternally inherited mutation p.R1607W is a missense mutation, and p.R1607W was ...",76,1082,BMC_Med_Genet_2010_May_26_11_79.txt
p.R702W,"...ne (NOD2, also known as CARD15), namely, p.G908R, p.R702W, and p.L1007fs [12-14]. These three varian...",22,209,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...ne (NOD2, also known as CARD15), namely, p.G908R, p.R702W, and p.L1007fs [12-14]. These three varian...",22,209,BMC_Med_Genet_2011_May_6_12_63.txt
p.R381Q,"...In the IL23R gene, a rare non-synonymous variant, p.R381Q, appears to be protective against developi...",22,658,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...f CD, such as 1.9 (95% CI: 1.1-3.2; p = 0.03) for p.R702W, 3.2 (95% CI: 2.2-4.9; p = 6.4*10-9) for p...",41,433,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"...ants (D' = 0.99, r2 = 0.17 between rs17221417 and p.G908R and D' = 0.97, r2 = 0.15 between rs2076756...",41,1110,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"...ants (D' = 0.99, r2 = 0.17 between rs17221417 and p.G908R and D' = 0.97, r2 = 0.15 between rs2076756...",41,1110,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,rs2066845	p.G908R	0.04	0.11	3.23 (2.15-4.85)	6.39*10-9,53,12,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...hich are specific to AJ individuals [28,29], with p.R702W, pG908R, and p.L1007fs accounting for 81% ...",158,726,BMC_Med_Genet_2011_May_6_12_63.txt
p.R2146Q,"...el compound heterozygous mutations, IVS11 + 1 and p.R2146Q, of MYO15A in one (SR903 family) of the 1...",10,67,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...). Of these, three variants in MYO15A (IVS11 + 1, p.R2146Q, and p.S3474G) were shared by both siblin...",67,187,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2140Q,"...s and their family. One variant, corresponding to p.R2140Q, was heterozygotic in the patient’s fathe...",67,545,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...mpound heterozygous mutations, IVS11 + 1G > A and p.R2146Q, are carried by both affected siblings, S...",69,243,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...the mother (SR-903 M), and the other heterozygous p.R2146Q mutation is from the father (SR-903 F). (...",69,411,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.T1321S,"...riants of known deafness genes (p.Q445R in GRHL2, p.T1321S in TECTA, and p.S2161F in MYO15A); only o...",71,84,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...ECTA, and p.S2161F in MYO15A); only one mutation, p.S2161F in MYO15A, was shared with an affected si...",71,147,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...d heterozygous mutations in MYO15A, IVS11 + 1 and p.R2146Q, were found in the SR-903 family, while a...",74,58,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,SR-903	Chr17:18049349	c.G6437A	p.R2146Q	Exon 29	MyTH4	0/409	Yes	0	0.99	-0.743,82,32,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,SR-903	Chr17:18049349	c.G6437A	p.R2146Q	Exon 29	MyTH4	0/409	Yes	0	0.99	-0.743,82,32,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.P2073S,"...yosin XVA, it has been reported that p.R2124Q and p.P2073S mutations located in the MyTH4 domain int...",109,773,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,...portant roles in the functions of myosin XVA. The p.R2146Q protein contains a prominent exposed hydr...,109,1219,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...FS and CEN [27]. Therefore, we speculate that the p.R2146Q mutation cripples the inter-MyTH4-FERM in...",109,1637,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...FS and CEN [27]. Therefore, we speculate that the p.R2146Q mutation cripples the inter-MyTH4-FERM in...",109,1637,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"...ted sibling. However, as the heterozygous variant p.G1220R was present in the Korean control exome d...",111,200,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,...for the hearing loss observed in this family: (1) p.G1220R contributes to the phenotype of the SR-28...,111,729,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,...for the hearing loss observed in this family: (1) p.G1220R contributes to the phenotype of the SR-28...,111,729,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.Pro240Leu,"...e two previously reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, as well as one novel...",10,154,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"... reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, as well as one novel mutation, p.Asn...",10,170,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...able S3). Two missense mutations, p.Pro240Leu and p.Glu1595Lys, were identified to be compound heter...",57,268,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...zygous mutations in the proband of SR-106 family. p.Pro240Leu was confirmed in the patient’s father ...,57,369,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...zygous mutations in the proband of SR-106 family. p.Pro240Leu was confirmed in the patient’s father ...,57,369,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...as detected. SR-209 family carried two mutations, p.Pro240Leu and p.Asn342Ser in the CDH23. Both var...",57,625,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...209 family carried two mutations, p.Pro240Leu and p.Asn342Ser in the CDH23. Both variants were also ...",57,641,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...riants were also found in an affected sibling and p.Pro240Leu was confirmed in the father by Sanger ...,57,724,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ent were heterozygous for p.Pro240Leu (2.15%) and p.Glu1595Lys (1.07%), respectively. Direct sequenc...",57,1001,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ent were heterozygous for p.Pro240Leu (2.15%) and p.Glu1595Lys (1.07%), respectively. Direct sequenc...",57,1001,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...tched negative controls (over 700). The mutations p.Asn342Ser and p.Glu1595Lys were absent in all co...,57,1138,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...and p.Glu1595Lys were absent in all controls, and p.Pro240Leu was detected in 2 (0.24%) of 818 Korea...",57,1200,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"... compound heterozygous mutations, p.Pro240Leu and p.Glu1595Lys, were identified. One heterozygous p....",59,232,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"... compound heterozygous mutations, p.Pro240Leu and p.Glu1595Lys, were identified. One heterozygous p....",59,232,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"... compound heterozygous mutations, p.Pro240Leu and p.Asn342Ser, were carried by an affected sibling a...",59,401,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...carried by an affected sibling and a heterozygous p.Pro240Leu mutation by the father. All pathogenic...,59,469,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...carried by an affected sibling and a heterozygous p.Pro240Leu mutation by the father. All pathogenic...,59,469,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...carried by an affected sibling and a heterozygous p.Pro240Leu mutation by the father. All pathogenic...,59,469,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"c.C719T	p.Pro240Leu	8	EC3	ㅡ	DAMAGING/0.02	0.999	−1	SR-106,...",75,9,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,c.G4783A	p.Glu1595Lys	36	EC15	DRE	DAMAGING/0	0.987	−1	SR-10...,77,10,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...g two previously reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, and one novel mutati...",85,97,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...ium binding below the threshold of detection. The p.Glu1595Lys mutation reduces the numbers of oxyge...,85,761,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...re wild-type and those of B and D are mutant. The p.Asn342Ser in EC3 and p.Glu1595Lys in EC15 are as...,87,459,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...of B and D are mutant. The p.Asn342Ser in EC3 and p.Glu1595Lys in EC15 are associated with highly co...,87,482,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala361Ser,2	Chr10:73377097	11	c.G1081T	p.Ala361Ser	.	.	1/30	Novel,100,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val424Met,3	Chr10:73405717	12	c.G1270A	p.Val424Met	rs2305207	.	1/30	rs2305207,101,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,4	Chr10:73405729	12	c.G1282A	p.Asp428Asn	rs188376296	1 (SR-68)	2/128	rs18837629...,102,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1437Gln,12	Chr10:73498355	33	c.G4310A	p.Arg1437Gln	rs56181447	5	8/30	[5],110,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1675Ile,15	Chr10:73537614	37	c.G5023A	p.Val1675Ile	rs17712523	8	7/30	[5],113,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1675Ile,15	Chr10:73537614	37	c.G5023A	p.Val1675Ile	rs17712523	8	7/30	[5],113,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1804Gln,16	Chr10:73544086	40	c.G5411A	p.Arg1804Gln	rs3802711	10	16/30	[5],114,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp1806Glu,17	Chr10:73544093	40	c.C5418G	p.Asp1806Glu	rs74145660	3	6/30	[5],115,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala3080Thr,25	Chr10:73571307	62	c.G9238A	p.Ala3080Thr	.	1 (SR-1016)	3/128	Novel,123,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...including the three (p.Pro240Leu, p.Asn342Ser and p.Glu1595Lys) detected in the present study, and f...",132,371,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"... one patient, respectively, were heterozygous for p.Pro240Leu and p.Glu1595Lys, and no other mutatio...",132,718,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...p.Glu1595Lys, and no other mutation was detected. p.Pro240Leu was reported in Japanese families with...",132,784,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...with ARNSHL caused by CDH23 mutations carried the p.Pro240Leu mutation and, additionally, two of 93 ...",132,1189,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...atients were heterozygous for the mutation. Thus, p.Pro240Leu is the most common cause of CDH23-asso...",132,1303,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...in. Of the three mutations, two (p.Glu1595Lys and p.Asn342Ser) affected highly conserved EC calcium-...",134,694,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ification, and dimerization of CDH23 [15,16]. The p.Glu1595Lys mutation may disrupt a conserved LDRE...",134,913,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,...uld not conclude that it is a causative mutation. p.Asp428Asn in SR-68 was also heterozygous. DNA sa...,136,405,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Phe2801Val,...enicity by segregation analysis. p.Val2283Ile and p.Phe2801Val were identified as compound heterozyg...,136,588,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.T5004I,".... Additionally, rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in three unr...",10,542,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.R5205H,"...e non-synonymous variant (rs150188026, c.G15614A, p.R5205H, MAF 0.018) is located in the Hemicentin ...",144,293,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.H5244Q,"...1; c.C15011T, p.T5004I, MAF 0.008, and c.C15732G, p.H5244Q, MAF 0.005) (Table 2 and Table 3). The ot...",144,655,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.V393A,"... DDHD domain containing 1 gene (DDHD1) (c.T1178C, p.V393A) and it causes an amino acid substitution ...",144,818,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.E1586D,"c.4758A > C	p.E1586D	Alagille syndrome 2, #610205",111,14,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.E1586D,"... [17]. Likewise, the NOTCH2 mutation(c.4758A > C, p.E1586D) identified in the index patient and his ...",118,440,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.His356Tyr,"...bases, resulting in only two homozygous variants; p.His356Tyr in OC90 and p.Gly243Arg in FBXO32. The...",64,579,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,"...glycine with arginine at amino acid position 243 (p.Gly243Arg, Fig. 5a). This missense mutation segr...",64,1368,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...rediction analysis for functional consequences of p.Gly243Ar,71,73,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...tilized to predict the functional consequences of p.Gly243Arg (c.727G > C). The Polyphen2 program pr...,72,150,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...a score of −3.624. SNPs&GO analysis predicted the p.Gly243Arg change as “disease” with a reliability...,72,398,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Arg242Cys,"...gous for a known pathogenic mutation (c.724C > T, p.Arg242Cys) and a mutation that has only been rep...",8,248,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...d once in the Portuguese population (c.521 T > C, p.Phe174Ser) [11]",23,246,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ealed the presence of two mutations: c.521 T > C (p.Phe174Ser), inherited from the mother and c.724C...",36,438,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ported in patients affected by SLOS [14, 15], the p.Phe174Ser has only been reported in one Portugue...",40,180,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ported in patients affected by SLOS [14, 15], the p.Phe174Ser has only been reported in one Portugue...",40,180,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ported in patients affected by SLOS [14, 15], the p.Phe174Ser has only been reported in one Portugue...",40,180,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...he c.521 T > C (p.Phe174Ser), and the c.724C > T (p.Arg242Cys) mutations. b In silico programs showi...",43,76,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,... mutations or with two mutations in loop 8–9. The p.Phe174Ser and the p.Arg242Cys mutations are in t...,48,530,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...e observations, it is possible to assume that the p.Phe174Ser variant is associated with mild forms ...",48,1260,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...able 1 Clinical features of patients carrying the p.Phe174Ser varian,48,1369,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg247Pro,"...resulting in an arginine-to-proline substitution (p.Arg247Pro), inherited by the mother; and a nonse...",28,198,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,"...9], displayed a mild form. The missense mutation (p.Arg247Pro) within the first HARP domain (HARP1),...",35,313,BMC_Nephrol_2014_Mar_3_15_41.txt
p.G2019S,... the Portuguese population the LRRK2 c.6055G > A; p.G2019S mutation has one of the highest frequenci...,6,204,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,We had previously shown that the c.6055G > A; p.G2019S mutation in LRRK2 is common in Portuguese...,22,47,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...iously been found to carry the LRRK2 c.6055G > A; p.G2019S mutation (n = 11). This selection led to ...,25,1159,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...amples tested positive for the LRRK2 c.6055G > A; p.G2019S mutation, sample S12 and sample S7. Notab...",67,56,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...vious report [15] we showed that the c.6055G > A; p.G2019S LRRK2 mutation underlies about 6% of late...,76,61,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...opulation. While we did not find any c.6055G > A; p.G2019S carriers in the 20 late-onset patients st...,76,190,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...opulation. While we did not find any c.6055G > A; p.G2019S carriers in the 20 late-onset patients st...,76,190,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...tients studied here, we did identify c.6055G > A; p.G2019S in 2 of 46 early-onset cases. One of thes...",76,281,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...r of mutations: the frequency of the c.6055G > A; p.G2019S is one of the highest in Europe, and in t...",85,208,BMC_Neurol_2008_Jan_22_8_1.txt
p.E64D,...llnik B Tong L Kruger R Riess O  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson di...,114,189,BMC_Neurol_2008_Jan_22_8_1.txt
p.E64D,...llnik B Tong L Kruger R Riess O  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson di...,114,189,BMC_Neurol_2008_Jan_22_8_1.txt
p.E64D,...llnik B Tong L Kruger R Riess O  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson di...,114,189,BMC_Neurol_2008_Jan_22_8_1.txt
p.E64D,...llnik B Tong L Kruger R Riess O  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson di...,114,189,BMC_Neurol_2008_Jan_22_8_1.txt
p.Asp511Asn,"...on 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in families MCP35 and MCP3, respectiv...",37,679,BMC_Neurol_2011_Oct_1_11_119.txt
p.R416W,...rginine to tryptophan at amino acid position 416 (p.R416W). Her daughter’s genomic DNA showed the sa...,48,294,BMC_Neurol_2016_Nov_4_16_211.txt
p.V87G,"...and spinal cord, Periventricular rim	c. 274 T > G	p.V87G",80,102,BMC_Neurol_2016_Nov_4_16_211.txt
p.S398Y,... medulla oblongata and cervical cord	c. 1193C > A	p.S398Y,89,128,BMC_Neurol_2016_Nov_4_16_211.txt
p.Gly12Asp,...ld-type result for sample 14 which was actually a p.Gly12Asp (G12D) mutation. While this sample was ...,90,79,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,"... re-testing. Laboratory #2 found the same result (p.Gly12Asp) in the second set of slides, but there...",92,478,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Leu1077Pro,The p.Leu1077Pro CFTR mutation was firstly described i...,4,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...tation. Although it is typical of Southern Italy, p.Leu1077Pro is not included in the mutation panel...",4,272,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...atients. 4 patients who were heterozygous for the p.Leu1077Pro mutation were included in the study,7,106,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,We found that the p.Leu1077Pro CFTR mutation is associated with a cl...,12,19,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,... Bozon et al. [8] firstly found evidence that the p.Leu1077Pro was associated with a pancreatic suff...,23,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,...tation in the second allele while one carried the p.Asn1303Lys (N1303K) mutation. The group included...,33,585,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,1	M	7 yrs	14.57 (Underweight)	Birth	p.Phe508del/p.Leu1077Pro	112	84/43,40,49,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,3	M	12	19.63 (Normal weight)	Birth	p.Phe508del/p.Leu1077Pro	97	181/100,42,48,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,3	M	12	19.63 (Normal weight)	Birth	p.Phe508del/p.Leu1077Pro	97	181/100,42,48,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...irth by sweat test. All of them had a p.Phe508del/p.Leu1077Pro genotype,103,230,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...irth by sweat test. All of them had a p.Phe508del/p.Leu1077Pro genotype,103,230,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Arg528Cys,"...nced, and a novel missense mutation, c.1582C > T (p.Arg528Cys), in CACNA1S was detected. Detection o...",7,977,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Gly,"...528th codon of CACNA1S, including p.Arg528His and p.Arg528Gly [5, 13]. The arginine residue encoded ...",42,1048,BMC_Urol_2014_Nov_28_14_96.txt
p.R258S,"...ed in the serine/threonine kinase domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375...",29,2781,Bone_Res_2015_Apr_14_3_15005.txt
p.G356D,"...se domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figure 2 shows that the ...",29,2812,Bone_Res_2015_Apr_14_3_15005.txt
p.G356D,"...se domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figure 2 shows that the ...",29,2812,Bone_Res_2015_Apr_14_3_15005.txt
p.Thr52Pro,"...giectasia type 2 with a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL1 gene Neurol Clin N...",240,149,Bone_Res_2015_Apr_14_3_15005.txt
p.V600E,"...id 600 within the BRAF gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the ...",43,385,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600D,"...F gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the BRAF gene, but does n...",43,406,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600D,"...F gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the BRAF gene, but does n...",43,406,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"... HT29 cell line, known to be heterozygous for the p.V600E mutation. Human genomic DNA (Roche, Basel,...",49,120,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,"...plex g.1798-1799GT>AA changes resulting in a BRAF p.V600K alteration, rather than the more common p....",74,521,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,...med these mutations to be p.V600E in 42 cases and p.V600K in 3 cases. A further tumour sample was sh...,76,182,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.Gly12Val,...ion melting analysis was able to discriminate the p.Gly12Val (H441) and the p.Gly13Asp (HCT116) DNA ...,54,63,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...ion melting analysis was able to discriminate the p.Gly12Val (H441) and the p.Gly13Asp (HCT116) DNA ...,54,63,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...3%. We were able to detect as little as 3% of MUT p.Gly12Val DNA in a WT background,54,429,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...3%. We were able to detect as little as 3% of MUT p.Gly12Val DNA in a WT background,54,429,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Asp,... showing aberrant melting curves (p.Gly12Val n=2; p.Gly12Asp n=1 and p.Gly13Asp n=1),56,824,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,...elting curves (p.Gly12Val n=2; p.Gly12Asp n=1 and p.Gly13Asp n=1),56,843,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...The horizontal line indicates WT control, and the p.Gly13Asp p.Gly12Val labelled lines indicate in d...",83,126,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Asp,"...he p.Gly13Asp HRMA-mutated sample, the second the p.Gly12Asp HRMA-mutated samples and the third and ...",87,523,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...mutated samples and the third and fourth show two p.Gly12Val HRMA-mutated samples,87,589,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...mutated samples and the third and fourth show two p.Gly12Val HRMA-mutated samples,87,589,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly2891Asp,...ells from patient A-T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncated ATM associated wit...,68,452,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...scured by the full-length ATM from the c.8672G>A (p.Gly2891Asp) allele (Figure 5, compare lanes 5 an...",68,634,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...in cells of patient A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,327,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...in cells of patient A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,327,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ant proteins were low, although expression of the p.Gly2891Asp mutant protein was significantly high...",72,581,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ant proteins were low, although expression of the p.Gly2891Asp mutant protein was significantly high...",72,581,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,"..., were homozygous for the ATM mutation c.7271T>G (p.Val2424Gly). The mutation was also identified in...",85,1052,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,"..., were homozygous for the ATM mutation c.7271T>G (p.Val2424Gly). The mutation was also identified in...",85,1052,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2716Ala,"...s et al, 2011). Only one ATM mutation (c.8147T>C (p.Val2716Ala)), which also has some ATM kinase act...",87,697,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.His2555Gln,...mutation (and also null mutation c.7665delinsGTGA;p.His2555Gln ins*) is slightly truncated (lanes 7 ...,112,564,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Arg3047X,...M from c.2T>C in patient AT187 is obscured by the p.Arg3047X (c.9139C>T) mutant protein (lanes 9 and...,112,702,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,... from c.1A>G in patient A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutant protein (lanes 5 a...,112,828,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Arg3047X,...ient A-T187 with a c.2T>C mutation and c.9139C>T (p.Arg3047X). (B) Histogram of relative levels of A...,112,1433,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Arg3047X,...ient A-T187 with a c.2T>C mutation and c.9139C>T (p.Arg3047X). (B) Histogram of relative levels of A...,112,1433,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,Figure 6 The p.Gly2891Asp protein has residual ATM kinase activ...,114,14,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...relative to the wt protein (pTAM2, lane 2) or the p.Gly2891Asp protein (8672G>A, lane 5). No ATM pro...",114,481,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ble to that of wt ATM (pTAM2, lanes 1 and 7). The p.Gly2891Asp (8672G>A) protein autophosphorylated ...",114,1326,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.H1047R,GLC82	PIK3CA	p.H1047R	R,128,14,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.E545K,H460	PIK3CA	p.E545K	R,129,13,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Q61H, 	KRAS	p.Q61H	 ,130,8,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.E545K, 	PIK3CA	p.E545K	 ,136,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.E545K, 	PIK3CA	p.E545K	 ,136,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12V,SW620	KRAS	p.G12V	S,143,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12V,SW620	KRAS	p.G12V	S,143,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Arg94X,"...carrying a heterozygous RPS19 mutation (c.280C>T, p.Arg94X), and healthy control samples were from o...",77,289,Br_J_Haematol_2015_Nov_25_171(4)_517-529.txt
p.Gly1961Glu,ARDM-135	42	24	0.4	0.6	STGD	c.5882G>A(42)	p.Gly1961Glu	c.1029_1030insT(8)	p.Asn344fsX	NP,76,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala762Glu,....16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762Glu	Yes,77,71,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-162	50	16	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	Yes,80,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1108His,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,45,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,...4) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,90,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,...	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Tyr	Yes,99,70,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Glu433Glu,10	c.1299A>G	p.Glu433Glu	This study,118,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val552Ile,12	c.1654G>A	p.Val552Ile	This study,119,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1315X,"...ations: three were nonsense mutations (p.Gln234X, p.Gln1315X “de novo” and p.Gln2187X); two splice-s...",130,102,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,"...wo previously described mutations [c.4537delC and p.Trp1724Cys], not included in the array by the ti...",130,870,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"...el ABCA4 variants detected in this screening, the p.Arg1129Leu mutation was found to be the most fre...",138,117,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...longing to family ARDM-197, the chip detected the p.Ala1598Asp mutation. However, dHPLC and direct s...",147,176,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...longing to family ARDM-197, the chip detected the p.Ala1598Asp mutation. However, dHPLC and direct s...",147,176,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"...4–25 years. Moreover, both patients presented the p.Gly1961Glu mutation, which is considered an alle...",154,663,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"...n previous studies of the Spanish population, the p.Arg1129Leu variant was identified as a major mut...",167,196,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,...6 The p.Cys2137Tyr change in combination with the p.Arg1129Leu allele produced a CRD phenotype. Ther...,167,1006,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"... prevalent missense disease-associated allele was p.Gly1961Glu (3/62; 4.8%), presenting a lower freq...",169,66,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"... prevalent missense disease-associated allele was p.Gly1961Glu (3/62; 4.8%), presenting a lower freq...",169,66,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val1433Ile,"...enotypes respectively, we identified the missense p.Val1433Ile mutation, located in the second trans...",179,104,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val374Rfs,...Exome	Exon 6 to 8 duplication; c.836-?_1119+?dup; p.Val374Rfs*8	Exon 6 to 8 duplication; c.836-?_111...,103,70,Brain_2013_Jan_3_136(1)_269-281.txt
p.Val374Rfs,...Exome	Exon 6 to 8 duplication; c.836-?_1119+?dup; p.Val374Rfs*8	Exon 6 to 8 duplication; c.836-?_111...,103,70,Brain_2013_Jan_3_136(1)_269-281.txt
p.Val374Rfs,...Exome	Exon 6 to 8 duplication; c.836-?_1119+?dup; p.Val374Rfs*8	Exon 6 to 8 duplication; c.836-?_111...,103,70,Brain_2013_Jan_3_136(1)_269-281.txt
p.E50K,"... (M) + c.[148G> A];c.[364-1G>A]a (P)	p.R95H (M) + p.E50K;Splice errors a (P)	30 min	Mills et al., 20...",47,71,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.P213S,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel,50,33,Brain_2014_May_18_137(5)_1350-1360.txt
p.P213S,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel,50,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,47,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,47,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"9	2 y	c.[98A>T] + c.[998A>T]	p.D33V + p.D33V	3 w	Hoffmann et al., 2007",55,31,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"10	23 y	c.[98A>T] + c.[358G>A]	p.D33V + p.E120K	2 m	Hoffmann et al., 2007 + novel...",56,33,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,...1	21 y	c.[98A>T] (P) + c.264-21_ 264-1delinsC (M)	p.D33V (P) + Splice errors (M)	3 h	Hoffmann et al....,57,53,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,"...1 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	14 d	Hoffmann et al., 2007 + no...",58,56,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,... y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,56,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,... c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,82,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,... c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	10 h	Novel,61,82,Brain_2014_May_18_137(5)_1350-1360.txt
p.Leu772X,...g a TAG stop codon at the site of the frameshift (p.Leu772X) (Fig. 2B). Segregation of the mutation ...,77,785,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,"... reduced amount of full length mRNA, carrying the p.Leu772X in the lymphocytes of Patient 1 (Fig. 2D...",81,745,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,...n a frameshift and incorporation of a stop codon (p.Leu772X). Our results confirm an autosomal reces...,92,328,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.E286Q,TP53	5	(10)	17	GAA>CAA/p.E286Q	X	NA	X	Missense	Transversion	1.00	 	Yes,129,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.M246T, 	 	 	 	ATG>ACG/p.M246T	X	NA	X	Missense	Transition	1.00	 	Yes,130,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.M246T, 	 	 	 	ATG>ACG/p.M246T	X	NA	X	Missense	Transition	1.00	 	Yes,130,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E68K, 	 	 	 	GAG>AAG/p.E68K	NA	NA	X	Missense	Transition	0.09	 	ND,131,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R2605Q, 	 	 	 	CGG>CAG/p.R2605Q	X	X	X	Missense	Transition	1.00	 	No cover...,135,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R2605Q, 	 	 	 	CGG>CAG/p.R2605Q	X	X	X	Missense	Transition	1.00	 	No cover...,135,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R2605Q, 	 	 	 	CGG>CAG/p.R2605Q	X	X	X	Missense	Transition	1.00	 	No cover...,135,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.F303L,TRMT5	2	(4)	14	TTT>CTT/p.F303L	X	X	X	Missense	Transition	0.04	 	Yes,142,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.F303L,TRMT5	2	(4)	14	TTT>CTT/p.F303L	X	X	X	Missense	Transition	0.04	 	Yes,142,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E152Q, 	 	 	 	GAG>CAG/p.E152Q	NA	X	X	Missense	Transversion	0.03	 	ND,143,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E152Q, 	 	 	 	GAG>CAG/p.E152Q	NA	X	X	Missense	Transversion	0.03	 	ND,143,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.L540V,PIK3CA	2	(4)	3	CTC>GTC/p.L540V	NA	NA	X	Missense	Transversion	0.99	 	ND,144,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.L540V,PIK3CA	2	(4)	3	CTC>GTC/p.L540V	NA	NA	X	Missense	Transversion	0.99	 	ND,144,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Q546P, 	 	 	 	CAG>CCG/p.Q546P	NA	NA	X	Missense	Transversion	1.00	 	ND,145,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.P292S, 	 	 	 	CCT>TCT/p.P292S	NA	NA	X	Missense	Transition	0.34	 	ND,147,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.P77S,BBS9	1	(2)	7	CCA>TCA/p.P77S	X	X	X	Missense	Transition	1.00	 	No coverag...,150,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.A406T,EIF2B5	1	(2)	3	GCA>ACA/p.A406T	X	*	X	Missense	Transition	0.05	 	Yes,152,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.A406T,EIF2B5	1	(2)	3	GCA>ACA/p.A406T	X	*	X	Missense	Transition	0.05	 	Yes,152,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.A659P,FMN2	1	(2)	1	GCT>CCT/p.A659P	X	*	*	Missense	Transversion	0.74	 	No cove...,153,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.N167S,PCF11	1	(2)	11	AAT>AGT/p.N167S	X	X	X	Missense	Transition	0.02	 	Yes,156,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.K279N,PLCL1	1	(2)	2	AAG>AAT/p.K279N	X	X	X	Missense	Transversion	0.98	 	No cove...,157,23,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.D339A,ST7L	1	(2)	1	GAT>GCT/p.D339A	X	X	X	Missense	Transversion	1.00	 	Yes,161,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.D339A,ST7L	1	(2)	1	GAT>GCT/p.D339A	X	X	X	Missense	Transversion	1.00	 	Yes,161,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.D339A,ST7L	1	(2)	1	GAT>GCT/p.D339A	X	X	X	Missense	Transversion	1.00	 	Yes,161,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.V600E,...otein is the murine counterpart of the human BRAF p.V600E oncogenic variant. V637 is encoded in Braf...,129,92,Cancer_Cell_2013_Jul_8_24(1)_15-29.txt
p.V600E,...ical staining for BRAFV600E mutation. We detected p.V600E-mutated cells in the perivascular region o...,12,970,Case_Rep_Dermatol_2015_Sep_12_7(3)_237-240.txt
p.Ser459Ter,"c.1376C>G, p.Ser459Ter",52,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Trp897Ter,"c.2691G>A, p.Trp897Ter",55,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Trp1689X,"c5067G>A, p.Trp1689X",71,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Glu693X,"c.2076_2077InsT, p.Glu693X",72,18,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Glu693X,"c.2076_2077InsT, p.Glu693X",72,18,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Lys1450X,"c.4975A>T, p.Lys1450X",75,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Y328X,"c.984C>A, p.Y328X	Ahmad et al., 2007 [15]",85,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg523Ter,"c.1567C>T, p.Arg523Ter	Kurban et al., 2010 [17]",96,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.L541P,"... in the ABCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,670,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.L541P,"... in the ABCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,670,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.A1038V,"...of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous variant in exon 2 of...",29,619,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.K249N,...ygous variant in exon 6 of the RGR gene (c.747A>T p.K249N). Based on previous knowledge of these thr...,29,772,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.N306I,"....917 A>T), leading to an amino-acid substitution (p.N306I), may have a role in EV.4, 5 It has also b...",7,723,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.N306I,...th decision. We also analyzed the effect of EVER2 p.N306I polymorphism on these mechanisms,13,266,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.N306I,"...ent of an asparagine with an isoleucine residue, (p.N306I), has been associated with β-HPV persisten...",62,329,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.N306I,"...ent of an asparagine with an isoleucine residue, (p.N306I), has been associated with β-HPV persisten...",62,329,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.N306I,"...ffectively than EVER2 N306 (Figure 6d). Thus, the p.N306I polymorphism was sufficient to modulate th...",64,785,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.T172Vfs,(D) The protein change p.T172Vfs*51 is predicted to generate a 223 amino ...,99,24,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
p.R1113X,...in the rod domain of DSP. Two of these mutations (p.R1113X and p.R1934X) affect all three isoforms; ...,70,102,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1255K,"...R1934X) affect all three isoforms; another three (p.R1255K, p.R1267X and p.N1324fsZ23) affect DSPI a...",70,167,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.L1654P,"...fect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect only DSPI while leav...",70,256,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,"... DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect only DSPI while leaving DSPIa and...",70,269,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,"...the single nonsense mutation affecting only DSPI, p.Q1446X, causes recessive cardio-cutaneous diseas...",70,508,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,"...the single nonsense mutation affecting only DSPI, p.Q1446X, causes recessive cardio-cutaneous diseas...",70,508,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,"...se when inherited with another nonsense mutation, p.Q673X, which affects all isoforms (Asimaki et al...",70,607,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,"...neous disease (Uzumcu et al. 2006). In this case (p.R1267X/p.R1267X), the cutaneous phenotype is rel...",70,1111,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,...enotype is relatively mild (compared with p.Q673X/p.Q1446X) presumably because of normal DSPII expre...,70,1197,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,...diac phenotype might be considered more severe in p.R1267X/p.R1267X with cardiac failure at age 4 ye...,70,1421,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.S358L,P 13 — Deleterious effects of theTMEM43mutation p.S358L found in a German family with arrhythmogen...,1137,49,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.S358L,...clearly been demonstrated. The female carriers of p.S358L presented a rather mild arrhythmogenic phe...,1153,574,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.R649X,...ate founder mutations for RPGRIP1L (c. 1945 C > T p.R649X) and CC2D2A (c. 3540delA p.R1180SfsX6). Tw...,13,288,Cilia_2012_Oct_1_1_18.txt
p.T615P,"...PGRIP1L	RPGRIP1L	JBTS7, NPHP8	[6]	Mixed European -p.T615P	[11]",30,65,Cilia_2012_Oct_1_1_18.txt
p.R441C,...ritish	TMEM67	c. 1392 C > T p.R441C	c. 1392 C > T p.R441C	 	+	 	+	 	 	some dialation of pancreatic d...,73,56,Cilia_2012_Oct_1_1_18.txt
p.Q376P,P95	Pakistani	TMEM67	c. 1127A > C p.Q376P	c. 1127A > C p.Q376P	+	+	 	+	 	 	 ,76,35,Cilia_2012_Oct_1_1_18.txt
p.R85X,162 + 163	British	TMEM216	c. 253 C > T p.R85X†	c. 253 C > T p.R85X†	+	+	+	+	+	 	facial dy...,96,40,Cilia_2012_Oct_1_1_18.txt
p.R85X,162 + 163	British	TMEM216	c. 253 C > T p.R85X†	c. 253 C > T p.R85X†	+	+	+	+	+	 	facial dy...,96,40,Cilia_2012_Oct_1_1_18.txt
p.P476S,176 + 177	British	TMEM67	c. 1426 C > T p.P476S††	c. 2440–3 C > A	+	+	+	+	 	 	flexion defo...,97,40,Cilia_2012_Oct_1_1_18.txt
p.M252T,83527	Norwegian-Indian	TMEM67	c. 755 T > C p.M252T	c. 2882 C > A p.S961YN	+	+	 	+	 	 	 ,100,44,Cilia_2012_Oct_1_1_18.txt
p.V673A,"... + b	 	TMEM67	c. 1351 C > T p.R451X	c. 2108 T > A p.V673A	 	+	 	+	 	 	mental retardation, retinal co...",101,57,Cilia_2012_Oct_1_1_18.txt
p.Q662X,"...	CEP290	c. 679_680delGA p.E227SfsX2	c. 1984 C > T p.Q662X	 	+	 	+	 	+	abnormal cerebellum, wide nasa...",102,66,Cilia_2012_Oct_1_1_18.txt
p.Q662X,"...	CEP290	c. 679_680delGA p.E227SfsX2	c. 1984 C > T p.Q662X	 	+	 	+	 	+	abnormal cerebellum, wide nasa...",102,66,Cilia_2012_Oct_1_1_18.txt
p.R751X,153 + 154	French	CEP290a	c. 2251 C > T p.R751X	c. 4864insTdelCG p.R1622FfsX9N	 	+	 	 	 	 ...,103,40,Cilia_2012_Oct_1_1_18.txt
p.R751X,153 + 154	French	CEP290a	c. 2251 C > T p.R751X	c. 4864insTdelCG p.R1622FfsX9N	 	+	 	 	 	 ...,103,40,Cilia_2012_Oct_1_1_18.txt
p.H610P,166	British	RPGRIP1L	c. 1829A > C p.H610P	c. 721_724delAATG p.N241fsX25	+	+	+	 	 	+	...,104,35,Cilia_2012_Oct_1_1_18.txt
p.W1182R,128	British	CC2D2A	c. 3544 T > C p.W1182R	c. 3774_3774insT p.E1259fsX1	 	 	 	 	 	 	...,105,34,Cilia_2012_Oct_1_1_18.txt
p.R85X,"....D1264N, ** in cis with c. 3893 T > A p.V1298D; † p.R85X allele was present in 2/10,266 European/Afr...",109,241,Cilia_2012_Oct_1_1_18.txt
p.P476S,"...ls in the Exome Variant Server (EVS) database, †† p.P476S allele present in 6/7,012 European/America...",109,361,Cilia_2012_Oct_1_1_18.txt
p.R208X,"... in 6/7,012 European/American controls (EVS), ††† p.R208X allele present in 8/7,012 European/America...",109,433,Cilia_2012_Oct_1_1_18.txt
p.R208X,"... in 6/7,012 European/American controls (EVS), ††† p.R208X allele present in 8/7,012 European/America...",109,433,Cilia_2012_Oct_1_1_18.txt
p.L63R,...ative pathogenic mutation in TMEM216 c. 188 T > G p.L63R,109,850,Cilia_2012_Oct_1_1_18.txt
p.R549C,...178 has the single heterozygous missense mutation p.R549C that is likely to be pathogenic because th...,113,659,Cilia_2012_Oct_1_1_18.txt
p.R441L,"...e mutation affecting the same amino-acid residue, p.R441L, has also been reported previously in an M...",122,65,Cilia_2012_Oct_1_1_18.txt
p.R441L,"...e mutation affecting the same amino-acid residue, p.R441L, has also been reported previously in an M...",122,65,Cilia_2012_Oct_1_1_18.txt
p.M252T,1c). The heterozygous missense mutation p.M252T accounted for 30% of identified alleles in...,130,41,Cilia_2012_Oct_1_1_18.txt
p.M252T,1c). The heterozygous missense mutation p.M252T accounted for 30% of identified alleles in...,130,41,Cilia_2012_Oct_1_1_18.txt
p.M252T,"...nsanguinity, testing the TMEM67 missense mutation p.M252T may be useful, but the most common mutatio...",138,1170,Cilia_2012_Oct_1_1_18.txt
p.R440Q,"...rthermore, some MKS mutations, such as the TMEM67 p.R440Q missense mutation, are allelic for Joubert...",138,1456,Cilia_2012_Oct_1_1_18.txt
p.R248G,"...dy showed a missense mutation in BMPR2, c.742A>G (p.R248G) located in exon six, and another mutation...",33,163,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.R248G,"...dy showed a missense mutation in BMPR2, c.742A>G (p.R248G) located in exon six, and another mutation...",33,163,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.D254N,"...on six, and another mutation in ACVRL1, c.760G>A (p.D254N. These mutations are described for the fir...",33,235,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.D254N,"...on six, and another mutation in ACVRL1, c.760G>A (p.D254N. These mutations are described for the fir...",33,235,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.D254N,"...on six, and another mutation in ACVRL1, c.760G>A (p.D254N. These mutations are described for the fir...",33,235,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.Cys1298Phe,"...e replacement of a cysteine with a phenylalanine (p.Cys1298Phe), causing the loose of a cysteine in ...",52,744,Clin_Case_Rep_2016_Sep_28_4(11)_1045-1048.txt
p.Cys1298Phe,"...e replacement of a cysteine with a phenylalanine (p.Cys1298Phe), causing the loose of a cysteine in ...",52,744,Clin_Case_Rep_2016_Sep_28_4(11)_1045-1048.txt
p.Cys134Trp,...losa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402>CG) PLoS One 2010 5 e8789 20098...,80,186,Clin_Exp_Reprod_Med_2016_Mar_31_43(1)_1-8.txt
p.E632X,NR3C2 mutation (c.1894G>T; p.E632X). The arrow indicates th,50,28,Clin_Pediatr_Endocrinol_2016_Oct_18_25(4)_135-138.txt
p.E632X,We identified a novel mutation (p.E632X) in NR3C2 in a Japanese famil,69,33,Clin_Pediatr_Endocrinol_2016_Oct_18_25(4)_135-138.txt
p.R1267X,...ng both isoforms. A homozygous nonsense mutation (p.R1267X) in the DSP-1 specific region of exon 23 ...,72,287,Clin_Res_Cardiol_2011_Dec_26_100(12)_1087-1093.txt
p.R1267X,...ng both isoforms. A homozygous nonsense mutation (p.R1267X) in the DSP-1 specific region of exon 23 ...,72,287,Clin_Res_Cardiol_2011_Dec_26_100(12)_1087-1093.txt
p.Ala944Thr,p.Ala944Thr	One copy	One copy	Zero copies	Missense...,51,1,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
p.Gly1324Ser,...the von Willebrand disease (vWD) type 2M mutation p.Gly1324Ser has been recently published in the Jo...,3,1577,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...ction, quality control and crystallization of the p.Gly1324Ser vWD variant of the A1 domain of VWF. ...",5,93,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...ction, quality control and crystallization of the p.Gly1324Ser vWD variant of the A1 domain of VWF. ...",5,93,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...p.Gly1324Ser vWD variant of the A1 domain of VWF. p.Gly1324Ser A1 was expressed in Escherichia coli ...,5,143,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...hy and crystallized. The crystal structure of the p.Gly1324Ser mutant of the A1 domain is deposited ...,5,393,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...hy and crystallized. The crystal structure of the p.Gly1324Ser mutant of the A1 domain is deposited ...,5,393,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,Experimental features	The crystal structure of p.Gly1324Ser was determined via X-ray crystallogra...,16,48,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,Experimental features	The crystal structure of p.Gly1324Ser was determined via X-ray crystallogra...,16,48,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...ed process for expression and purification of the p.Gly1324Ser A1 domain is described,23,61,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...1 domain containing the loss-of-function mutation p.Gly1324Ser. Furthermore, the data shows quality ...",34,142,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...1 domain containing the loss-of-function mutation p.Gly1324Ser. Furthermore, the data shows quality ...",34,142,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,2.1 Production of p.Gly1324Ser A1 in Escherichia col,37,19,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,2.1 Production of p.Gly1324Ser A1 in Escherichia col,37,19,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...1 domain containing the loss-of-function mutation p.Gly1324Ser was expressed in E. coli M15 cells as...,38,74,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,p.Gly1324Ser A1 was shipped on ice overnight for c...,56,1,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...ear aggregates and then concentrated to 20 mg/mL. p.Gly1324Ser A1 was screened against the Wizard Cl...,56,175,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,Fig. 1Fig. 2 Photograph of the VWF A1 p.Gly1324Ser crystals taken with a polarized light...,74,39,Data_Brief_2016_May_10_7_1700-1706.txt
p.E66Q,...i M  Yokoseki A  Kuwano R  Narita I   Role of the p.E66Q variant of GLA in the progression of chroni...,138,106,Dement_Geriatr_Cogn_Dis_Extra_2016_Jan_19_6(1)_10-19.txt
p.Gly68Asp,"...R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248L...",34,136,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Ile225Met,"... K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly...",34,203,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Gly261Arg,"...C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of these s...",34,248,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Asp217Asn,"...1R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of these six mutations, five had bee...",34,274,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.N88S,"...pe caused by heterozygous mutations in BSCL2 gene p.N88S in Austrian and German families, these pati...",88,280,Diagn_Pathol_2013_May_9_8_78.txt
p.N88S,"...pe caused by heterozygous mutations in BSCL2 gene p.N88S in Austrian and German families, these pati...",88,280,Diagn_Pathol_2013_May_9_8_78.txt
p.Ser90Trp,"2	c.269C>G	p.Ser90Trp	dHMN, CMT2	[22]",101,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Tyr187Cys,4	c.560A>G	p.Tyr187Cys	CGL2	[15],104,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Ala212Pro,"5	c.634G>C	p.Ala212Pro	CGL2	[5,25]",106,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Ala212Pro,"5	c.634G>C	p.Ala212Pro	CGL2	[5,25]",106,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Arg275X,7	c.823C>T	p.Arg275X	CGL2	[31],108,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Arg275X,7	c.823C>T	p.Arg275X	CGL2	[31],108,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Gln391X,10	c.1171C>T	p.Gln391X	CGL2	[27],109,14,Diagn_Pathol_2013_May_9_8_78.txt
p.T790M,7	M	exon19 (p.E746-S752) and exon20 (p.T790M)	SD	First scan	E−	NA	NA	NA	Aberrant arteri...,91,38,EJNMMI_Res_2016_Feb_9_6_10.txt
p.G719S,8	M	exon18 (p.G719S) and exon20 (p.S768I)	SD	First scan	E−	Yes...,95,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.P753Q,10	F	exon19 (p.delL747-S752 and p.P753Q) and exon20 (p.T790M)	Slow PD	First scan	E...,101,33,EJNMMI_Res_2016_Feb_9_6_10.txt
p.P753Q,10	F	exon19 (p.delL747-S752 and p.P753Q) and exon20 (p.T790M)	Slow PD	First scan	E...,101,33,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,...F	exon19 (p.delL747-S752 and p.P753Q) and exon20 (p.T790M)	Slow PD	First scan	E+	Yes	Yes	NA	No [15O]...,101,54,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,13	F	exon21 (p.L858R) and exon20 (p.T790M)	Slow PD	First scan	E−	Yes	Yes	Yes,110,35,EJNMMI_Res_2016_Feb_9_6_10.txt
p.N34S,...eatitis and its association with CTRC and SPINK1 (p.N34S) variants Eur J Gastroenterol Hepatol 2009 ...,242,149,EMBO_Mol_Med_2011_Aug_3(8)_451-464.txt
p.N34S,...eatitis and its association with CTRC and SPINK1 (p.N34S) variants Eur J Gastroenterol Hepatol 2009 ...,242,149,EMBO_Mol_Med_2011_Aug_3(8)_451-464.txt
p.N34S,...eatitis and its association with CTRC and SPINK1 (p.N34S) variants Eur J Gastroenterol Hepatol 2009 ...,242,149,EMBO_Mol_Med_2011_Aug_3(8)_451-464.txt
p.A734E,"...ng-defective, recessive sticky missense mutation (p.A734E) in AARS (alanyl-tRNA synthetase) in a mou...",38,479,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.N71Y,"...w pathological mutations were identified in AARS: p.N71Y, p.E778A and p.D893N (Lin et al, 2011; McLa...",38,1387,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.E778A,"...ogical mutations were identified in AARS: p.N71Y, p.E778A and p.D893N (Lin et al, 2011; McLaughlin e...",38,1395,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.D893N,"...ions were identified in AARS: p.N71Y, p.E778A and p.D893N (Lin et al, 2011; McLaughlin et al, 2012; ...",38,1407,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.D893N,"...ions were identified in AARS: p.N71Y, p.E778A and p.D893N (Lin et al, 2011; McLaughlin et al, 2012; ...",38,1407,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.F52L,"...blastic anemia. A pathogenic, recessive mutation (p.F52L) in the YARS2 gene (mitochondrial tyrosyl-t...",100,328,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.L200V,"... synthetase) at two highly conserved amino acids (p.L200V and p.V368L), and an alternative splice-de...",103,367,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.V368L,"... at two highly conserved amino acids (p.L200V and p.V368L), and an alternative splice-derived deleti...",103,379,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.V368L,"... at two highly conserved amino acids (p.L200V and p.V368L), and an alternative splice-derived deleti...",103,379,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.D390G,"...scle specimens. A pathogenic, recessive mutation (p.D390G) in the enzymatic active site of SARS2 (mi...",106,562,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.D390G,"...scle specimens. A pathogenic, recessive mutation (p.D390G) in the enzymatic active site of SARS2 (mi...",106,562,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.R592W,"...e, was sequenced. A homozygous missense mutation (p.R592W) was identified in AARS2 (mitochondrial al...",109,306,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.R592W,"...e, was sequenced. A homozygous missense mutation (p.R592W) was identified in AARS2 (mitochondrial al...",109,306,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.Arg85Cys,...ted patients (two males) and two PROKR2 variants (p.Arg85Cys and p.Arg248Glu) in two unrelated femal...,3,2251,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,...wo males) and two PROKR2 variants (p.Arg85Cys and p.Arg248Glu) in two unrelated female patients. Fiv...,3,2266,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,...wo males) and two PROKR2 variants (p.Arg85Cys and p.Arg248Glu) in two unrelated female patients. Fiv...,3,2266,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,...s from previous functional studies indicated that p.Arg85Cys moderately compromises receptor signall...,3,2714,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,+ pathways while p.Arg248Glu decreases calcium mobilization but has...,4,18,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"Three missense variants, p.Ser107Leu, p.Arg448Trp and p.Pro772Ser, were ide...",47,26,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"...tation Taster, SIFT and Polyphen-2 tools, whereas p.Ser107Leu and p.Pro772Ser were predicted to be d...",47,343,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ing Project (ESP6500). To date, the FGFR1 variant p.Arg448Trp has not been described in population d...",54,479,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ing Project (ESP6500). To date, the FGFR1 variant p.Arg448Trp has not been described in population d...",54,479,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,The PROKR2 variant p.Arg85Cys has been described in the databases of ...,56,20,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,p.Ser107Leu varian,59,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,p.Arg448Trp varian,62,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,p.Arg448Trp varian,62,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,We identified the FGFR1 variant p.Pro772Ser in heterozygous state in two unrelated...,66,33,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,p.Arg85Cys varian,71,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,p.Arg248Glu varian,74,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,p.Arg248Glu varian,74,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,...nstream of the MAPK pathway. Cells expressing the p.Ser107Leu and p.Pro772Ser variants elicited dose...,81,326,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,...nstream of the MAPK pathway. Cells expressing the p.Ser107Leu and p.Pro772Ser variants elicited dose...,81,326,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,...APK pathway. Cells expressing the p.Ser107Leu and p.Pro772Ser variants elicited dose–response curves...,81,342,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...milar to the WT FGFR1c curve (Fig. 1A and B). The p.Arg448Trp variant, on the other hand, demonstrat...",81,445,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ring three different FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with...",84,541,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ring three different FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with...",84,541,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...rent FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with PROKR2 variants...",84,557,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...rent FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with PROKR2 variants...",84,557,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"The p.Arg448Trp variant, on the other hand, has not be...",92,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"The p.Arg448Trp variant, on the other hand, has not be...",92,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"The p.Arg448Trp variant, on the other hand, has not be...",92,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro483Ser,"...terozygous variants (p.Thr112Thr, p.Ser450Phe and p.Pro483Ser) were found in FGFR1 in three differen...",94,198,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,...re means±s.e.m. of three independent experiments. p.Ser107Leu (A) and p.Pro772Ser (B) variants had n...,120,192,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,...hree independent experiments. p.Ser107Leu (A) and p.Pro772Ser (B) variants had normal signalling act...,120,212,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,...hree independent experiments. p.Ser107Leu (A) and p.Pro772Ser (B) variants had normal signalling act...,120,212,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,...hree independent experiments. p.Ser107Leu (A) and p.Pro772Ser (B) variants had normal signalling act...,120,212,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,... of total protein and maturation levels of WT and p.Arg448Trp receptors. Plotted are means±s.e.m. of...,120,629,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,c.320C>T	p.Ser107Leu	Ig-like C2-type 1 domain	Disease-causi...,140,11,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,c.320C>T	p.Ser107Leu	Ig-like C2-type 1 domain	Disease-causi...,140,11,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-causing	Tolera...,147,12,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-causing	Tolera...,150,12,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Thr112Thr,p.Thr112Thr	NS	NS	10,215,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Thr112Thr,p.Thr112Thr	NS	NS	10,215,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Val102Ile,p.Val102Ile	↓	NS	69	3	100	2,223,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,p.Ser107Leu	=	NS				1,226,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,p.Pro772Ser	=	NS				1.25,229,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Leu471Arg,... c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p.Leu471Arg) in exon 9 (Fig. 1) Targeted genotypin...,57,1011,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Leu471Arg,... c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p.Leu471Arg) in exon 9 (Fig. 1) Targeted genotypin...,57,1011,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Ala386Glu,...ping performed in proband's parents revealed that p.Ala386Glu was inherited from the father (carrier...,57,1108,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Leu471Arg,...Glu was inherited from the father (carrier) while p.Leu471Arg was inherited from the mother. Neither...,57,1166,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Leu471Arg,...irl carrying two novel mutations (p.Ala386Glu and p.Leu471Arg) of the CYP11B1 gene who shows a typic...,80,99,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Met918Thy,"...a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy) was detected by targeted next generat...",4,1189,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
p.A218V,"...have reported five Japanese alleles carrying STAR p.A218V (1). However, other STAR mutations appear ...",25,185,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.Q258X,"...h Tsp45 I and BstN1 to screen for the common STAR p.Q258X and STAR p.R182L mutations, as previously ...",34,384,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.M225T,"...vo mutations. Some STAR mutations, including STAR p.M225T in exon 4, induce only a 45% reduction in ...",48,177,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.M225T,"...ilar to that of the WT protein. For example, STAR p.M225T is folded similarly to WT protein. Thus, w...",54,183,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...nt proteolysis patterns, suggesting that the STAR p.N148K mutant is folded differently from the WT S...",54,934,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...nt proteolysis patterns, suggesting that the STAR p.N148K mutant is folded differently from the WT S...",54,934,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...nt proteolysis patterns, suggesting that the STAR p.N148K mutant is folded differently from the WT S...",54,934,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...free synthesized, radiolabeled WT and mutant STAR p.N148K were proteolyzed, and the proteolytic patt...",56,138,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.Q258X,...etic clusters identified to date include the STAR p.Q258X mutation in Japanese and Korean population...,62,386,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.Lys1385Thr,"...rozygous ABCC8 gene missense mutation (c.4154A>T/ p.Lys1385Thr), who was initially responsive to dia...",4,573,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
p.Lys1385Thr,...el missense mutation in the ABCC8 gene (c.4154A>T/p.Lys1385Thr). Since the lysine residue is highly ...,31,394,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
p.Ala561Thr,...stitution at position 561 of the encoded protein (p.Ala561Thr) and is located in the pore-forming re...,35,1193,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala561Thr,...n of the Ikr potassium channel showing that KCNH2 p.Ala561Thr mutation is located in the S5 transmem...,36,903,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala561Thr,...n of the Ikr potassium channel showing that KCNH2 p.Ala561Thr mutation is located in the S5 transmem...,36,903,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala561Thr,...n of the Ikr potassium channel showing that KCNH2 p.Ala561Thr mutation is located in the S5 transmem...,36,903,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Val174Ala,... were different at different races. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP we...,148,197,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Arg307Gln,...s mass extension. We found association of c.946A (p.Arg307Gln) with lower LS-BMD at baseline (P=0.00...,3,2590,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Glu496Ala,"...C, produces an amino acid change at position 496 (p.Glu496Ala) in the C terminus, which impairs mult...",18,287,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Glu496Ala,"...C, produces an amino acid change at position 496 (p.Glu496Ala) in the C terminus, which impairs mult...",18,287,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,"...ptor to the cell surface,35 the c.946G>A variant (p.Arg307Gln) abolishes ATP binding to the extracel...",18,618,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.His155Tyr,"... in ablated ATP response.37 The c.489C>T variant (p.His155Tyr), located in the extracellular domain ...",18,1188,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lower LS BMD i...,43,17,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lower LS BMD i...,43,17,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Glu496Ala,"...al22 demonstrated that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associat...",50,871,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.I568N,"...2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associated with an increased 10-year...",50,899,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.R307Q,rs28360457	c.946G>A (p.R307Q)	0.02	1.00 (0.01)	0.88 (0.03)	*	0.004 (0.0...,90,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.T357S,rs2230911	c.1096C>G (p.T357S)	0.07	1.00 (0.01)	1.03 (0.02)	1.09 (0.12)	...,91,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.E496A,rs3751143	c.1513A>C (p.E496A)	0.17	1.00 (0.01)	1.00 (0.02)	1.01 (0.06)	...,92,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.E496A,rs3751143	c.1513A>C (p.E496A)	0.17	1.00 (0.01)	1.00 (0.02)	1.01 (0.06)	...,92,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.H155Y,rs208294	c.489C>T (p.H155Y)	0.43	0.96 (0.01)	0.98 (0.01)	0.97 (0.02)	...,106,20,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.I568N,rs1653624	c.1729T>A (p.I568N)	0.02	0.97 (0.01)	0.93 (0.02)	1.22**	0.63	...,110,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Asn1303Lys, N1303K	c.3909C>G	p.Asn1303Lys,164,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly85Glu, G85E	c.254G>A	p.Gly85Glu,169,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly85Glu, G85E	c.254G>A	p.Gly85Glu,169,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg347Pro, R347P	c.1040G>C	p.Arg347Pro,172,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg347Pro, R347P	c.1040G>C	p.Arg347Pro,172,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu92Lys, E92K	c.274G>A	p.Glu92Lys,192,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp110His, D110H	c.328G>C	p.Asp110His,195,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117Cys, R117C	c.349C>T	p.Arg117Cys,196,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly178Arg, G178R	c.532G>A	p.Gly178Arg,201,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.His199Tyr, H199Y	c.595C>T	p.His199Tyr,205,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Pro205Ser, P205S	c.613C>T	p.Pro205Ser,206,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu206Trp, L206W	c.617 T>G	p.Leu206Trp,207,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu206Trp, L206W	c.617 T>G	p.Leu206Trp,207,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg347His, R347H	c.1040G>A	p.Arg347His,217,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg347His, R347H	c.1040G>A	p.Arg347His,217,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser492Phe, S492F	c.1475C>T	p.Ser492Phe,229,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser492Phe, S492F	c.1475C>T	p.Ser492Phe,229,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val520Phe, V520F	c.1558G>T	p.Val520Phe,231,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val520Phe, V520F	c.1558G>T	p.Val520Phe,231,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser549Arg, S549R	c.1647 T>G	p.Ser549Arg,236,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ala559Thr, A559T	c.1675G>A	p.Ala559Thr,238,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ala559Thr, A559T	c.1675G>A	p.Ala559Thr,238,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu927Pro, L927P	c.2780 T>C	p.Leu927Pro,264,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly970Arg, G970R	c.2908G>C	p.Gly970Arg,266,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu1077Pro, L1077P	c.3230 T>C	p.Leu1077Pro,274,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly1244Glu, G1244E	c.3731G>A	p.Gly1244Glu,284,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly1244Glu, G1244E	c.3731G>A	p.Gly1244Glu,284,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu558Ser, L558S	c.1673 T>C	p.Leu558Ser,299,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu558Ser, L558S	c.1673 T>C	p.Leu558Ser,299,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Tyr569Asp, Y569D	c.1705 T>G	p.Tyr569Asp,300,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp579Gly, D579G	c.1736 A>G	p.Asp579Gly,301,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly1069Arg, G1069R	c.3205G>A	p.Gly1069Arg,305,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly1069Arg, G1069R	c.3205G>A	p.Gly1069Arg,305,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1070Gln, R1070Q	c.3209G>A	p.Arg1070Gln,306,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg31Cys, R31C	c.91C>T	p.Arg31Cys,312,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg31Cys, R31C	c.91C>T	p.Arg31Cys,312,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Met470Val, M470V	c.1408 A>G	p.Met470Val,316,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg668Cys, R668C	c.2002C>T	p.Arg668Cys,318,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val754Met, V754M	c.2260G>A	p.Val754Met,319,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val754Met, V754M	c.2260G>A	p.Val754Met,319,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu997Phe, L997F	c.2991G>C	p.Leu997Phe,320,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1162Leu, R1162L	c.3485G>T	p.Arg1162Leu,323,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1162Leu, R1162L	c.3485G>T	p.Arg1162Leu,323,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1162Leu, R1162L	c.3485G>T	p.Arg1162Leu,323,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser1235Arg, S1235R	c.3705 T>G	p.Ser1235Arg,324,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp1270Asn, D1270N	c.3808G>A	p.Asp1270Asn,325,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp1270Asn, D1270N	c.3808G>A	p.Asp1270Asn,325,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu206Trp,"...e508del, p.Gly542★…); LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with ...",396,100,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117His,"...ith variable disease penetrance (IVS8-5 T allele, p.Arg117His-7 T …); U, variants of unproven or unc...",396,196,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117His,"...ith variable disease penetrance (IVS8-5 T allele, p.Arg117His-7 T …); U, variants of unproven or unc...",396,196,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1162Leu,"...or uncertain CF clinical relevance (p.Pro1013His, p.Arg1162Leu …); A, accepted; R, refused",396,290,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.L997F,"...is variants in population-based screening panels: p.L997F, further genotype/phenotype correlation da...",575,131,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp19His,...orted rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amino-acid variant is believed t...,92,780,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.Asp19His,...orted rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amino-acid variant is believed t...,92,780,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.Tyr54Cys,...an earlier report of NM_022437.2(ABCG8):c.161A>G (p.Tyr54Cys) (r2~0.2 between rs4299376:G>T and rs41...,92,1079,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.L266V,"56,295,441	exon 8	C	G	G	G	G	missense (p.L266V)	rs31110637",297,39,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.K794Q,"56,429,368	exon 23	A	C	C	C	C	missense (p.K794Q)	rs31090430",305,40,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.V811M,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid substitutions cause",314,51,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.R262X,the OCA2 protein (p.R262X) (Fig. 4Fig. 4. Sequence chromatograms of ...,319,19,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.Asn109Ser,"...hese, TET2 (p.Thr1027fs, p.Cys1263Ser) and RUNX1 (p.Asn109Ser) were identified in in the peripheral ...",10,363,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Cys1263Ser,"The 2-bp insertion (p.Thr1027fs) and the SNV (p.Cys1263Ser) in TET2, and the SNV (p.Asn109Ser) i...",51,47,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Cys1263Ser,"The 2-bp insertion (p.Thr1027fs) and the SNV (p.Cys1263Ser) in TET2, and the SNV (p.Asn109Ser) i...",51,47,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.I2490T,15	c.7469T>C	p.I2490T	1	13.6	19.9	Y	N/N	238	ND	ND,166,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.S2704F,18	c.8111C>T	p.S2704F	1	11.5	7.3	Y	N/N	1	ND	ND,167,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.E462G,"...is is the case for: p.R496C in BRCA1 [31, 32] and p.E462G [29, 33, 34] and p.V2908G [34] in BRCA2",189,488,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.E462G,"...is is the case for: p.R496C in BRCA1 [31, 32] and p.E462G [29, 33, 34] and p.V2908G [34] in BRCA2",189,488,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.Arg320X, 9a	F4	0	Exon 10	g.64348C>T	p.Arg320X	Bil	Yes	Enucl	Epithelial	C (49),86,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 15a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(37),92,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 16a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(45),93,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 17a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(21),94,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 17a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(21),94,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Tyr606X, 24	F25	NA	Exon 19	g.153211T>A	p.Tyr606X	Bil	No	RT	Melanoma	(35),101,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Glu737X," 27	F14	2 (53, 50)	Exon 21	g.160832G>T	p.Glu737X	Ul	Yes	Enucl	Epithelial	O (58)",106,40,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Glu737X, 28	F14		Exon 21	g.160832G>T	p.Glu737X	Bil	No	RT	Osteosarcoma	(20),107,30,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg787X, 30a	F28	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT	Sarcoma	Lipo (12),109,33,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Gln444Gln, 32	F7	1 (29)	Exon 13	g.73869G>A	p.Gln444Gl,112,34,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.C121G,"...ne, c.T361G, leads to an amino acid substitution (p.C121G) and absence of activity of the encoded 7β...",68,1596,FEBS_Lett_2016_Jun_27_590(11)_1651-1662.txt
p.C121G,...homozygous for the missense polymorphism/mutation p.C121G (c.T361G) in UGT3A1 because these patients...,225,1384,FEBS_Lett_2016_Jun_27_590(11)_1651-1662.txt
p.E38X,"...auwen et al., 2015). The first mutation, c.G112T (p.E38X), is linked to lipodystrophy and leads to a...",45,423,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.P158P,"...008). Two of the frameshift mutations, c.474delA (p.P158P fsX22), and c.473delC (p.P158H fsX22), gen...",45,579,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.P158H,"...ations, c.474delA (p.P158P fsX22), and c.473delC (p.P158H fsX22), generate a novel 21 amino acid-lon...",45,610,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.Thr226Arg,...letal deformities are expressed with the mutation p.Thr226Arg and not by p.Thr226Ala and p.Thr226Met...,32,624,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Val408Ala,"...damo et al., 1999). By inserting the heterozygous p.Val408Ala mutation in one Kv1.1 allele a mouse m...",84,1137,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Val408Ala,"...damo et al., 1999). By inserting the heterozygous p.Val408Ala mutation in one Kv1.1 allele a mouse m...",84,1137,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.R181P,"...ient 3 carried p.T312M in MCM4, patient 4 carried p.R181P in CYP11B1, patient 12 had three variants,...",201,176,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.R181P,"...ient 3 carried p.T312M in MCM4, patient 4 carried p.R181P in CYP11B1, patient 12 had three variants,...",201,176,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.R181P,"...ient 3 carried p.T312M in MCM4, patient 4 carried p.R181P in CYP11B1, patient 12 had three variants,...",201,176,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.L649R,"...n NNT, patient 15 had two, p.Q364R in CYP11A1 and p.L649R in MCM4, and patient 17 had two, p.H24_Y25...",201,322,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.S386F,"...atient 17 had two, p.H24_Y25delinsQI in NR5A1 and p.S386F in TXNRD2. The contribution of these varia...",201,394,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.S386F,"...atient 17 had two, p.H24_Y25delinsQI in NR5A1 and p.S386F in TXNRD2. The contribution of these varia...",201,394,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.L206R,"...e sequencing in ACA-S (14). The somatic mutation, p.L206R/c.617A > G was present in more than one-th...",19,598,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.L206R,...atalytic and regulatory subunits of PKA (25). The p.L206R point mutation results in the introduction...,19,1031,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.L206R,...atalytic and regulatory subunits of PKA (25). The p.L206R point mutation results in the introduction...,19,1031,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.L206R,...the synthesis of cortisol and other steroids. The p.L206R and Leu199_Cys200insTrp mutations in the P...,23,638,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.Pro271Ser,UNC13D	c.811C > T p.Pro271Ser htz	None detected	None detected,51,19,Front_Immunol_2014_Jan_14_4_515.txt
p.R928C,c.2782C > T p.R928C hmz,52,14,Front_Immunol_2014_Jan_14_4_515.txt
p.R928C,"...nd homozygous for an uncommon UNC13D c.2782C > T (p.R928C, frequency 0.01 in a Caucasian population ...",83,611,Front_Immunol_2014_Jan_14_4_515.txt
p.R226X,6	MLH1a	c.676 C > T	p.R226X	8	Causal	ACI	CRC (36),44,21,Front_Oncol_2016_Aug_24_6_189.txt
p.R226Q,"8	MLH1	c.677 G > A	p.R226Q	8	Causal	ACI	CRC (38), EC (52)",45,20,Front_Oncol_2016_Aug_24_6_189.txt
p.R226Q,"8	MLH1	c.677 G > A	p.R226Q	8	Causal	ACI	CRC (38), EC (52)",45,20,Front_Oncol_2016_Aug_24_6_189.txt
p.P349R,DA	MSH2	c.1046C > G	p.P349R	6	Causal	ACI	BC (41),57,21,Front_Oncol_2016_Aug_24_6_189.txt
p.R270H,"...Subsequent in vitro experiments revealed that the p.R270H mutant, which was significantly associated...",28,2268,Front_Pharmacol_2014_Nov_6_5_236.txt
p.Arg870His,NM_000257.3(MYH7):c.2609G > A (p.Arg870His) rs36211715	Pathogenic/Likely pathogen...,57,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Arg870His,NM_000257.3(MYH7):c.2609G > A (p.Arg870His) rs36211715	Pathogenic/Likely pathogen...,57,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Val606Met,NM_000257.3(MYH7):c.1816G > A (p.Val606Met) rs121913627	Pathogenic / Likely patho...,59,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Gly716Arg,NM_000257.3(MYH7):c.2146G > A (p.Gly716Arg) rs121913638	Conflicting interpretatio...,60,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Asp896Asn,"NM_000257.3(MYH7):c.2686G > A (p.Asp896Asn) rs606231340	Pathogenic	Rani et al., 2...",61,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Trp1214Ter,NM_000256.3(MYBPC3):c.3641G > A (p.Trp1214Ter) rs730880597	Pathogenic	Bashyam et al...,64,35,Front_Physiol_2016_Oct_28_7_499.txt
p.Asp770Asn,NM_000256.3 (MYBPC3):c.2308G > A (p.Asp770Asn) rs36211723	Pathogenic/Likely pathogen...,66,36,Front_Physiol_2016_Oct_28_7_499.txt
p.Asp770Asn,NM_000256.3 (MYBPC3):c.2308G > A (p.Asp770Asn) rs36211723	Pathogenic/Likely pathogen...,66,36,Front_Physiol_2016_Oct_28_7_499.txt
p.Arg144Trp,NM_001001430.2 (TNNT2):c.430C >T (p.Arg144Trp) rs483352832	Conflicting interpretatio...,70,36,Front_Physiol_2016_Oct_28_7_499.txt
p.Ile106Met,NM_001001430.2 (TNNT2):c.318C > G (p.Ile106Met) rs3729547	Uncertain significance	Rani...,72,37,Front_Physiol_2016_Oct_28_7_499.txt
p.Arg141Gln,NM_000363.4 (TNNI3):c.422G > A (p.Arg141Gln) rs397516347	Pathogenic/Likely pathoge...,76,34,Front_Physiol_2016_Oct_28_7_499.txt
p.Arg141Gln,NM_000363.4 (TNNI3):c.422G > A (p.Arg141Gln) rs397516347	Pathogenic/Likely pathoge...,76,34,Front_Physiol_2016_Oct_28_7_499.txt
p.R870H,...i G. R. Gopikrishna M. Narasimhan C.   (2007 ). A p.R870H mutation in the beta-cardiac myosin heavy ...,180,72,Front_Physiol_2016_Oct_28_7_499.txt
p.K111E,"...7A>C_p.Q56P (0.13,1125, PIK3CA:NM 006218:c.331A>G p.K111E [0.13,765]), and CTNNB1:NM_001904:c.101G>A...",77,200,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
p.G34E,...rformed targeted sequencing of the CTNNB1 region (p.G34E mutation) within the whole-genome–amplified...,77,508,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
p.G34E,...rformed targeted sequencing of the CTNNB1 region (p.G34E mutation) within the whole-genome–amplified...,77,508,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
p.Val438Met,MCCC1	1	A2	F	Homozygous	c.1315G>A	p.Val438Met	Nonsyn	This study,88,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Pro632Ser,p.Pro632Ser	Stop; Nonsyn	This study,91,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln129Arg,p.Gln129Arg	Nonsyn; Nonsyn	This study,100,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ala291Val,A23	F	Compound Het.	c.872C>T; UND	p.Ala291Val	Nonsyn	This study,105,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Asp532His,S5	F	Homozygous	c.1594G>C*	p.Asp532His	Nonsyn/splicing	Ref. 15,111,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln372X,c.1882G>T	p.Gln372X,114,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln372X,c.1882G>T	p.Gln372X,114,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln198X,MCCC2	1	A6	F	Homozygous	c.592C>T	p.Gln198X	Stop	This study,117,34,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A7	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,118,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser101Phe,A13	F	Compound Het.	c.302C>T; UND	p.Ser101Phe	Nonsyn	This study,120,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ile200Asn,p.Ile200Asn	Frameshift; Nonsyn	This study,125,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Glu99Gln,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser39Phe,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.E368K,"...tions in two patients, both in exon 8, one known (p.E368K) and one novel (p.F372C), which is found i...",32,1125,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.E368K,"The mutation found in Patient 2 (p.E368K, in exon 8) is the second most frequent in...",52,34,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.R248Q,"... included missense mutations in TP53 (c.743G > A, p.R248Q), MAX (c.179G > A, p.R60Q), BRAF (c.1447A ...",110,493,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...F (c.1447A > G, p.K483E), and RPTOR (c.2252C > T, p.A751V), and a nonsense mutation in ROS1 (c.1176 ...",110,582,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...F (c.1447A > G, p.K483E), and RPTOR (c.2252C > T, p.A751V), and a nonsense mutation in ROS1 (c.1176 ...",110,582,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"...tation in ROS1 (c.1176 T > A, p.C392*). The TP53 (p.R248Q) and APC (p.R790*) mutations had allelic f...",110,659,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,Functional characterization of MAX p.R60,127,36,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,Functional characterization of MAX p.R60,127,36,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...sight into the functional consequence of the MAX (p.R60Q) mutation, we performed in silico modeling ...",128,727,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... left. e, f Structures of wild-type BRAF and BRAF p.K483E mutant. e Model of the BRAF kinase domain ...",128,3282,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...tant. Overall, our analysis predicts that the MAX p.R60Q mutant could form a stable heterodimer with...",135,361,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...alogued in the COSMIC database suggests that BRAF p.K483E may paradoxically result in downstream pat...,141,1222,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...ified somatic mutations in MAX (p.R60Q) and BRAF (p.K483E) predicted these mutations to be deleterio...,164,152,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...ified somatic mutations in MAX (p.R60Q) and BRAF (p.K483E) predicted these mutations to be deleterio...,164,152,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...gation. In the case of the MAX (p.R60Q) and BRAF (p.K483E) mutations, in silico modeling of the muta...",164,462,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...ability to efficiently bind C-MYC. Hence, the MAX p.R60Q mutation promotes an imbalance of the MAX t...",167,610,Genome_Med_2016_Oct_31_8_116.txt
p.V600E,... function as either activated monomers (e.g. BRAF p.V600E) or constitutive dimers with wild-type BRA...,169,80,Genome_Med_2016_Oct_31_8_116.txt
p.D594A,"...RAF mutants with no kinase activity, such as BRAF p.D594A, are able to promote ERK phosphorylation b...",169,231,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... of the dimer [58, 76]. We demonstrated that BRAF p.K483E expression increased ERK1/2 activation des...",169,378,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...sion increased ERK1/2 activation despite the BRAF p.K483E mutant harboring a catalytically dead kina...,169,442,Genome_Med_2016_Oct_31_8_116.txt
p.G12V,... Detection of a somatic KRAS mutation (c.35G > T; p.G12V) in DNA extracted from micro-dissected tumo...,26,1573,Gynecol_Oncol_Res_Pract_2016_May_5_3_5.txt
p.Lys618Ala,...erera S Bapat B The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu74...,107,52,Hered_Cancer_Clin_Pract_2012_Jul_23_10(1)_9.txt
p.Leu749Gln,...ys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation Hum Muta...,107,95,Hered_Cancer_Clin_Pract_2012_Jul_23_10(1)_9.txt
p.C634R,"The RET mutations (p.C634Y [n = 10], p.C634R [n = 9], p.C634F [n = 2], p.C618Y [n = 8],...",10,38,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,"...RET mutations (p.C634Y [n = 10], p.C634R [n = 9], p.C634F [n = 2], p.C618Y [n = 8], p.C618R [n = 3],...",10,55,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R,"....C634R [n = 9], p.C634F [n = 2], p.C618Y [n = 8], p.C618R [n = 3], and p.M918T [n = 1]) were confirm...",10,89,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R,"....C634Y [n = 3], p.C634R [n = 2], p.C634F [n = 1], p.C618R [n = 1]), 1 family had FMTC (p.C618Y [n = ...",45,531,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y,"...34F [n = 1], p.C618R [n = 1]), 1 family had FMTC (p.C618Y [n = 1]), and 1 family had MEN2B (p.M918T ...",45,568,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,  F1	2	1/1	28-58	p.C634F	43.0	1/26,66,18,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,  F1	2	1/1	28-58	p.C634F	43.0	1/26,66,18,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R, F5	3	2/1	19-32	p.C634R	24.7	2/40.5,70,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R, F7	3	1/2	21-36	p.C618R	27.3	1/40,72,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F, p.C634F/Y/R	21	12	9,106,2,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...ed with PHEOs, including 5 males and 3 females (7 p.C634Y/R/F and 1 p.C618R RET-mutations) (Table 4)...",186,82,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y,"... heterozygous missense mutations within exons 10 (p.C618Y [n = 8] and p.C618R [n = 3]), 11 (p.C634Y ...",227,177,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R,"...se mutations within exons 10 (p.C618Y [n = 8] and p.C618R [n = 3]), 11 (p.C634Y [n = 10], p.C634R [n...",227,197,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,"...= 3]), 11 (p.C634Y [n = 10], p.C634R [n = 9], and p.C634F [n = 2]), 16 (p.M918T [n = 1]). It was sur...",227,258,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...ly proband (F2-II1 and F9-II3) had the p.C634Y or p.M918T mutation, while his consanguineous parents...",227,408,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...T mutations [30]. In the current study, in 2 (F2 [p.C634Y] and F9 [p.M918T]) of 9 families (Figure 1...",238,177,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...T mutations [30]. In the current study, in 2 (F2 [p.C634Y] and F9 [p.M918T]) of 9 families (Figure 1...",238,177,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...ll the other consanguineous family members had no p.C634Y or p.M918T mutations, which suggested that...",238,317,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...r consanguineous family members had no p.C634Y or p.M918T mutations, which suggested that both patie...",238,328,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.R48K,"... rare among Arabs, as only one missense mutation (p.R48K) has been reported (Table 2, Figure 2)",64,1009,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R48K,"... rare among Arabs, as only one missense mutation (p.R48K) has been reported (Table 2, Figure 2)",64,1009,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.I641N,"... Two heterozygous missense mutations, p.R479S and p.I641N, were detected in TCTN3 and AHI1, respecti...",88,621,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.I641N,"... Two heterozygous missense mutations, p.R479S and p.I641N, were detected in TCTN3 and AHI1, respecti...",88,621,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G2663Afs,"...di Arabia carrying one possible founder mutation (p.G2663Afs*40) have been reported (Table 2, Figure...",92,753,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R515W,p.R515,231,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R515W,p.R515,239,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R515W,p.R515,239,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R512Q,JS_D	1	H	c.1535G>A	p.R512Q	Yes,244,21,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Y534D,c.1862G>A	p.Y534,250,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Y534D,c.1862G>A	p.Y534,250,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.C641R,p.C641,273,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.V443D,p.V443,317,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.V443D,p.V443,317,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.V443D,p.V443,337,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,422,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,449,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G821S,ND	Ht	c.2461G>A	p.G821S	No	digenic	Egyptian,476,18,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1019*,p.R1019,502,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A126T,p.A126,663,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G2663Afs,p.G2663Afs*4,725,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.E750Lfs,ND	3 (1 died)	H	c.2244_2247delAAGA	p.E750Lfs*7	Yes,749,37,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.E750Lfs,ND	3 (1 died)	H	c.2244_2247delAAGA	p.E750Lfs*7	Yes,749,37,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.L292P,... impairment. Here we describe a missense variant (p.L292P) within a mutation-rich region of FRMD7 de...,15,192,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,...ution of leucine (L) by proline (P) at codon 292 (p.L292P). This variant co-segregated in all three ...,21,845,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,...ution of leucine (L) by proline (P) at codon 292 (p.L292P). This variant co-segregated in all three ...,21,845,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,...y-committee/best-practice-guidelines/). The FRMD7 p.L292P mutant protein was predicted with high con...,27,977,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,...y-committee/best-practice-guidelines/). The FRMD7 p.L292P mutant protein was predicted with high con...,27,977,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,"Taking these lines of evidence together, p.L292P appears to exert a marked effect on FRMD7 ...",29,42,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.Arg44Gln,2	 	Sporadic	Exon5	c.131G>A	Missense	p.Arg44Gln	PD	No	21	M	Total/total	−/−	+/+	−/−	+/+	...,52,38,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Gln27X,3	 	Sporadic	Exon5	c.79C>T	Nonsense	p.Gln27X	PD	Yes	9	M	Total/total	−/−	+/+	−/−	+/+	−/...,53,37,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg240X,17	4	Familial	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	29	M	Total/total	−/−	+/+	−/−	+/+	...,68,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Glu268X,19	 	Sporadic	Exon10	c.802G>T	Nonsense	p.Glu268X	PST	Yes	6	F	Total/total	−/−	−/−	−/−	+/+	...,70,40,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg317X,21	 	Sporadic	Exon11	c.949C>T	Nonsense	p.Arg317X	PST	Yes	10	M	Total/total	−/−	−/−	+/+	+/+...,72,40,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.N1007S,...an syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene J. Med. Genet. 2007 44...,66,181,Hum_Mol_Genet_2009_Apr_15_18(R1)_R60-R64.txt
p.R796X,"...t predicted a premature stop mutation (c.2386C>T; p.R796X), whereas the maternally transmitted varia...",3,2460,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.R796X,"...o result in premature termination of translation (p.R796X). The second variant, a c.5560G>A in exon ...",46,1560,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.D1854N,...KA enzymes expressed in COS-7 cells. Wild-type or p.D1854N mutant enzymes were prepared and assayed ...,80,203,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.G608G,"... mutation in exon 11 of the LMNA gene (c.1824C>T, p.G608G). Although this mutation does not result i...",10,332,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
p.N410H,...A. et al  (2014 ) Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration . Acta. ...,123,191,Hum_Mol_Genet_2015_Nov_1_24(21)_6198-6212.txt
p.R27Lfs,"...t fibroblasts with mutations in AP5Z1 (Patient 3: p.R27Lfs*3), SPG11 or SPG15 were probed with antib...",43,402,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.L1679Rfs,...her from Syria carries the homozygous c.5036delT (p.L1679Rfs*1687) mutation (10). One SPG11 patient ...,83,284,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.G305R,p.G305R	c.913G>A	3.58	4.90	B	1,18,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,p.G305R	c.913G>A	3.58	4.90	B	1,18,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,p.G307S	c.919G>A	0.16	0.50	B	88	ECE: undetectable ...,19,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,p.G307S	c.919G>A	0.16	0.50	B	88	ECE: undetectable ...,19,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,p.I278T	c.833T>C	0.00	0.00	B	146	PE: Vmax 0.8–1.4%...,26,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,p.A114V	c.341C>T	8.94	18.07	S	10	ECE: tetramer + a...,34,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,p.V180A	c.539T>C	5.15	15.50	S	1	ECE: 3–8% WT activ...,36,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,p.V180A	c.539T>C	5.15	15.50	S	1	ECE: 3–8% WT activ...,36,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,p.I435T	c.1304T>C	16.11	38.50	S	1	ECE: tetramer [J...,39,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,p.I435T	c.1304T>C	16.11	38.50	S	1	ECE: tetramer [J...,39,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,p.S466L	c.1397C>T	0.23	0.40	B	1	ECE: ∼310% WT acti...,42,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...92]. Seven mutant plasmids, namely, the c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), ...",58,159,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G148R,"...asmids, namely, the c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), r.1224_1358del; p.W4...",58,179,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...t with the wild-type CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have c...",65,246,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,"...e wild-type CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared t...",65,255,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,"...pe CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared the effect...",65,264,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,"...pe CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared the effect...",65,264,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,"...ur mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared the effects of the foll...",65,277,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,"...ontained the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant pro...",78,635,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,"...the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant proteins exp...",78,644,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,"...the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant proteins exp...",78,644,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"... included the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D...",88,387,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P422L,"...than 9% (with the exception of mutations p.C165Y, p.P422L, and p.S466L that belong to buried mutatio...",108,1571,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T262R,"...see Table 2). Only three mutant proteins—p.G305R, p.T262R, and p.N228K—did not exhibit any measurabl...",118,239,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,B	p.C165Y	1.1±0.1	0.6±0.04	0.9±0.01	0.5±0.05	N/A	N/A...,134,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,B	p.I278T	0.4±0.04	0.6±0.1	0.4±0.1	0.9±0.2	N/A	N/A,136,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P49L,S	p.P49L	147.9±38.9	512.8±147.3	170.9±34.1	103.4±43....,137,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,S	p.K102N	8.8±1.7	25.7±4.3	9.2±0.9	13.6±10.2	58.2±44...,138,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,S	p.R125Q	2.3±0.3	8.1±2.5	2.7±0.3	19.4±8.8	141.8±78....,139,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,S	p.E302K	136.2±19.3	147.5±10.1	112.3±4.3	81.5±28.9	...,141,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,Dimer–dimer interface	S	p.P78R	13.8±5.0	43.4±12.2	13.2±4.9	26.4±9.2	149.7±...,143,25,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,S	p.A114V	109.7±10.5	303.3±36.7	117.0±19.0	13.0±1.2	...,144,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,S	p.V180A	13.1±3.5	24.5±5.3	21.7±0.05	127.3±15.2	457...,146,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,S	p.I435T	196.5±48.2	268.872±.9	186.6±52.8	215.4±72....,149,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,B	p.S466L	346.2±69.1	325.2±63.1	353.7±59.9	208.7±98....,152,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.L539S,Regulatory domain – second CBS domain	B	p.L539S	1.2±0.1	1.2±0.1	1.6±0.2	4.1±0.2	N/A	N/A,153,41,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T191M,"... p.E302K was inhibited by AdoHcy, and the p.H65R, p.T191M and p.C165Y appeared to be inhibited by bo...",165,461,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,".... In addition, mutations p.E302K, p.W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I27...",165,582,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E144K,"...ations p.E302K, p.W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p.S466L we...",165,600,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,"...W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p.S466L were not activated b...",165,618,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,"...W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p.S466L were not activated b...",165,618,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"...amers/oligomers of the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p....",168,1066,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"... the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. However, th...",168,1084,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,"...-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. However, this foldin...",168,1093,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,"...e Table 2). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited more than a...",170,226,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,"... proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited more than approximately twofold i...",170,248,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...rroring the increased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V...",175,654,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,"...he increased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). Ho...",175,663,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,"...he increased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). Ho...",175,663,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,"...., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, changes in amounts of tetramers...",175,701,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.Ser2Gly,... relevance is the fact that the invariant c.4A>G (p.Ser2Gly) SHOC2 mutation was observed to provoke ...,84,1151,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
p.Ser2Gly,... relevance is the fact that the invariant c.4A>G (p.Ser2Gly) SHOC2 mutation was observed to provoke ...,84,1151,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
p.Glu26Lys,...ctural variant of normal hemoglobin (HBB c.79G>A; p.Glu26Lys) affecting the production rate of HbA. ...,29,64,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
p.Asn1009Lys,"...Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP. H‐NNT residues h...",99,606,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,"...Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP. H‐NNT residues h...",99,606,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"...e opposite domain I. C: Phe215, which harbors the p.Phe215Ser substitution, is a conserved interface...",104,520,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,p.Phe215Ser	9	Phe(100.0%)	0 D	1.00 D	47 Poss D	Lik...,118,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr357Ala,"p.Thr357Ala	8	Thr(88.9%), Ser(5.6%), Ile(5.6%)	0 D...",120,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Tyr388Ser,"p.Tyr388Ser	7	Tyr(94.4%), Phe(5.6%)	0 D	1.00 D	85 ...",122,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala533Val,"p.Ala533Val	8	Ala(94.4%), Phe(5.6%)	0 D	0.986 D	80...",124,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr589Ser,"p.Thr589Ser	2*	Thr(62.5%), Asp(25.0%), Gln(6.3%), ...",125,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr731Met,"p.Thr731Met	1	Thr(52.9%), Glu(23.5%), Ala(11.8%), ...",129,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu977Pro,p.Leu977Pro	9	Leu(100.0%)	0 D	1.00 D	92 D	Likely d...,131,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ser193Asn,"p.Ser193Asn, homozygous in FGD patient [Meimaridou...",138,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"p.Phe215Ser, homozygous in FGD patient [Yamaguchi ...",144,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"p.Phe215Ser, homozygous in FGD patient [Yamaguchi ...",144,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gln557Ter,"...d heterozygosity in an FGD patient in addition to p.Gln557Ter, which is predicted to cause nonsense‐...",159,80,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gln557Ter,"...d heterozygosity in an FGD patient in addition to p.Gln557Ter, which is predicted to cause nonsense‐...",159,80,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,"p.Gly664Arg, found in compound heterozygosity in a...",165,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly678Arg,"p.Gly678Arg, found in a patient with FGD in compou...",168,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,p.Ala1008Pro and p.Asn1009Lys. Both variations wer...,177,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,p.Ala1008Pro and p.Asn1009Lys. Both variations were found in patien...,177,18,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,"...p.Ala1008Pro was present in homozygosity, whereas p.Asn1009Lys was in compound heterozygosity with p...",177,131,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Lys63Arg,p.Lys63Arg	ENST00000264663.5:c.188A > G	PASS	Misse...,185,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe	ENST00000264663.5:c.1987C > T	PASS	Mis...,186,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ile993Val,p.Ile993Val	ENST00000264663.5:c.2977A > G	PASS	Mis...,187,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Arg27His,p.Arg27His	ENST00000264663.5:c.80G > A	PASS	Missen...,189,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Arg27His,...anshydrogenases. Position 27 is not conserved and p.Arg27His is predicted benign by most prediction ...,192,264,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr589Ser,p.Thr589Ser (rs370370846) Thr589 is part of a loop...,198,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr589Ser,p.Thr589Ser (rs370370846) Thr589 is part of a loop...,198,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,"...isms could only be identified for two variations (p.Ala1008Pro and p.Asn1009Lys), which are located ...",216,95,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,"...to be the case for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We pre...",220,253,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,"...to be the case for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We pre...",220,253,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,"...to be the case for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We pre...",220,253,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,"...to be the case for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We pre...",220,253,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly678Arg,"...e for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We predicted that t...",220,266,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly862Asp,"...tions in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We predicted that these substitution...",220,283,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Q1028Q,... two nucleotides A (wild type) and G (mutant) (b) p.Q1028Q mutation in exon 14 of MAP3K1 (c) p.T428T...,42,350,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...t) (b) p.Q1028Q mutation in exon 14 of MAP3K1 (c) p.T428T heterozygous mutation in exon 6 of MAP3K1 ...,42,393,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...t) (b) p.Q1028Q mutation in exon 14 of MAP3K1 (c) p.T428T heterozygous mutation in exon 6 of MAP3K1 ...,42,393,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,In-silico analysis of p.D806N missense mutation has been carried out to ...,44,23,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...tation site. (a) A multiple sequence alignment of p.D806N mutation showing the conserved aspartate (...,46,175,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...aded box) (b) WebLogo showing the conservation of p.D806N mutation showing the conserved aspartate (...,46,315,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...eletion mutation (p.T942ins) and silent mutation (p.T428T) were identified in patient 10. The clinic...,59,103,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...eletion mutation (p.T942ins) and silent mutation (p.T428T) were identified in patient 10. The clinic...,59,103,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Val501Gly,...ine at a highly conserved amino acid residue 501 (p.Val501Gly). Other healthy family members were ei...,17,1121,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...yses using PolyPhen-2 and SIFT predicted that the p.Val501Gly mutation is functionally “damaging.” T...,17,1339,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"... the mutant TPO. In conclusion, a novel mutation, p.Val501Gly, in the TPO gene was detected expandin...",17,1507,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,... a homology model of the human TPO containing the p.Val501Gly mutation was also generated for struct...,38,645,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,... a homology model of the human TPO containing the p.Val501Gly mutation was also generated for struct...,38,645,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...ing site (His-494) [32] were also detected in the p.Val501Gly mutant (Figure 5(c)),48,518,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Pro499Leu,"...terestingly, Rivolta et al. in 2003 reported that p.Pro499Leu mutation in the TPO which is also loca...",55,980,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...l activity of the protein. The mechanism by which p.Val501Gly in the TPO may induce MNG remains to b...,55,1238,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"...onstrated a novel, homozygous c.1502T>G mutation (p.Val501Gly) in the TPO gene which could be associ...",58,72,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"...onstrated a novel, homozygous c.1502T>G mutation (p.Val501Gly) in the TPO gene which could be associ...",58,72,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...substitution of valine by glycine at residue 501 (p.Val501Gly),66,400,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...w indicates the positions of the mutated residue (p.Val501Gly),72,270,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...w indicates the positions of the mutated residue (p.Val501Gly),72,270,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...n arrow. (b) Ribbon presentation of wild type and p.Val501Gly mutant TPO proteins. The residues Val-...,74,361,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.A348V,1	IDH3B	chr20:2640199	NM_174855	Exon11	c.1043C>T	p.A348V	Damaging	Het	–	AR	RP46,70,50,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.N1469D,ABCA4	chr1:94495135	NM_000350	Exon30	c.4405A>G	p.N1469D	Tolerated	Het	–	AR	CORD3/STGD1/RP19,72,49,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.V78M,...SEMA4A	chr1:156126297	NM_001193300	Exon3	c.232G>A	p.V78M	Probably damaging	Het	–	AD/AR	CORD10/RP35,81,52,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.V78M,...SEMA4A	chr1:156126297	NM_001193300	Exon3	c.232G>A	p.V78M	Probably damaging	Het	–	AD/AR	CORD10/RP35,81,52,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.E4784K,USH2A	chr1:215822102	NM_206933	Exon66	c.14350G>A	p.E4784K	Probably damaging	Het	–	AR	RP39,82,51,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.Arg257X,"c.769 C>T (p.Arg257X)	Finnish, Northern Italian	Nagamine et a...",97,12,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Arg257X,"c.769 C>T (p.Arg257X)	Finnish, Northern Italian	Nagamine et a...",97,12,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Tyr85Cys,"c.254A>G (A374G, p.Tyr85Cys)	Iranian Jewish	Björses et al. (2000) [...",98,18,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Y77X,...on instead of tyrosine at amino acid position 77 (p.Y77X),42,847,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
p.L33P,"...in GPIIIa gene causes an amino acid substitution (p.L33P), leads to the creation of two distinct for...",27,535,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
p.Gly202Arg,"...cid exchange of glycine to argenine at codon 202 (p.Gly202Arg/G202R). In this way, his healthy paren...",221,260,Iran_J_Pediatr_2016_Mar_5_26(2)_e2493.txt
p.Ser2Gly,"...riant mutation in SHOC2, c.4A > G, predicting the p.Ser2Gly change in the encoded protein, underlies...",12,105,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Ser2Gly,"...esence of the disease-causing mutation (c.4A > G, p.Ser2Gly)",66,174,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Val244Leu,...on 23710.1186/s13052-016-0237-8Case ReportA novel p.Val244Leu mutation in MFN2 leads to Charcot-Mari...,3,136,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,The c.730G > C (p.Val244Leu) mutation in MFN2 is a likely pathogen...,11,17,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Met,...0th nucleotide in the encoding region (c.730G > A/p.Val244Met) [8],19,599,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,"...ntified a novel heterozygous mutation c.730G > C (p.Val244Leu) in MFN2, which occurred de novo",21,212,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Met,"...causing mutation at the same position (c.730G > A/p.Val244Met). In summary, the de novo pattern is c...",55,680,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,The c.730G > C (p.Val244Leu) mutation in MFN2 is a likely pathogen...,61,17,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.His586Pro,"...he arrow), predicting the amino acid substitution p.His586Pro at the protein level. C, Primary struc...",98,334,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,...3 major domains of the protein are indicated. The p.His586Pro mutation lies within the plakin domain...,98,484,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,p.His586Pro	Het	None	None,110,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,p.His586Pro	Het	None	None,110,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Ile293Val,DSG2	Desmoglein 2	p.Ile293Val	Het	rs2230234	0.0323,112,19,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Arg773Lys,p.Arg773Lys	Het	rs2278792	0.2400,113,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gly95Arg,PKP3	Plakophilin 3	p.Gly95Arg	Het	rs11246148	0.3608,124,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gly95Arg,PKP3	Plakophilin 3	p.Gly95Arg	Het	rs11246148	0.3608,124,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gln433Arg,EVPL	Envoplakin	p.Gln433Arg	Het	rs2071192	0.3241,127,17,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Ala1007Val,p.Ala1007Val	Het	rs2075639	0.1194,130,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Arg300Trp,"...erent missense mutations, p.Asp263His (family 3), p.Arg300Trp (families 2, 4, 5, 11), p.Ile322Thr (f...",60,542,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,"... (families 2, 4, 5, 11), p.Ile322Thr (family 10), p.Leu401Pro (family 8); 1 nonsense mutation, p.Tyr...",60,603,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"(36). The second missense mutation in exon 5, p.Arg300Trp, affects the last amino acid of the LA...",61,47,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,"...ic aneurysms (8). The 2 other missense mutations, p.Ile322Thr and p.Leu401Pro, affect highly conserv...",61,380,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...rtic wall of a patient carrying a TGFB3 mutation (p.Asp263His), we performed immunohistochemical ana...",75,91,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...rtic wall of a patient carrying a TGFB3 mutation (p.Asp263His), we performed immunohistochemical ana...",75,91,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Cys409Tyr,...and the patient reported by Rienhoff et al. (16) (p.Cys409Tyr) presented with short stature (5th per...,82,235,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"...d proteins is given for the 4 missense mutations (p.Arg300Trp: Family 2, 4, 5 and 11; p.Asp263His: F...",125,307,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,...11; p.Asp263His: Family 3; p.Leu401Pro: Family 8; p.Ile322Thr: Family 10). Previously published muta...,125,389,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...es, which cannot be modeled). The point mutations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu40...",129,653,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,"...d). The point mutations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are shown in red with...",129,679,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,"...d). The point mutations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are shown in red with...",129,679,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"... whereas the mutant side chain is in red. For the p.Arg300Trp mutation, side chains of nearby negati...",129,951,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,... in a Human Subject With TGFB3 Mutation (3-III:1; p.Asp263His,131,141,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Q463X,"...yosin-binding protein C (MYBPC3) gene (c.1387C>T, p.Q463X) (Figure5A) was identified in patient III4...",72,75,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
p.E334K,"... 4 carried a missense MYBPC3 mutation (c.1000G>A, p.E334K) (Figure5B), which was already described t...",72,779,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
p.E334K,"....1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A, p.E334K)",74,141,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
p.R332W,"...8), who identified a homozygous missense variant (p.R332W) in all affected members of the Turkish co...",72,755,J_Appl_Genet_2014_Oct_27_55(1)_105-115.txt
p.I12T,"...er D1S1661 were obtained. BSND mutation, that is, p.I12T, cosegregated in all extant members of our ...",15,1064,J_Biomed_Biotechnol_2011_Apr_4_2011_304612.txt
p.Arg266Cys,"...BM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) were identified, plus three previous...",51,760,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,...onsequent effect on SOST‐LRP5 binding. We predict p.Asn198Ser and p.Ala242Thr directly disrupt SOST ...,51,1552,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,... on SOST‐LRP5 binding. We predict p.Asn198Ser and p.Ala242Thr directly disrupt SOST binding; both co...,51,1568,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,... on SOST‐LRP5 binding. We predict p.Asn198Ser and p.Ala242Thr directly disrupt SOST binding; both co...,51,1568,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,... on SOST‐LRP5 binding. We predict p.Asn198Ser and p.Ala242Thr directly disrupt SOST binding; both co...,51,1568,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,... on SOST‐LRP5 binding. We predict p.Asn198Ser and p.Ala242Thr directly disrupt SOST binding; both co...,51,1568,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...usly reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; ...",81,173,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...P5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated ...",81,198,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 adults amo...",81,223,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 adults amo...",81,223,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,...rkedly thickened skull in male aged 30 years with p.Asn198Ser substitution (pedigree 1). (B) Mandibl...,352,136,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...s, Inc.The most frequent LRP5 mutation, c.724G>A; p.Ala242Thr, was identified in three unrelated fam...",354,84,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,A heterozygous c.266A>G; p.Gln89Arg mutation was identified in an active ma...,357,26,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,...hritis; he has never fractured. A novel c.518C>T; p.Thr173Met mutation was identified in a man aged ...,357,170,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,The p.Asn198Ser mutation directly affects the SOST int...,360,5,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,B). The similarly severe p.Ala242Thr mutation is predicted instead to disru...,362,26,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...dels of the LRP5‐SOST complex (A) with mutations; p.Asn198Ser (B), p.Ala242Thr (C), p.Arg266Cys (D),...",365,73,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"....Asn198Ser (B), p.Ala242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), and p.Thr173Met (F)",365,124,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...a242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), and p.Thr173Met (F)",365,144,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,The p.Thr173Met mutation site lies in one of the β‐pro...,374,5,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...enotypes associated with individuals carrying the p.Arg266Cys, p.Gln89Arg, and p.Thr173Met mutations...",375,152,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ser177X,...eterozygous nonsense variant in exon 2 (c.530C>A; p.Ser177X) in a woman aged 70 years who reported d...,378,74,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Val10Ile,"...n exon 1 in eight HBM cases (rs17882143, c.28G>A; p.Val10Ile, MAF T = 0.047%), predicted to be benig...",380,99,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...e in LRP5 HBM.43 Our most frequent LRP5 mutation (p.Ala242Thr), associated with BMD Z‐scores +3.1 to...",388,765,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,LRP5 mutation p.Gln89Arg was identified in one HBM case (no DNA ...,393,15,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...AF 8% in the Japanese population.45 Subsequently, p.Gln89Arg was associated with lower (not higher) ...",393,289,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,...tional role in canonical Wnt signaling.49 Whether p.Gln89Arg shares a rare haplotype with a function...,393,756,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"LRP5 mutation p.Thr173Met, identified in one isolated HBM case, ...",396,15,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...nly previous LRP5 protein modeling to date (using p.Asn198Ser and p.Ala242Thr mutations, although wi...",398,176,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,".... Interestingly, two LRP5 HBM cases (p.Arg266Cys; p.Asn198Ser) still had high BMD despite long‐term ...",400,1264,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,".... Interestingly, two LRP5 HBM cases (p.Arg266Cys; p.Asn198Ser) still had high BMD despite long‐term ...",400,1264,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.L450X,... gene that caused truncation of the Wip1 protein (p.L450,111,56,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.F99S,...dysfunctional as well due to a missense mutation (p.F99S) or normal (henceforth designated XPB−/− an...,24,242,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.Arg4893Gln,...1 revealed the heterozygous mutation [c.14678G>A (p.Arg4893Gln)] in exon 102 (Fig. 1B). This mutatio...,33,162,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Tyr4864Cys,... missense mutation affecting the same amino acid (p.Tyr4864Cys) has been reported previously in an E...,40,170,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Arg4893Trp,"... different amino acid change of the same residue (p.Arg4893Trp) presented as respiratory impairment,...",40,872,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.K659E,"...Endometrioid	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,61,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H1047R,"155	45	OC	Serous	IC	G1	PIK3CA p.H1047R, c.3140A>G	PIK3CA p.H1047R, c.3140A>G (3)...",39,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H1047R,"...OC	Serous	IC	G1	PIK3CA p.H1047R, c.3140A>G	PIK3CA p.H1047R, c.3140A>G (3)",39,58,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,30,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"...2	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,53,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"...2	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,53,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"...2	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,53,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"...2	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,53,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H168R,"...	44	OC	Serous	IIIA	G3	TP53 p.H168R, c.503A>G	TP53 p.H168R, c.503A>G (3)",41,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V216M,"...	71	OC	Serous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.L194R,"...	52	OC	Serous	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245V,"158	49	OC	Serous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245V,"...	49	OC	Serous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.W257C,"130	72	OC	Serous	IIIC	G2	PPP2R1A p.W257C, c.771G>T	PPP2R1A p.W257C, c.771G>T (1)",47,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.M237I,"132	64	OC	Serous	IIIC	G2	NA	TP53 p.M237I, c.711G>C (1)",48,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12A,"197	73	OC	Serous	IIIC	G3	NA	KRAS p.G12A, c.35G>C (1)",53,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Q61R,"...C	Malignant mixed Müllerian tumor	IIIC	G3	NA	NRAS p.Q61R, c.182A>G (1)",55,59,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Q61R,"...C	Malignant mixed Müllerian tumor	IIIC	G3	NA	NRAS p.Q61R, c.182A>G (1)",55,59,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G13D,"..., partly serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,73,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12D,"147	60	OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,37,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.M1004V,"198	59	OC	Serous	IVB	G3	NA	PIK3CA p.M1004V, c.3010A>G (1)",60,35,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12V,"...infertility, polyp of the cervix mucosa			NA	KRAS p.G12V, c.35G>T (1)",74,70,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V600E,...r sequencing for the detection of p.V600E and non-p.V600E BRAF mutations BMC Cancer 2014 14 13 10.11...,183,301,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
p.F858L,...variant [15] in one patient and the c.2572 T > C (p.F858L) missense mutation [16] in other two patie...,29,576,J_Exp_Clin_Cancer_Res_2016_Sep_6_35(1)_135.txt
p.Arg63Trp,...of an arginine by a tryptophan (p.Arg63Trp). This p.Arg63Trp polymorphism is associated with increas...,9,606,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Y1216H,ATM	c.3646T>C	p.Y1216H	12	Tolerated	Damaging (probably),32,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Q336L,CHEK2	c.1007A>T	p.Q336L	54	Damaging	Benign,35,17,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K471R,EXO1	c.1412A>G	p.K471R	18	Tolerated	Benign,38,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.F3418L,PRKDC	c.10252T>C	p.F3418L	31	Damaging	Damaging (probably),43,18,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R273C,TP53	c.817C>T	p.R273C	67	Damaging	Damaging (probably),46,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R335W,"... NER pathways. The “Other” category refers to the p.R335W mutation in the DNTT gene, which encodes f...",50,327,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.E528K,"... addition to the p.Q336L somatic mutation and the p.E528K germline variant, identified by SOLiD, 11 ...",61,195,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D293X,"...in CHEK2 included a somatic frameshift insertion (p.D293X), a splice-site mutation (c.319+2T>A), and...",61,469,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I364T,"...e mutation (c.319+2T>A), and a missense mutation (p.I364T) located in the kinase domain of CHEK2 (Ta...",61,541,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.E528K,"...of CHEK2 (Table 2). Five rare variants, including p.E528K, were specific for the patient cohort, as ...",61,629,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R117G,"...errant splicing of CHEK2 transcripts, whereas the p.R117G and p.D438Y substitutions were shown to ha...",61,881,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I157T,"...ol samples, including a c.1100delC deletion and a p.I157T substitution (Table 2) that was previously...",61,1129,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I157T,"...ol samples, including a c.1100delC deletion and a p.I157T substitution (Table 2) that was previously...",61,1129,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R180C,"...ples derived from healthy blood donors, where the p.R180C and p.I157T substitutions, previously iden...",61,1390,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D293X,c.876dupT	p.D293X	Novel	1/171	Somatic	Swedish	0	0	-	-,67,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R3W,c.7C>T	p.R3W	rs199708878	1/171	Germline	Swedish	0	0	Damag...,70,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R117G,c.349A>G	p.R117G	rs28909982	1/171	ND	Swedish	0	0	Damaging	D...,71,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D438Y,c.1312G>T	p.D438Y	rs200050883	2/164	ND	Swedish	0	0	Damaging	...,73,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R180C,c.538C>T	p.R180C	rs77130927	1/171	ND	Swedish	0.006	0.001	Da...,76,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S776G,c.2326A>G	p.S776G	Selector & Sanger	Novel	Germline	Chinese	0...,88,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y930C,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0.003	Damagi...,90,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y930C,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0.003	Damagi...,90,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y930C,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0.003	Damagi...,90,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.P439L,MSH2	c.1316C>T	p.P439L	Sanger	Novel	ND	Chinese	0	Damaging	Damagin...,92,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,c.1619A>G	p.S540G	Selector & Sanger	Novel	Somatic	Chinese	0	...,93,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L833V,c.2498C>G	p.L833V	Selector & Sanger	Novel	Somatic	Chinese	0	...,94,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.M1120I,c.3360G>A	p.M1120I	454 amplicon	Novel	ND	Swedish	0	Tolerated...,98,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R179Q,DCLRE1C	c.536G>A	p.R179Q	454 amplicon	rs150854849	ND	Swedish	0	Dama...,99,18,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.V741I,c.2221G>T	p.V741I	454 amplicon	rs28756990	ND	Swedish	0.004	T...,103,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I988M,c.2964C>G	p.I988M	Selector	Novel	Germline	Chinese	0	Damaging...,105,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.T283A,XRCC5	c.847A>G	p.T283A	Selector	Novel	Somatic	Chinese	0	Damaging	...,107,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.T283A,XRCC5	c.847A>G	p.T283A	Selector	Novel	Somatic	Chinese	0	Damaging	...,107,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.T283A,XRCC5	c.847A>G	p.T283A	Selector	Novel	Somatic	Chinese	0	Damaging	...,107,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L833V,"...ddition to the two somatic mutations (p.S540G and p.L833V) discovered by the latter approach, anothe...",112,170,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.V741I,"...rs, respectively. The MLH3 missense rare variant (p.V741I) was previously shown to segregate with di...",114,640,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.A223D,"...ted somatic mutations in PMS1 (p.R847K) and MLH1 (p.A223D), respectively. The DLBCL sample with a p....",124,1136,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.P439L,"... (p.A223D), respectively. The DLBCL sample with a p.P439L mutation in MSH2 was analyzed with Promega...",124,1184,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.H371Y,"...rers confirmed all genotypes. For the c.1100delC, p.H371Y and p.D438Y CHEK2 variants control typing ...",174,818,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L124P,"...(ak2hg16, denoted as ak2L124P) carrying a c.T371C/p.L124P missense mutation within ak2 exon 4 from a...",110,457,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
p.R486X,"...iency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T; P4, p>R173W/R173W; P...",96,274,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
p.R486X,"...iency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T; P4, p>R173W/R173W; P...",96,274,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
p.Q248X,"...A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene. Affected an...",75,122,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
p.S610X,"...ng detectable. There were two nonsense mutations (p.S610X, p.L727X), three deletion frameshift mutat...",32,251,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S610X,"...ng detectable. There were two nonsense mutations (p.S610X, p.L727X), three deletion frameshift mutat...",32,251,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.L727X,"...able. There were two nonsense mutations (p.S610X, p.L727X), three deletion frameshift mutations (c.3...",32,260,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P76S,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E...",34,35,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P76S,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E...",34,35,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.T94I,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372...",34,43,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.T94I,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372...",34,43,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P123S,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N39...",34,51,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P123S,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N39...",34,51,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.A372V,"...P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G43...",34,87,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.A372V,"...P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G43...",34,87,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.N392Y,"...94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S44...",34,96,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.N392Y,"...94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S44...",34,96,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.N392Y,"...94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S44...",34,96,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.I529S,"...96E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V65...",34,159,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S532I,"...10M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S66...",34,168,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...65Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluate the evolutionary...",34,231,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...ts with normal hearing, but with the exception of p.H723R in 1 case, no mutations were detected",34,705,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...ns in east Asians, namely p.H723R and c.919-2A>G. p.H723R is most prevalent in the Japanese and Kore...",56,330,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...ients homozygous for the most prevalent mutation, p.H723R, hearing level at low frequency varied fro...",60,739,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.Arg145Pro,6	EX6	c.434G>C	p.Arg145Pro	missense,90,16,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Leu247Pro,"...p.Leu247Arg (Kucharczyk et al. 2009a, b, c), atp6-p.Leu247Pro (Kucharczyk et al. 2010), and Δatp6 (R...",99,2294,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu222Pro,...lemi et al. 2005; Childs et al. 2007). m.9191T>C (p.Leu222Pro) has been described in a patient with ...,101,719,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Trp94Arg,"...ater, it has been shown in a yeast model that the p.Trp94Arg mutation decreases the solubility of th...",115,745,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Trp94Arg,"...ater, it has been shown in a yeast model that the p.Trp94Arg mutation decreases the solubility of th...",115,745,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Gly301Cys,"...ense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe) (Tomatsu ...",164,760,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.Ile113Phe,"...Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe) (Tomatsu et al 2005a). However, their...",164,788,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.Ile113Phe,"...d changes, such as the common pathogenic mutation p.Ile113Phe, highlighting the difficulty in predic...",182,660,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.N301K,"2	F	1.5	1.8	2.1	903 C > G (p.N301K) exon 5, S384N, 1152 G > A, exon 6	903 C >...",56,28,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.V323G,"4	M	1.2	2.8	3.0	995 T > G (p.V323G), exon5	995 T > G (p.V323G), exon5	Rapid	5...",58,28,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.V323G,"...1.2	2.8	3.0	995 T > G (p.V323G), exon5	995 T > G (p.V323G), exon5	Rapid	554 (194)	Y	Y	N	4	4	Y	N",58,55,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"8	F	3.0	7.4	7.8	629A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	214 (124)...",63,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"...	2.0	7.8	8.3	454C > T (p.R152W), exon 2	454C > T (p.R152W), exon 2	Slow	254 (124)	N	Y	N	3	2	Y	N",64,54,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"10	M	7.0	10.1	18.3	454 C > T (p.R152W), exon2	454 C > T (p.R152W), exon2	Slow	10...",65,31,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"...consisted of patients who were homozygous for the p.R152W mutation (n = 3, all of Turkish Ancestry)....",108,132,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.P313A,"...group had a p.Y210C mutation combined with either p.P313A or p.R327X (n = 4, all of Dutch Ancestry)....",108,244,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.P313A,"...group had a p.Y210C mutation combined with either p.P313A or p.R327X (n = 4, all of Dutch Ancestry)....",108,244,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,...t was reported by Swiedler et al. (2005) that the p.Y210C mutation was associated with low GAG excre...,159,430,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,...t was reported by Swiedler et al. (2005) that the p.Y210C mutation was associated with low GAG excre...,159,430,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"...e of the four children, p.Y210C was combined with p.R327X, a nonsense mutation leading to no product...",159,561,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G12S,"...ry Methods). A somatic heterozygous HRAS c.34G>A, p.G12S substitution was found in each (Figure 2a)....",15,330,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...ry Methods). A somatic heterozygous HRAS c.34G>A, p.G12S substitution was found in each (Figure 2a)....",15,330,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...and NRAS (Hafner et al., 2012) including the HRAS p.G12S mutation found in WHN (Hafner et al., 2011)...",17,267,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...m germline heterozygous HRAS mutations, including p.G12S (Gripp and Lin, 2012; Siegel et al., 2012)....",17,564,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...ts, 64 additional samples were screened, and HRAS p.G12S mutations were not found (Levinsohn et al.,...",21,307,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...d tissue of WHN100 and WHN101 confirmed this HRAS p.G12S mutation. (c) In WHN100, there is a small m...",50,726,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.S200N,"...tin et al., 2001). Note that Variant 1 (c.599G7A; p.S200N) was present in three patients, and, there...",14,1395,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.R682W,...-galactosidase determination (Fig. 1b). Mutations p.R682W and p.S200N were not capable of upregulati...,16,1168,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.R682W,...-galactosidase determination (Fig. 1b). Mutations p.R682W and p.S200N were not capable of upregulati...,16,1168,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S200N,"...se determination (Fig. 1b). Mutations p.R682W and p.S200N were not capable of upregulation of NF-κB,...",16,1180,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.L228R,"2	75/M	70/70	2	1	rs142246283	c.683T>G, p.L228R	no data	Probably damaging	Tolerated	Pathol...",45,40,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.R682W,"3	46/F	21/21	2	1	rs117918077	c.2044C>T, p.R682W	T: 1.2	Probably damaging	Damaging	Patholog...",46,41,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.R682W,"3	46/F	21/21	2	1	rs117918077	c.2044C>T, p.R682W	T: 1.2	Probably damaging	Damaging	Patholog...",46,41,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.R682W,"3	46/F	21/21	2	1	rs117918077	c.2044C>T, p.R682W	T: 1.2	Probably damaging	Damaging	Patholog...",46,41,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.Gly303Arg,... of the nine predicted transmembrane domains. The p.Gly303Arg mutation was previously reported in Ja...,29,231,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Pro227Ser,... highly conserved sterol-sensing domain (14). The p.Pro227Ser mutation is located in the second cyto...,29,424,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Thr93Met,"...g228Trp (18). Three mutations including IVS-1G→C, p.Thr93Met, and p.Val326Leu account for 50% of the...",29,611,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Arg325Gln,"...ns in Caucasian patients (19). On the other hand, p.Arg325Gln is the most common mutation in Japanes...",29,731,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Arg325Gln,"...ns in Caucasian patients (19). On the other hand, p.Arg325Gln is the most common mutation in Japanes...",29,731,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Arg352Trp,...arbored compound heterozygous mutations including p.Arg352Trp and p.Lys376ArgfsX37 (12). DHCR7 mutat...,29,900,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Ala52Ser,"...68Cys and p.Arg72His) [3], and in spasmodic mice (p.Ala52Ser) [13]. The functional analysis performe...",35,963,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ala52Ser,"...68Cys and p.Arg72His) [3], and in spasmodic mice (p.Ala52Ser) [13]. The functional analysis performe...",35,963,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Trp68Cys,...reported missense mutations in this region (human p.Trp68Cys and p.Arg72His and murine p.Ala52Ser) a...,35,1604,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Arg72His,...se mutations in this region (human p.Trp68Cys and p.Arg72His and murine p.Ala52Ser) are all associat...,35,1619,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ala52Ser,...egion (human p.Trp68Cys and p.Arg72His and murine p.Ala52Ser) are all associated with the recessive ...,35,1641,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Asp18Asn,...i N Hiragi T Ohshima Y Heike T Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurologica...,113,109,J_Med_Case_Rep_2014_Nov_22_8_381.txt
p.R495Q,MYBPC3	NM_000256:c.G1484A:p.R495Q	3	0.008333333	0	0.001833766	Not present	Ye...,221,27,J_Med_Genet_2013_Apr_8_50(4)_228-239.txt
p.A104V,TNNT2	NM_001001432:c.C296T:p.A104V	3	0.008333333	0	0.001833766	Not present	Ye...,222,28,J_Med_Genet_2013_Apr_8_50(4)_228-239.txt
p.Thr1620Met,...4	M	35	21	SCN5A	38593004  C>T	NM_198056.2	4859C>T	p.Thr1620Met	Probably damaging	Probably damaging	8...,134,60,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Met659Thr,... 19§	V	?	?	MYH7	23896054  T>C	NM_000257.2	1976T>C	p.Met659Thr	Probably damaging	Probably damaging	81...,139,58,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Met659Thr,... 19§	V	?	?	MYH7	23896054  T>C	NM_000257.2	1976T>C	p.Met659Thr	Probably damaging	Probably damaging	81...,139,58,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Lys259Glu,...0	M	?	?	?	TPM1	63356265 A>G	NM_001018020.1	775A>G	p.Lys259Glu	Not reliable	Not reliable	56	0.00	C55	...,160,60,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Gly515Ser,...	F	58	16	Yes	VCL	75854219 G>A	NM_014000.2	1543G>A	p.Gly515Ser	Probably damaging	Probably damaging	56...,162,61,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Ser189Leu,...25	M	44	20	?	LDB3	88441437 C>T	NM_007078.2	566C>T	p.Ser189Leu	Benign	Benign	145	0.1	C0	2/10 806	VUS3...,165,59,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Ser189Leu,...25	M	44	20	?	LDB3	88441437 C>T	NM_007078.2	566C>T	p.Ser189Leu	Benign	Benign	145	0.1	C0	2/10 806	VUS3...,165,59,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Arg293Cys,...	M	67	28	?	TNNT2	201328349 C>T	NM_000364.2	877C>T	p.Arg293Cys	Probably damaging	Probably damaging	18...,170,61,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.T312S,... identified a known pathogenic missense mutation (p.T312S) and a likely pathogenic intronic variant ...,182,169,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.Cys873Gly,"...of network centrality for phenotype prediction is p.Cys873Gly in MSH2 (UniProt: P43246), which has b...",81,105,J_Mol_Biol_2014_Jul_15_426(14)_2692-2701.txt
p.Cys873Gly,"...of network centrality for phenotype prediction is p.Cys873Gly in MSH2 (UniProt: P43246), which has b...",81,105,J_Mol_Biol_2014_Jul_15_426(14)_2692-2701.txt
p.E197X,"...mozygous for a novel nonsense mutation, c.589G>T; p.E197X, in exon 3 of the UMOD gene (Figure 2). Th...",30,352,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.E197X,"...s revealed a heterozygote substitution, c.589G>T; p.E197X. Glutamic acid 197 resides in a highly con...",45,127,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys217Gly,7	c.649T>G (p.Cys217Gly)	Pathogeni,110,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys148Tyr,9	c.443G>A (p.Cys148Tyr)	Pathogeni,114,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys148Tyr,9	c.443G>A (p.Cys148Tyr)	Pathogeni,114,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Asn128Ser,10	c.383A>G (p.Asn128Ser)	Pathogeni,116,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Asn128Ser,10	c.383A>G (p.Asn128Ser)	Pathogeni,116,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Gly103Cys,12	c.307G>T (p.Gly103Cys)	Pathogeni,120,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys77Tyr,13	c.230G>A (p.Cys77Tyr)	Pathogeni,122,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.A146T,"... p.G12C, while FAP polyps 12A11S and 9A5S carried p.A146T and p.G13D changes, respectively. All of t...",116,1235,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.A146T,"... p.G12C, while FAP polyps 12A11S and 9A5S carried p.A146T and p.G13D changes, respectively. All of t...",116,1235,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.G13D,"...le FAP polyps 12A11S and 9A5S carried p.A146T and p.G13D changes, respectively. All of these variant...",116,1247,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.Arg59X,c.175C>T; p.Arg59X	0.56	0.04	0.5	49	1	2	0,167,12,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Asp371Gly,c.1112A>G p.Asp371Gly	0.91	0.3	0.67	77	1	1	0,192,12,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Val62Ile,"...owing SNPs CFH −331C>T (rs3753394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His ...",220,140,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Gln672Gln,"....1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G; p.Gln672Gln (rs3753396), CFH IVS15 −543G>A intron ...",220,218,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Gln672Gln,"....1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G; p.Gln672Gln (rs3753396), CFH IVS15 −543G>A intron ...",220,218,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Asp371Gly,The CFB variant p.Asp371Gly (patient 8) has not previously been de...,250,17,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Y402H,... Concolino P Capoluongo E Rapid detection of CFH (p.Y402H) and ARMS2 (p.A69S) polymorphisms in age-r...,209,87,J_Transl_Med_2013_Sep_25_11_228.txt
p.A69S,...ngo E Rapid detection of CFH (p.Y402H) and ARMS2 (p.A69S) polymorphisms in age-related macular degen...,209,107,J_Transl_Med_2013_Sep_25_11_228.txt
p.L858R,...edictive value of frequent alterations (DEL19 and p.L858R) is more or less equivalent but some studi...,25,62,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...nce: -i- is EGFR mutation distribution, including p.T790M, heterogeneous within the primary tumor?; ...",39,123,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...nce: -i- is EGFR mutation distribution, including p.T790M, heterogeneous within the primary tumor?; ...",39,123,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P20	p.G719A	1	0	4	0	5	5	0	 ,101,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P28	p.L858R	4	0	2	0	6	6	0	 ,109,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	3	3	0	 ,112,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P32	p.L858R	0	3	0	1	4	4	0	 ,113,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P34	p.L858R	1£	1	0	1	3	3	0	 ,115,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P35	p.L858R	4	0	2	0	6	6	0	 ,116,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P37	p.L858R	3	0	0	0	3	3	0	 ,118,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P38	p.L858R	3	0	0	0	3	3	0	 ,119,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P39	p.L858R	3	0	0	0	3	3	0	 ,120,5,J_Transl_Med_2014_May_16_12_131.txt
p.G719X,"...utation panel (DEL19, INS20, p.L858R, p.L861Q and p.G719X)",130,537,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,"... PCR technology (CAST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M wer...",132,543,J_Transl_Med_2014_May_16_12_131.txt
p.G719C,"...nology (CAST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M were analyze...",132,552,J_Transl_Med_2014_May_16_12_131.txt
p.G719C,"...nology (CAST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M were analyze...",132,552,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...en patients had an exon 19 deletion (DEL19), 12 a p.L858R point mutation, 6 an exon 20 insertion (IN...",143,294,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,"...samples with expected p.L858R, p.L861Q/p.T790M or p.G719A mutations (Table",144,130,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,All specimens were tested for the p.T790M mutation. This alteration was identified i...,148,35,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,All specimens were tested for the p.T790M mutation. This alteration was identified i...,148,35,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P21	p.G719A	5	0	2	0	 	6	1,203,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P33	p.L858R	0	3	0	0	1	1	1,215,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P35	p.L858R	4	0	2	0	 	6	 ,217,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P39	p.L858R	3	0	0	0	 	2	1,221,5,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,[38]. The p.T790M resistance mutation was studied in all pat...,243,11,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"... the alteration was found once concomitantly to a p.L861Q mutation, both alleles were equally repres...",244,61,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...was homogeneous suggesting that in this case, the p.T790M alteration is a driver mutation altogether...",244,188,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"[15,30,39]. In our series, there was no p.T790M heterogeneity. Considering that our detect...",315,41,J_Transl_Med_2014_May_16_12_131.txt
p.P660L,"...s mutation in TMC1 located in exon 20, c.1979C>T, p.P660L in a three-generation, 14-member family (S...",29,97,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"To determine the potential effects of the p.P660L missense mutation on TMC1 function, we fur...",71,43,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,138691	c.1979C>T	p.P660L	Hom	SIFT	Polyphen2	MutationTaster,76,19,J_Transl_Med_2016_Jan_28_14_29.txt
p.R34X,...Mustapha M  Delmaghani S    High frequency of the p.R34X mutation in the TMC1 gene associated with n...,123,98,J_Transl_Med_2016_Jan_28_14_29.txt
p.Tyr657X,...n itself. Cells studied from one patient with the p.Tyr657X PIK3R1 mutation expressed abundant trunc...,3,4180,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"... (P2–P4) all with the same rare missense variant, p.Arg649Trp (R649W), in the C-terminal SH2 domain ...",39,220,JCI_Insight_1(17)_e88766.txt
p.Tyr657X,"...orted C-terminal PIK3R1 mutations, including both p.Tyr657X and p.Arg649Trp, to be the cause of SHOR...",41,108,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...al PIK3R1 mutations, including both p.Tyr657X and p.Arg649Trp, to be the cause of SHORT syndrome (24...",41,122,JCI_Insight_1(17)_e88766.txt
p.Tyr657X,...ssion of WT p85α or one of two p85α mutants — the p.Tyr657X mutation studied in primary cells and th...,50,271,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...Tyr657X mutation studied in primary cells and the p.Arg649Trp mutation, which accounts for around 50...",50,323,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...r1-null murine fibroblasts in which WT or mutant (p.Arg649Trp) PIK3R1 was stably overexpressed, a st...",64,541,JCI_Insight_1(17)_e88766.txt
p.C436Y,...pound heterozygous missense mutations on SLC12A1 (p.C436Y and p.L560P) and atypical clinical and lab...,3,1894,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.C436Y,...pound heterozygous missense mutations on SLC12A1 (p.C436Y and p.L560P) and atypical clinical and lab...,3,1894,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.F177Y,... intrinsic partial transport defect caused by the p.F177Y mutation. The partial function of NKCC2-F1...,30,1975,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.A555V,...patient with BS type I (compound heterozygous for p.A555V and p.G809V mutations) who presented with ...,30,2247,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.G809V,... BS type I (compound heterozygous for p.A555V and p.G809V mutations) who presented with asymptomatic...,30,2259,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.H186D,...nt our experience with a patient carrying a novel p.H186D heterozygous mutation in the KCNJ11 gene w...,3,2235,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
p.H186D,We report a case of PNDM caused by a novel p.H186D heterozygous mutation in the KCNJ11 gene w...,12,44,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
p.Arg270His,"...t the proband’s father was carrier of c.809G > A (p.Arg270His) mutation, meanwhile his mother and br...",44,646,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Leu279Arg,... gene mutations: a missense mutation (c.836 T > G p.Leu279Arg) and a large fragment deletion (deleti...,44,888,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Arg270His,... (proband A) was found compound heterozygosity of p.Arg270His and p.Trp421* mutations on LPL gene. L...,44,1362,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Arg270His,... (proband A) was found compound heterozygosity of p.Arg270His and p.Trp421* mutations on LPL gene. L...,44,1362,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Arg270His,... (proband A) was found compound heterozygosity of p.Arg270His and p.Trp421* mutations on LPL gene. L...,44,1362,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Arg270His,"...ealed compound heterozygote mutations (c.809G > A p.Arg270His, c.1262G > A p.Trp421*) in the LPL gen...",53,242,Lipids_Health_Dis_2016_May_6_15_88.txt
p.G292R,"...ations and 3 cases were homozygous for the DFNB59 p.G292R variant. Mutations in the WFS1, GJB3, ESRR...",4,851,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G1151R,...edigrees (Figure 2B). Of the 2 missense variants (p.G1151R and p.R1604S) which predictably resulted ...,43,349,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,...no acid residue (Figure 2C). The pathogenicity of p.R1604S was less confirmable given its low PolyPh...,43,758,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.E49X,"...ations identified in the present study, including p.E49X, p.L1582fs, p.P1441_P1443dup, p.G1151R, p.S...",47,134,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G1151R,"...y, including p.E49X, p.L1582fs, p.P1441_P1443dup, p.G1151R, p.S622fs, and p.R1604S. Sequencing data ...",47,171,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,"...1582fs, p.P1441_P1443dup, p.G1151R, p.S622fs, and p.R1604S. Sequencing data are shown on either the ...",47,195,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,Three cases were homozygous for the DFNB59 p.G292R (c.874G > A) variant. This variant was pre...,49,44,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...ism.32,33 However, the allele frequency of DFNB59 p.G292R in the 12 cases, which were recruited from...",49,194,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...r of 1 patient (DE3039) homozygous for the DFNB59 p.G292R variant, whereas imaging findings were nor...",59,366,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...ients. One patient (DE3138) homozygous for DFNB59 p.G292R showed moderate speech perception scores, ...",59,544,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,...uld be consistent with the hypothesis that DNFB59 p.G292R is a pathogenic allele with incomplete pen...,68,987,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,...uld be consistent with the hypothesis that DNFB59 p.G292R is a pathogenic allele with incomplete pen...,68,987,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,.... Another possible explanation is that the DFNB59 p.G292R variant is not a causative mutation for de...,68,1094,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,.... Another possible explanation is that the DFNB59 p.G292R variant is not a causative mutation for de...,68,1094,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...ausative mutation in these 3 patients, the DFNB59 p.G292R variant still might serve as a predictor f...",68,1407,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G3658E,"3.3 In silico analysis of (c.10973G > A, p.G3658E) varian",42,42,Meta_Gene_2016_May_18_9_124-127.txt
p.Arg3527Gln,"...them being novel. 13 (8%) individuals carried the p.Arg3527Gln mutation in APOB, and overall the det...",12,122,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln,"...them being novel. 13 (8%) individuals carried the p.Arg3527Gln mutation in APOB, and overall the det...",12,122,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln,"...them being novel. 13 (8%) individuals carried the p.Arg3527Gln mutation in APOB, and overall the det...",12,122,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln,"...mutation. The most frequent mutation was in APOB (p.Arg3527Gln), found in 13 (8%) patients. No patie...",43,330,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln,"...mutation. The most frequent mutation was in APOB (p.Arg3527Gln), found in 13 (8%) patients. No patie...",43,330,Metabolism_2016_Mar_65(3)_48-53.txt
p.Trp483Cys,"...r four novel mutations, p.Ala612Ser, p.Asp579Gly, p.Trp483Cys, and p.Val127Asp were also predicted t...",52,59,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val127Asp,"...tions, p.Ala612Ser, p.Asp579Gly, p.Trp483Cys, and p.Val127Asp were also predicted to be pathogenic; ...",52,76,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg,...1 Family co-segregation of the novel c.1862C > G (p.Thr621Arg) LDLR mutation. (A) A family pedigree ...,92,56,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr62Met, c.185C > T	p.Thr62Met	1	2	Probably damaging	Tolerated	Disease...,138,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val127Asp, c.380T > A	p.Val127Asp	1	41	Possibly damaging	Not tolerated	D...,139,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe, c.986G > T	p.Cys329Phe	4	71	Probably damaging	Not tolerated	D...,147,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg416Trp, c.1246C > T	p.Arg416Trp	2	9	Probably damaging	Not tolerated	Di...,150,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Pro685Leu, c.2054C > T	p.Pro685Leu	1	14	Probably damaging	Not tolerated	D...,161,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asn515Asn, c.1545C > T	p.Asn515Asn	1	10	n/a	Tolerated	Polymorphism	No,178,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg744Gln, c.2231G > A	p.Arg744Gln	1	15	Benign	Tolerated	Polymorphism	No,183,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln, c.10580G > A	p.Arg3527Gln	13	APOB ex26	Probably damaging	Not to...,189,15,Metabolism_2016_Mar_65(3)_48-53.txt
p.C89R,"...nd’s sister presented with the same HJV c.265T>C (p.C89R) homozygote mutation. In addition, we found...",43,446,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"...nd’s sister presented with the same HJV c.265T>C (p.C89R) homozygote mutation. In addition, we found...",43,446,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.G320V,"...olaou et al. showed that 80% of HJV mutations are p.G320V, however until now more than 25 different ...",62,1012,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"...he proband, case III-9 was a homozygote c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p....",317,122,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.V295A,... (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation for HFE. The latter mutation has...,317,170,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,...m Iran which is reported as a novel HJV mutation (p.C89R),340,447,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.Ser577Ser,(p.Ser577Ser),84,2,Mol_Cancer_2014_Jan_24_13_11.txt
p.Lys195X,(p.Lys195X),88,2,Mol_Cancer_2014_Jan_24_13_11.txt
p.Glu470Gln,"We found a missense mutation (c.1408 G>C, p.Glu470Gln) in one patient and a nonsense mutatio...",12,43,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
p.Glu470Gln,"We found a missense mutation (c.1408 G>C, p.Glu470Gln) in one patient and a nonsense mutatio...",12,43,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
p.Gly245Arg,"...d one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heterozygous in...",12,276,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
p.L1291F,Fig. 3. The location of the p.L1291F mutation (blue) is close to two functiona...,83,29,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu1291Phe,c.3871C>T	p.Leu1291Phe	Motor	Heterozygous	Profound	This stud...,104,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val1400Met,c.4198G>A	p.Val1400Met	Motor	Homozygous	Severe to profound	C...,106,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Asp1451Asn,c.4351G>A	p.Asp1451Asn	Motor	Homozygous	Severe to profound	N...,109,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Ser1481Pro,c.4441T>C	p.Ser1481Pro	Motor	Homozygous	Severe to profound	C...,110,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu1730Pro,c.5189T>C	p.Leu1730Pro	Motor	Homozygous	Severe to profound	N...,114,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gly1831Val,c.5492G>T	p.Gly1831Val	Motor	Homozygous	Profound	Kalay et al...,115,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val2114Met,c.6340G>A	p.Val2114Met	MyTH4 1	Heterozygous	Severe to profou...,122,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val2114Met,c.6340G>A	p.Val2114Met	MyTH4 1	Heterozygous	Severe to profou...,122,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg2146Gln,c.6437G>A	p.Arg2146Gln	MyTH4 1	Heterozygous	Severe to profou...,124,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val2792Ala,c.8375T>C	p.Val2792Ala		Heterozygous	Severe to profound	Gao ...,134,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val2792Ala,c.8375T>C	p.Val2792Ala		Heterozygous	Severe to profound	Gao ...,134,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Pro221Leu,...es both the exon 1 (p.Val19fs*24) and the exon 5 (p.Pro221Leu) mutations (Fig. 1b). As the parents a...,16,130,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.D281Afs,10	c.842delA	p.D281Afs*7	f	Novel	28,41,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.H603Ifs,17	c.1806_1807insAT	p.H603Ifs*59	i	Novel	31,60,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.K654Sfs,18	c.1961_1962delAA	p.K654Sfs*21	f	Novel	43,62,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Y69Vfs,IVS2	c.205-2_205-1delAGinsT	p.Y69Vfs*33	f	Stahl et al. (2008)	43,68,29,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Q112Ffs,7	c.334_337delCAAA	p.Q112Ffs*13	f	Novel	20,76,20,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.I131Sfs,7	c.391delA	p.I131Sfs*4	f	Novel	1,77,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.A119Gfs,IVS8	c.475-2A>G	p.A119Gfs*423	i	Novel	22,78,17,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.W740S,"...his study, with two mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7%. Other ...",82,1060,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.W740S,"...his study, with two mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7%. Other ...",82,1060,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.L76P,"... mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7%. Other frequent mutations ...",82,1079,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Asp106Gly,"...ted as pathogenic for a given codon (i.e., PTPN11 p.Asp106Gly rather than p.Asp106Ala)",21,1250,Mol_Genet_Genomic_Med_2015_Mar_3_3(2)_99-110.txt
p.Asp106Gly,"...ted as pathogenic for a given codon (i.e., PTPN11 p.Asp106Gly rather than p.Asp106Ala)",21,1250,Mol_Genet_Genomic_Med_2015_Mar_3_3(2)_99-110.txt
p.V399V,"...th PKU, and previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were detected",10,646,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.A403V,"...nd previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were detected",10,655,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,....5). The patient was a compound heterozygote of a p.Y356X (c.1068 C to A transversion) and a p.A403V...,50,766,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,"...the 2 cases were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previously reporte...",55,301,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,"...the 2 cases were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previously reporte...",55,301,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,"...the 2 cases were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previously reporte...",55,301,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Asp816His,"...el, p.Lys558_Glu562del) and exon 17 (c.2446G > C, p.Asp816His) was used [26]. Xenografts were establ...",35,120,Mol_Imaging_Biol_2011_Dec_16_13(6)_1234-1240.txt
p.Val502Asp,"...he FVIII gene (F8) was found in this patient. The p.Val502Asp mutation, which has been reported prev...",3,1606,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,"...omain. The compound heterozygote mutations in F8, p.Val502Asp and p.Met1093Ile, caused HA in this fe...",3,1814,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,"...omain. The compound heterozygote mutations in F8, p.Val502Asp and p.Met1093Ile, caused HA in this fe...",3,1814,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile) were identified using multiplex PCR ...",12,237,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"...rted missense point mutation (exon 14, c.3279G>A, p.Met1093Ile) (Fig. 1)",31,189,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...ting from F8 compound heterozygous mutations. The p.Val502Asp mutation located in A2 domains was fir...,44,169,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...ting from F8 compound heterozygous mutations. The p.Val502Asp mutation located in A2 domains was fir...,44,169,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"..., inactivation and clearance (30). Therefore, the p.Met1093Ile mutation in the B domain also affects...",44,1319,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"..., inactivation and clearance (30). Therefore, the p.Met1093Ile mutation in the B domain also affects...",44,1319,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... compound heterozygous mutations (p.Val502Asp and p.Met1093Ile) are causative gene defects, which re...",44,1740,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...ns 10 and 14. (A) Exon 10: NM_000132.3 c.1505T>A (p.Val502Asp). (B) Exon 14: NM_000132.3 c.3279G>A (...,51,94,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...tructure of the B domain. (C and D) Comparison of p.Val502Asp mutation structural images in A2 domai...,53,609,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...tructure of the B domain. (C and D) Comparison of p.Val502Asp mutation structural images in A2 domai...,53,609,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.R603I,"... results identified two novel missense mutations, p.R603I and p.G749 V. These mutations were not ide...",3,1985,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,"... of the SIFT for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mu...",24,1037,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,"... of the SIFT for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mu...",24,1037,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,The p.R603I and p.G749V mutations identified in the present study ...,37,17,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,The p.R603I and p.G749V mutations identified in the present study ...,37,17,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,The p.R603I and p.G749V mutations identified in the present study ...,37,17,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,"...nt study identified two novel missense mutations, p.R603I and p.G749V, in the ATP2A2 gene in two fam...",39,75,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,"...ntified two novel missense mutations, p.R603I and p.G749V, in the ATP2A2 gene in two families contai...",39,87,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,"...ntified two novel missense mutations, p.R603I and p.G749V, in the ATP2A2 gene in two families contai...",39,87,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G51D,...t Parkinson’s disease with dementia carrying SNCA p.G51D mutation Parkinsonism Relat Disord 2014 20 ...,307,191,Mol_Neurodegener_2015_Aug_27_10_41.txt
p.H50Q,"...ion M  Sherman H  Yu I  Shah B    Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson’...",322,100,Mol_Neurodegener_2015_Aug_27_10_41.txt
p.K318E,"... located in PLXNB2 at 22q13 (rs28379706, c.A952G, p.K318E; PCC=1.31 × 10-5, beta=−0.04±0.009, odds r...",80,354,Mol_Psychiatry_2016_Aug_4_21(8)_1145-1151.txt
p.R400W,Exon 12	c.1198C>T	p.R400W	LCA		 [2],53,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R400W,Exon 12	c.1198C>T	p.R400W	LCA		 [2],53,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R420P,Exon 13	c.1259G>C	p.R420P	Early onset RP	Found in compound heterozyg...,56,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R420P,Exon 13	c.1259G>C	p.R420P	Early onset RP	Found in compound heterozyg...,56,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.I459K,Exon 14	c.1376 T>A	p.I459K	Early onset RP	Found in compound heterozyg...,57,20,Mol_Vis_2008_Apr_21_14_675-682.txt
p.L461V,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.L461V,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.L461V,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.K489R,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.K489R,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.K489R,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.Glu72Lys,c.214G>A	missense	p.Glu72Lys	exon 4	5	5	2	17.86,89,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Glu72Lys,c.214G>A	missense	p.Glu72Lys	exon 4	5	5	2	17.86,89,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Arg141Cys,c.421C>T	missense	p.Arg141Cys	exon 5	6	6+1	3	21.42+1.79,91,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Arg141Cys,c.421C>T	missense	p.Arg141Cys	exon 5	6	6+1	3	21.42+1.79,91,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Arg141His,c.422G>A	missense	p.Arg141His	exon 5	5	4	1	16.07,92,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Pro192Leu,"...ing revealed a novel missense mutation (c.575C>T, p.Pro192Leu) in exon 6 of family 7. In addition, t...",121,865,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.R733X,...a novel heterozygous nonsense mutation c.2197C>T (p.R733X). The 2 novel mutations cosegregated with ...,120,231,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.R733X,...a novel heterozygous nonsense mutation c.2197C>T (p.R733X). The 2 novel mutations cosegregated with ...,120,231,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.R733X,The novel nonsense mutation c.2197C>T (p.R733X) detected in family F2 presumably caused p...,126,40,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.Glu150Lys,...two Pakistani families studied here share the RHO p.Glu150Lys mutation due to a common ancestry,16,318,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...ed [15]. Here we report the identification of the p.Glu150Lys RHO mutation in affected individuals f...,23,899,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Asn225Ser,c.674A>G	p.Asn225Ser	CPHD	[22],52,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Asn225Ser,c.674A>G	p.Asn225Ser	CPHD	[22],52,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Gln97X,c.289C>T	p.Gln97X	Inferior iris coloboma OD/ retinal colobo...,60,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Gln99X,c.295C>T	p.Gln99X	bilateral anopthalmia	[11],70,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.R240X,... c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations in the affected members o...,13,430,Mol_Vis_2009_Oct_17_15_2074-2083.txt
p.Ser15Cys,C20orf72 (NM_018152)	c.43A>T	p.Ser15Cys	rs11551768	Y (hetero) Score=18	N	Y (het...,82,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ser15Cys,C20orf72 (NM_018152)	c.43A>T	p.Ser15Cys	rs11551768	Y (hetero) Score=18	N	Y (het...,82,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr109Thr,OVOL2 (NM_021220)	c.327C>A	p.Thr109Thr	rs6111803	Y (hetero) Score=17	N	Y (het...,92,28,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr109Thr,OVOL2 (NM_021220)	c.327C>A	p.Thr109Thr	rs6111803	Y (hetero) Score=17	N	Y (het...,92,28,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val400Gly,CSRP2BP (NM_020536)	c.1199T>G	p.Val400Gly	rs1205193	Y (homo) Score=23	Y (homo) S...,95,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro479Pro, 	c.1437C>T	p.Pro479Pro	rs1205194	N	N	N	N,96,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro741Pro, 	c.2223T>C	p.Pro741Pro	rs2747404	Y (homo) Score=25	Y (homo) S...,98,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro741Pro, 	c.2223T>C	p.Pro741Pro	rs2747404	Y (homo) Score=25	Y (homo) S...,98,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu14Leu,C20orf12 (NM_018152)	c.40T>C	p.Leu14Leu	rs6035051	Y (hetero) Score=25	Y (homo) ...,102,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val164Met,SEC23B (NM_032985)	c.490G>A	p.Val164Met	rs36023150	N	N	N	N,111,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.His489Gln, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score=27	N	Y(he...,114,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr222Ala, 	c.664A>G	p.Thr222Ala	rs6081271	N*	N*	Y (homo)	Y (homo),118,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr222Ala, 	c.664A>G	p.Thr222Ala	rs6081271	N*	N*	Y (homo)	Y (homo),118,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr222Ala, 	c.664A>G	p.Thr222Ala	rs6081271	N*	N*	Y (homo)	Y (homo),118,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Gln92X,LOC100132358 (NC_000020)	c.274C>T	p.Gln92X	rs6081369	Y (hetero) Score=24	Y (hetero) ...,129,35,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg448Arg,1343G>A	p.Arg448Arg	rs80046336	Y (hetero) Score=22	Y (hete...,134,10,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg448Arg,1343G>A	p.Arg448Arg	rs80046336	Y (hetero) Score=22	Y (hete...,134,10,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val55Ile,c.163G>A	p.Val55Ile	rs1569767	N	Y (hetero) Score=17	N	Y (he...,140,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ala123Ala,c.369G>A	p.Ala123Ala	rs3790261	Y (Hetero) Score=26	Y (homo)...,141,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ile218Ile,c.654T>C	p.Ile218Ile	rs3790279	Y (homo) Score=26	Y (homo) S...,143,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg514Pro,...ctural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. A...,13,598,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...ly 1, two novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), in exon 11 of TGFBI (F...",61,148,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,"... results of the heterozygote mutations c.1876A>G (p.His572Arg) of TGFBI in Family 3, and their corre...",67,70,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...quences of TGFBI displayed a high conservation of p.Arg514Pro and Phe515Leu in the chimpanzee, cow, ...",69,475,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...tion could be detected. In Family 1, the mutation p.Arg514Pro is predicted to shorten the helix and ...",74,257,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T (p. Arg12...,77,238,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T (p. Arg12...,77,238,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T (p. Arg12...,77,238,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg124Leu,...e. Dighiero and colleagues [10] suggest that both p.Arg124Leu and p.Thr125_Glu126del compound hetero...,79,769,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Gly470X,...’s daughter who carries the heterozygous mutation p.Gly470X alone was unaffected. This raises the qu...,79,1136,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Gly470X,...’s daughter who carries the heterozygous mutation p.Gly470X alone was unaffected. This raises the qu...,79,1136,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Gly470X,...ld be pathogenic. The authors speculated that the p.Gly470X nonsense mutation might be nonpathogenic...,79,1313,Mol_Vis_2010_Feb_15_16_224-230.txt
p.K1370E,"...d only in the RP patients. Two missense variants (p.K1370E and p.R1652L), which are conserved in pri...",15,135,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... RP patients. Two missense variants (p.K1370E and p.R1652L), which are conserved in primates, were p...",15,148,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... RP patients. Two missense variants (p.K1370E and p.R1652L), which are conserved in primates, were p...",15,148,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,"...1 protein. The other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered benign",15,308,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L2015L,"...he other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered benign",15,320,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L1808P,"...8], p.K663N [16], p.A669T [18], p.D984G [21], and p.L1808P [16], have been found to be disease causi...",25,1280,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R677X,...th mixed phenotypes. We found that RP1 mutations (p.R677X and p.D984G) accounted for about 1.2% of o...,27,163,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.S1691P,"... 1). Among them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs...",46,100,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,Exon 4	c.1222A>C	p.I408L	Novel	20090	0/190,54,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,Exon 4	c.1222A>C	p.I408L	Novel	20090	0/190,54,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G706R,Exon 4	c.2116G>C *	p.G706R	 [26]	20121	1/190,55,20,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R872H,Exon 4	c.2615G>A	p.R872H	rs444772	43/55	130/190,56,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1008Q,Exon 4	c.3024G>A	p.Q1008Q	 [26]	20090	1/190,58,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L2015L,Exon 4	c.6045A>G	p.L2015L	Novel	20090	0/190,64,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1008Q,"...ied eight rare variants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both the case...",69,66,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L2015L,...jects from different areas of China. Two of them (p.L2015L and intronic c.787+34T>C) did not lead to...,69,258,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ndex of 7) by PMUT. With a Grantham score of 102, p.R1652L should be moderately radical and highly l...",71,810,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"... RP1 wild type protein and the missense variants, p.K1370E and p.R1652L, were analyzed by web-based ...",81,134,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...e protein and the missense variants, p.K1370E and p.R1652L, were analyzed by web-based analysis prog...",81,147,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,A. Description	Wild type	p.K1370E,82,26,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"Difference between wild type and the p.K1370E variant, at position around residue 1370....",90,38,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"Difference between wild type and the p.K1370E variant, at position around residue 1370....",90,38,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...due 1370. B. Difference between wild type and the p.R1652L variant, at position around residue 1652....",90,129,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... partially), showing the location of p.K1370E and p.R1652L. The two residues are not conserved acros...",92,127,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... partially), showing the location of p.K1370E and p.R1652L. The two residues are not conserved acros...",92,127,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,...ssment. By using these tools we would expect that p.I408L is less likely to be a functional mutation...,95,1047,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,...ssment. By using these tools we would expect that p.I408L is less likely to be a functional mutation...,95,1047,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...-be-identified mutation. In contrast, the variant p.R1652L was likely to be a deleterious substituti...",95,1689,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"...PolyPhen, SIFT, PMUT, and Grantham score. Variant p.K1370E was also predicted to be deleterious by t...",95,1823,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"... mutation carrier [29]. Notably, the p.R1652L and p.K1370E carriers were classified as sRP because t...",95,2797,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...sentations of the two putative missense mutation (p.K1370E and p.R1652L) carriers. They both appear ...,97,83,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...m (ERG) and automated visual field reports of the p.K1370E carrier. B: Fundus photographs and automa...,97,283,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R677X,"...revious studies, we identified two RP1 mutations, p.R677X and p.D984G, in two out of 173 Hong Kong C...",99,59,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.N985Y,"...ee and absent in 105 controls. Interestingly, the p.N985Y variant was found to be very common in our...",99,754,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.P903L,"...ther three missense variants (p.P63I, p.G79E, and p.P903L) were also found to occur at high frequenc...",99,1194,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K663N,p.K663N	c.1989G.>T	U.S.A.	ADRP	[16],106,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.A669T,p.A669T	c.2005G>A	Pakistan	ARRP	[18],107,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,p.R1652L	c.4955G>T	Chinese	SRP	Present Study,111,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L1808P,p.L1808P	c.5423T>C	U.S.A.	ADRP	[16],112,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L1808P,p.L1808P	c.5423T>C	U.S.A.	ADRP	[16],112,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L1808P,p.L1808P	c.5423T>C	U.S.A.	ADRP	[16],112,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...tified two novel missense mutations (p.R1652L and p.K1370E). These mutations were predicted to have ...,119,75,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.V107I,...acement of highly conserved Valine by Isoleucine (p.V107I),46,260,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"....1). We found that codon 107, where the mutation (p.V107I) occurred, was phylogenetically conserved ...",56,444,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"...ecies reveals that codon 107, where the mutation (p.V107I) occurred, is highly conserved",58,166,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"...ecies reveals that codon 107, where the mutation (p.V107I) occurred, is highly conserved",58,166,Mol_Vis_2010_Mar_25_16_534-539.txt
p.I576T, 	m.14063T>C (p.I576T)	MT-ND5	Yes	Yes	No	12/15859	0.25	0.582,45,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.Y159H," 	m.12811T>C (p.Y159H)	MT-ND5	Yes	Yes	Yes (H3h, A2h1, M7b1’2’4–8...",46,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I278V,...identified in Le329 and Le337 (m.5301A>G [MT-ND2: p.I278V]; m.14063T>C [MT-ND5: p.I576T]; m.12811T>C...,56,660,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.Y159H,"...m.14063T>C [MT-ND5: p.I576T]; m.12811T>C [MT-ND5: p.Y159H] and m.15237T>C [MT-CYB: p.I164T]), Le569 ...",56,720,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.L95F,"...[MT-ATP6: p.F9L]), FJ969382.1 (m.7868C>T [MT-CO2: p.L95F]; m.9071C>T [MT-ATP6: p.S182L] and m.12358A...",56,864,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.S182L,"... (m.7868C>T [MT-CO2: p.L95F]; m.9071C>T [MT-ATP6: p.S182L] and m.12358A>G [MT-ND5: p.T8A]), and FJ96...",56,893,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I576T,... A: Variants m.12811T>C (p.Y159H) and m.14063T>C (p.I576T) changed the structure of the membrane-spa...,58,230,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I576T,... A: Variants m.12811T>C (p.Y159H) and m.14063T>C (p.I576T) changed the structure of the membrane-spa...,58,230,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I576T,... A: Variants m.12811T>C (p.Y159H) and m.14063T>C (p.I576T) changed the structure of the membrane-spa...,58,230,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I164T,...ion of the MT-ND5 protein. B: Variant m.15237T>C (p.I164T) changed the structure of the membrane-spa...,58,339,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.S182L,...gion of the MT-CYB protein. C: Variant m.9071C>T (p.S182L) changed the structure of the membrane-spa...,58,447,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.Val234Ile,CA4	p.Val234Ile	44	280	48	222	0*	-	0*	-	0*	-,81,5,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Cys214Tyr,PRPH2	p.Cys214Tyr	40	48	67	27	0*	-	0*	-	0*	-,86,7,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Arg310Lys,p.Arg310Lys	0*	-	48	40	100	25	92	24	96	28,89,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Asn985Tyr,p.Asn985Tyr	0*	-	0*	-	60	20	53	17	46	55,92,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Arg310Lys,... 2). The sequences also revealed the polymorphism p.Arg310Lys in exon 3 of PRPH2 [20] in a heterozyg...,97,433,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Arg310Lys,... 2). The sequences also revealed the polymorphism p.Arg310Lys in exon 3 of PRPH2 [20] in a heterozyg...,97,433,Mol_Vis_2013_Mar_21_19_654-664.txt
p.R144W,"...4_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c.672_701dup30 (p.Ala224_Ala234dup10...",12,138,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,...he mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are two novel missense mutations,12,338,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,"..._Ala234dup10), c.313C>A (p. N105H), and c.430G>T (p.R144W; Figure 3). These mutations were also pres...",53,201,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.N105H,"...—c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene...",82,92,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,"...4_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene in four Han Chinese fam...",82,116,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.F1442S,"...SH2A) compound heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in ex...",10,82,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,"...s mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in exons 20 and 70, respectivel...",10,108,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,"...s mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in exons 20 and 70, respectivel...",10,108,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...as found for these mutations. The missense mutant p.F1442S residue, buried in a fibronectin type III...",82,314,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...ective USH2A membrane anchorage. Furthermore, the p.F1442S change affects long and short isoforms wh...",87,926,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...ective USH2A membrane anchorage. Furthermore, the p.F1442S change affects long and short isoforms wh...",87,926,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.Tyr343Asp,"...ico analysis predicted that the missense variant, p.Tyr343Asp, disrupted the CYP4V2 surface electros...",10,724,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,"...44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,62,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,"...44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,62,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,1	c.31C>T	p.Q11X	1/0	0/200	2/184	novel,66,11,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.R320X,7	c.958C>T	p.R320X	0/1	ND	1/184	Reported,75,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.H331P,8	c.992A>C	p.H331P	0/22	ND	22/184	Reported,76,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.H331P,8	c.992A>C	p.H331P	0/22	ND	22/184	Reported,76,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.P396L,9	c.1187C>T	p.P396L	0/2	ND	2/184	Reported,80,13,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Tyr343Asp,"...h resulted in a tyrosine to aspartic acid change (p.Tyr343Asp). In patient 60, a nonsense mutation (...",84,502,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Gln11X,"...ermination codon (TAG) at amino acid position 11 (p.Gln11X) in exon 1 was identified (Figure 4C,D), ...",84,661,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Tyr343Asp,Mutant molecular model showed that p.Tyr343Asp affected the alpha spiral structure on...,96,36,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.E820Gfs,"...fied three homozygous mutations [c.2458_2459insG (p.E820Gfs*23), c.1721+1G>A and c.760C>T (p.Q254*)]...",72,90,Mol_Vis_2014_Jun_12_20_790-796.txt
p.E820Gfs,(p.E820Gfs*23)	Exon 18	Frameshift	Homozygous	Saudi ...,89,2,Mol_Vis_2014_Jun_12_20_790-796.txt
p.H395R,...he MKKS/BBS6 gene in both patients resulting in a p.H395R substitution in the MKKS/BBS6 protein. Thi...,10,287,Mol_Vis_2016_Jan_24_22_73-81.txt
p.G3083D,"... elongation of its neighboring β-sheet induced by p.G3083D (c.9248G>A), which could alter the tertia...",12,947,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"... elongation of its neighboring β-sheet induced by p.G3083D (c.9248G>A), which could alter the tertia...",12,947,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"ARRP07	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Hom	E32	DA (0.03)	PD (0.68)	DE (...",68,37,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"ARRP07	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Hom	E32	DA (0.03)	PD (0.68)	DE (...",68,37,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"6: 64,430,679	c.9248G>A	p.G3083D	missense	Het	E43	DA (0.02)	DA (0.979)	N (...",70,25,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"6: 64,430,679	c.9248G>A	p.G3083D	missense	Het	E43	DA (0.02)	DA (0.979)	N (...",70,25,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"ARRP09	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Het	E32	DA (0.03)	PD (0.68)	DE (...",72,37,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2410Gfs,"6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	NA	NA	Novel...",73,28,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"...cine to the acidic aspartic acid at residue 3083 (p.G3083D; Figure 1A,E and Figure 3). The crystal s...",78,455,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,... The crystal structure of the mutant protein with p.G3083D indicated shortening of the neighboring β...,78,541,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,... The crystal structure of the mutant protein with p.G3083D indicated shortening of the neighboring β...,78,541,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,...eine to the hydrophobic tyrosine at residue 2139 (p.C2139Y). Our previous work revealed the generati...,78,829,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2498P,3$	c.7492G>C (Hom)	p.A2498P (Hom)	W159–1	IRDs	34/M	20	20/40	20/50	-	-...,110,20,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,3$	c.6416G>A (Hom)	p.C2139Y (Hom)	W75–1	IRDs	31/M	20	20/100	20/100	-	...,113,20,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"...thalmic examinations. The recurrent mutation, EYS p.G2186E, a mutational hotspot among multiple ethn...",116,261,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,...e one patient in this study carrying a homozygous p.G2186E mutation claims to have had night blindne...,116,738,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,"...same allele with the reported pathogenic mutation p.C2139Y. Another recurrent mutation, the frameshi...",118,763,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,"...same allele with the reported pathogenic mutation p.C2139Y. Another recurrent mutation, the frameshi...",118,763,Mol_Vis_2016_Jun_16_22_646-657.txt
p.Gly113Asp,"...23GlufsX9, p.Ile48ValfsX55, p.His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, and p.Cys126Arg, includi...",10,112,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, and p.Cys126Arg, including five novel ones), were obse...",10,142,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, and p.Cys126Arg, including five novel ones), were obse...",10,142,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,"...ons were novel, including three missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two ...",68,456,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...ee missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two small base pair frame shift d...",68,485,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...ee missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two small base pair frame shift d...",68,485,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...s observed in three familial FEVR cases while the p.Gly113Asp, p.Cys126Arg, and p.Arg121Gln changes ...",68,658,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...s observed in three familial FEVR cases while the p.Gly113Asp, p.Cys126Arg, and p.Arg121Gln changes ...",68,658,Mol_Vis_2016_May_16_22_491-502.txt
p.Arg121Gln,"...EVR cases while the p.Gly113Asp, p.Cys126Arg, and p.Arg121Gln changes were observed in three sporadi...",68,688,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,... in three sporadic cases (Figure 1). Although the p.His50Asp change segregated with the disease phen...,68,771,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damaging (0.997)	...,89,11,Mol_Vis_2016_May_16_22_491-502.txt
p.C126R,"... the novel missense changes (p.H50D, p.G113D, and p.C126R) demonstrates the evolutionarily conserved...",96,150,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,...ovascular traction. B: Patient ID: family 33-I:2 (p.H50D; affected mother of the proband); the left ...,101,394,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...cular dragging. C, D: Patient ID: family 72-IV:1 (p.H50D); the right (C) and left (D) eyes show drag...",101,549,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...cular dragging. C, D: Patient ID: family 72-IV:1 (p.H50D); the right (C) and left (D) eyes show drag...",101,549,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,...n ectopic macula. E: Patient ID: family 139-II:2 (p.H50D); the right eye of the patient shows an ava...,101,687,Mol_Vis_2016_May_16_22_491-502.txt
p.Arg121Gln,"...ygous p.Ile48ValfsX55, p.Ser57*, p.Gly113Asp, and p.Arg121Gln changes were phenotypically normal on ...",103,648,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...el missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) were located in the highly conserved ...",110,86,Mol_Vis_2016_May_16_22_491-502.txt
p.R1163X,"...ntified a somatic truncating mutation, c.3487A>T; p.R1163X (Fig. 1b). While the phase of this mutati...",25,340,Nat_Commun_2014_Aug_7_5_4398.txt
p.Lys101Asn,c.303G>C; p.Lys101Asn	 	Possibly damaging	Tolerated	No effec...,168,11,Nat_Commun_2014_Aug_7_5_4398.txt
p.Glu443Asp,c.1329G>T; p.Glu443Asp	 	Benign	Tolerated	No effect	2	 ,173,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Gly966Ala,c.2897G>C; p.Gly966Ala	rs192522878	Benign	Tolerated	No effect...,186,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Gly966Ala,c.2897G>C; p.Gly966Ala	rs192522878	Benign	Tolerated	No effect...,186,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Lys1050Arg,c.3149A>G; p.Lys1050Arg	rs141131642	Benign	Tolerated	No effec...,189,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Arg1095Lys,c.3284G>A; p.Arg1095Lys	rs141434094	Possibly damaging	Tolerat...,194,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.V1184A,...umans. Electrophysiological analysis reveals that p.V1184A shifts the voltage dependence of channel ...,3,2636,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ividuals, a missense change in SCN11A, c.3551T>C, p.V1184A (chr3:38913144A>G, hg19), was the most li...",20,1199,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"To analyse the consequences of mutation p.V1184A for the function of NaV1.9, we performed ...",23,41,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...aV1.9 at 30 and 20 °C; 9.8±1.0 and 9.8±0.7 mV for p.V1184A at 30 and 20 °C, respectively; both P>0.0...",25,1612,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"When overexpressed in DRG neurons, p.V1184A mutant channels depolarized the cell memb...",34,36,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f 1.6±0.1 (P<0.001, two-tailed t-test) for mutant p.V1184A (Fig. 5b,d). Thus, attenuation of DRG neu...",36,837,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Comparison of mutation p.V1184A with p.L811,38,24,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...t to that of the NaV1.9 gain-of-function mutation p.L811P, which results in pain insensitivity1516. ...",39,215,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ned elusive. Therefore, we analysed the impact of p.L811P on excitability of DRG neurons under ident...",39,385,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...der identical experimental conditions as used for p.V1184A. As illustrated in Supplementary Fig. 1, ...",39,476,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ed with current injections for 2 s, revealed that p.L811P rendered neurons hyperexcitable at both te...",39,957,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...shable firing patterns between neurons expressing p.L811P or p.V1184A (Fig. 6). As illustrated in Fi...,39,1282,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...eurons expressing p.L811P (P<0.01, Z-test). Thus, p.L811P channels increase the probability of cumul...",39,1714,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...eurons expressing p.L811P (P<0.01, Z-test). Thus, p.L811P channels increase the probability of cumul...",39,1714,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f KV and NaV channel structures26272829, mutation p.V1184A is located within a conserved sequence at...",44,550,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f KV and NaV channel structures26272829, mutation p.V1184A is located within a conserved sequence at...",44,550,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f KV and NaV channel structures26272829, mutation p.V1184A is located within a conserved sequence at...",44,550,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...e can trigger painful episodes in carriers of the p.V1184A mutation, we analysed the effect of tempe...",46,482,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,... temperature. We further showed that the mutation p.V1184A did not affect the Q10 values of the gati...,46,906,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...nario would be in line with our data showing that p.V1184A does not affect the intrinsic temperature...,48,1083,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1316A,...homologous mutation p.V1316A in NaV1.7 (ref. 10): p.V1316A in NaV1.7 causes warmth-aggravated severe...,50,730,Nat_Commun_2015_Dec_8_6_10049.txt
p.A808G,"...s in patients carrying NaV1.9 mutation p.R225C or p.A808G. Notably, Han et al.36 described mutation ...",50,1715,Nat_Commun_2015_Dec_8_6_10049.txt
p.A808G,"...s in patients carrying NaV1.9 mutation p.R225C or p.A808G. Notably, Han et al.36 described mutation ...",50,1715,Nat_Commun_2015_Dec_8_6_10049.txt
p.G699R,"...p.A808G. Notably, Han et al.36 described mutation p.G699R, located in the S4/S5 linker in domain II ...",50,1765,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... contrast to the NaV1.9 gain-of-function mutation p.L811P that results in pain insensitivity1516. Th...,52,176,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...d elusive. To infer potential differences between p.V1184A and p.L811P we assessed the functions of ...,52,346,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... only −20 mV, clearly demonstrating that mutation p.L811P facilitates opening of NaV1.9 more strongl...",52,1517,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...tes opening of NaV1.9 more strongly than mutation p.V1184A (Fig. 7b). As a result, the window curren...",52,1583,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...tes opening of NaV1.9 more strongly than mutation p.V1184A (Fig. 7b). As a result, the window curren...",52,1583,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ntary Fig. 1d–g). Thus, neurons expressing either p.V1184A or p.L811P must be considered hyperexcita...",54,282,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...d–g). Thus, neurons expressing either p.V1184A or p.L811P must be considered hyperexcitable under th...",54,294,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...d–g). Thus, neurons expressing either p.V1184A or p.L811P must be considered hyperexcitable under th...",54,294,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...ed in a substantial portion of neurons expressing p.L811P mutant channels (Fig. 6). This instability...,54,692,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... may be caused by increased influx of Na+ through p.L811P as it is predicted by the larger window cu...,54,792,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... may be caused by increased influx of Na+ through p.L811P as it is predicted by the larger window cu...,54,792,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...er inactivation kinetics of p.L811P compared with p.V1184A or wild-type NaV1.9 (Fig. 7a). Excessive ...,54,920,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...nactivation of NaV1.9 is not affected by mutation p.V1184A while mutation p.L811P slows down channel...,148,222,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...rrent is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9. (c) Current traces ...,148,701,Nat_Commun_2015_Dec_8_6_10049.txt
p.Trp124Ter,"... R01-013A (c.993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter; p.Leu117Val), indicating that these m...",20,1375,Nat_Commun_2015_Jun_16_6_7092.txt
p.Leu117Val,p.Leu117Val	Exon 6	3.63	deleterious	probably damag...,150,1,Nat_Commun_2015_Jun_16_6_7092.txt
p.Trp124Ter,p.Trp124Ter	Exon 6	4.46			26.5,154,1,Nat_Commun_2015_Jun_16_6_7092.txt
p.Trp124Ter,p.Trp124Ter	Exon 6	4.46			26.5,154,1,Nat_Commun_2015_Jun_16_6_7092.txt
p.Thr468Met,Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation . Am. J. Med. Genet. A,303,46,Nat_Commun_2015_Nov_30_6_8859.txt
p.S621G,...e with glycine at codon 621 at the protein level (p.S621G). Sanger sequencing of 29 family members d...,17,1234,Nat_Commun_2016_Apr_15_7_11253.txt
p.S621G,"...re transfected with wild-type or mutant cyclin F (p.S621G) expression constructs, and cells were col...",116,79,Nat_Commun_2016_Apr_15_7_11253.txt
p.S621G,"... h. (a,b) Cells transfected with mutant cyclin F (p.S621G) show increased levels (normalized to tran...",116,194,Nat_Commun_2016_Apr_15_7_11253.txt
p.S621G,"... h. (a,b) Cells transfected with mutant cyclin F (p.S621G) show increased levels (normalized to tran...",116,194,Nat_Commun_2016_Apr_15_7_11253.txt
p.K97R, p.K97R	290A>G	4	1/159 UK FALS	0/897 UK controls0/9...,122,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.S509P, p.S509P	1525T>C	13	1/99 IT FALS1/168 CA SALS	0/361...,124,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.S509P, p.S509P	1525T>C	13	1/99 IT FALS1/168 CA SALS	0/361...,124,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.R392T, p.R392T	1175G>C	11	1/99 US FTLD	0/1038 US controls...,130,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.T543I, p.T543I	1628C>T	15	1/283 JA SALS	0/514 JA controls...,131,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.T543I, p.T543I	1628C>T	15	1/283 JA SALS	0/514 JA controls...,131,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.A64T,"...w-frequency coding variant in RNF186 (rs41264113, p.A64T, MAF=0.8%) was found to confer increased ri...",27,390,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,...discovery and replication component of this study p.R179X was found to lie on the haplotype backgrou...,27,531,Nat_Commun_2016_Aug_9_7_12342.txt
p.A64T,"...ith rs3806308 or the low-frequency coding variant p.A64T (Supplementary Fig. 3). Naturally, the prot...",27,719,Nat_Commun_2016_Aug_9_7_12342.txt
p.A64T,"...ith rs3806308 or the low-frequency coding variant p.A64T (Supplementary Fig. 3). Naturally, the prot...",27,719,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,... expression (ASE) data for individual carriers of p.R179X in the GTEx project. Within GTEx we identi...,33,80,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,...d two individual carriers containing ASE data for p.R179X in transverse colon and sigmoid colon. The...,33,183,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,...be necessary to determine the molecular impact of p.R179X on RNF186 function (ref. 5). The gene cont...,33,527,Nat_Commun_2016_Aug_9_7_12342.txt
p.Trp977X,c.2931G>A	p.Trp977X	UK	4 wks	+	+	10.52	1.1/1.0 [0.55-1.87],184,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Ser770Asn,c.2309G>A	p.Ser770Asn	IT	10.6 yrs	+	+	26.54	21.5/21.4 [8.5-1...,257,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Phe91Ser,"...milies, we found a homozygous mutation (c.272T>C; p.Phe91Ser) of CIB2 (Figs. 1 and 2a; Supplementary...",24,435,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Phe91Ser,"...p.Phe91 lines the effector-binding pocket, and so p.Phe91Ser may disrupt effector-binding. Similarly...",28,1333,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Phe91Ser,"...p.Phe91 lines the effector-binding pocket, and so p.Phe91Ser may disrupt effector-binding. Similarly...",28,1333,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,"...B2 interacting with IP receptors.10-13 3 However, p.Cys99Trp abolished the ability of CIB2 to decrea...",30,572,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,"... mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p.Ile123Thr)] co-segrega...",118,632,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,...iceable changes of CIB2 distribution (not shown). p.Cys99Trp abolished CIB2’s ability to decrease se...,120,885,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Arg725Gln,"...two SNPs in ERAP1, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, recessively conferred disease risk. T...",7,726,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...two SNPs in ERAP1, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, recessively conferred disease risk. T...",7,726,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Ile129Ser,"...170 and rs1841958, encoding KLRC4 p.Asn104Ser and p.Ile129Ser. In a meta-analysis, we combined the T...",15,804,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...60 and rs17482078, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, which conferred risk for BD with uvei...",17,625,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...60 and rs17482078, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, which conferred risk for BD with uvei...",17,625,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...ariant in strong linkage disequilibrium [LD] with p.Arg725Gln) was too low in the Japanese populatio...,19,540,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...n psoriasis21, 22 and AS12. ERAP1 p.Asp575Asn and p.Arg725Gln, which are in strong LD, confer protec...",21,239,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...asis between HLA-B*51 and ERAP1 rs17482078 (ERAP1 p.Arg725Gln) coding variant in B,70,65,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Q185X,"...sing TRIB3 and HOIL1, and the nonsense c.553 C>T, p.Q185X mutant allele in HOIL1. Pedigree of kindre...",103,189,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
p.A597D,"...tary Methods). Three missense mutations (p.T232P, p.A597D and p.H1204P) could be scored with these a...",17,1545,Nature_2011_Jan_27_469(7331)_539-542.txt
p.H1204P,"...). Three missense mutations (p.T232P, p.A597D and p.H1204P) could be scored with these alignments. T...",17,1557,Nature_2011_Jan_27_469(7331)_539-542.txt
p.L1872P,"...ygous missense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both cases (PD2126, PD2127) ha...",29,221,Nature_2011_Jan_27_469(7331)_539-542.txt
p.L1872P,"...ygous missense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both cases (PD2126, PD2127) ha...",29,221,Nature_2011_Jan_27_469(7331)_539-542.txt
p.V600E,...ng LH  Zheng G  Dudley J  Illei P  Gocke CD   Non-p.V600E BRAF mutations are common using a more sen...,131,67,Neoplasia_2016_Sep_20_18(9)_577-583.txt
p.V600E,...ng LH  Zheng G  Dudley J  Illei P  Gocke CD   Non-p.V600E BRAF mutations are common using a more sen...,131,67,Neoplasia_2016_Sep_20_18(9)_577-583.txt
p.S13F,...collected the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studie...,7,54,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...collected the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studie...,7,54,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... p.S13F carriers (eight index patients) and of 21 p.N342D carriers (three index patients). The cardi...,10,221,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... p.S13F carriers (eight index patients) and of 21 p.N342D carriers (three index patients). The cardi...,10,221,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...weakness is a prominent and presenting symptom in p.N342D carriers, their cardiac phenotype is simil...",10,506,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,....S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy and haploty...,10,621,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ms were (1) to describe new families carrying the p.S13F or p.N342D DES mutations, (2) to investigat...",28,394,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ligate Dutch carriers (35 with p.S13F and 19 with p.N342D). Some of these data have been described p...,35,211,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...so summarised the published cardiological data on p.S13F and p.N342D carriers of other origin,35,669,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ed the published cardiological data on p.S13F and p.N342D carriers of other origin,35,680,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ed the published cardiological data on p.S13F and p.N342D carriers of other origin,35,680,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ed the published cardiological data on p.S13F and p.N342D carriers of other origin,35,680,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T442I,"...s at the protein level: p.S13F, p.N342D, p.R454W, p.T442I, and p.T453I (Table 1). Previously, we pub...",48,168,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...nd p.T453I (Table 1). Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other ...",48,228,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...3I (Table 1). Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other mutation...",48,236,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R454W,"... Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other mutations (p.T442I an...",48,249,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R454W,"... Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other mutations (p.T442I an...",48,249,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T442I,"...342D, and p.R454W [6–8]. The two other mutations (p.T442I and p.T453I) have been newly identified in...",48,289,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T442I,"...342D, and p.R454W [6–8]. The two other mutations (p.T442I and p.T453I) have been newly identified in...",48,289,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T442I,"...342D, and p.R454W [6–8]. The two other mutations (p.T442I and p.T453I) have been newly identified in...",48,289,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.G27S,"...ng in the following changes at the protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342...",48,617,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R315H,"...protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, the following intro...",48,652,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R315H,"...protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, the following intro...",48,652,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R315H,"...protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, the following intro...",48,652,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R315H,"...protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, the following intro...",48,652,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,p.N342D	This article	2 families	Dutch	Founder,54,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R454W,p.R454W	7	1 family	Dutch,57,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T442I,p.T442I	11	1 family	French,59,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...leading to death. In total, 35 known and obligate p.S13F carriers (including eight index patients) h...",68,762,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,D-III-4 8	F	p.S13F	screening (32)	IVCD (32)	normal (32)	normal...,73,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"E-I-2 8	F	p.S13F	MW (54)	incomplete RBBB (62), incomplete RB...",74,11,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-I-2 12	F	p.S13F	screening	NA	NA	very mild proximal and dist...,80,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-II-2 12	F	p.S13F	screening	NA	NA	very mild proximal and dist...,81,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-II-4 12	M	p.S13F	screening	NA	NA	mild proximal and distal li...,83,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...with the data published on four Singapore-Chinese p.S13F carriers [12] (Table 2). Many patients show...,90,94,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...aled a different haplotype in a Singapore-Chinese p.S13F carrier (individual Pica II-3) [12] (see on...,93,440,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...aled a different haplotype in a Singapore-Chinese p.S13F carrier (individual Pica II-3) [12] (see on...,93,440,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"... cardiopathy” were reported [13]. We identified a p.N342D mutation in these families, thereby provin...",96,149,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"O-III-15	F	p.N342D	MW (38)	atrial rhythm, repolarisation abno...",109,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"O-III-15	F	p.N342D	MW (38)	atrial rhythm, repolarisation abno...",109,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"O-IV-9	F	p.N342D	MW (23)	normal (35)	normal (35)	bulbar, ne...",111,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"O-IV-9	F	p.N342D	MW (23)	normal (35)	normal (35)	bulbar, ne...",111,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,U-III-15	F	p.N342D	NA	Repolarisation abnormality (45)	NA	scap...,119,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,U-III-15	F	p.N342D	NA	Repolarisation abnormality (45)	NA	scap...,119,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"U-III-17	F	p.N342D	MW (16)	PACs, PVCs, ventricular bigeminy, ...",120,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"U-III-17	F	p.N342D	MW (16)	PACs, PVCs, ventricular bigeminy, ...",120,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"D-I-3 1,14	F	p.N342D (index)	MW (30)	normal	NA	distal, CK 364 (...",128,14,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,Genealogy and haplotype analysis of families with p.N342,136,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,Genealogy and haplotype analysis of families with p.N342,136,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,Genealogy and haplotype analysis of families with p.N342,136,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ibution of known, obligate and likely carriers of p.S13F (n = 26) or p.N342D (n = 25) in the Netherl...",140,88,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ibution of known, obligate and likely carriers of p.S13F (n = 26) or p.N342D (n = 25) in the Netherl...",140,88,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ig. 4 Pedigrees of families O and U with mutation p.N342D. Updated pedigrees of the two families (O ...,140,555,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...ekens et al. [13] in which we identified mutation p.N342D. Square symbols indicate men, circles wome...",140,690,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,Fig. 5 Geographical distribution of carriers of p.S13F (A) and p.N342D (B). The geographical distr...,142,49,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...ligate and likely carriers of p.S13F (n = 26) and p.N342D (n = 25), respectively, in the Netherlands...",142,169,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"... all carriers of two Dutch DES founder mutations (p.S13F and p.N342D), including three new index pat...",147,89,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"... all carriers of two Dutch DES founder mutations (p.S13F and p.N342D), including three new index pat...",147,89,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"... all carriers of two Dutch DES founder mutations (p.S13F and p.N342D), including three new index pat...",147,89,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...rs of two Dutch DES founder mutations (p.S13F and p.N342D), including three new index patients with ...",147,100,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...ular phenotype is more prominent in carriers with p.N342D than in those with p.S13F, because all p.N...",151,153,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...ular phenotype is more prominent in carriers with p.N342D than in those with p.S13F, because all p.N...",151,153,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...th p.N342D than in those with p.S13F, because all p.N342D carriers presented with a neuromuscular ph...",151,200,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...th p.N342D than in those with p.S13F, because all p.N342D carriers presented with a neuromuscular ph...",151,200,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...oblems seem to have been the cause of death. Five p.N342D carriers (5/18, aged between 21-30 years) ...",151,620,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...oblems seem to have been the cause of death. Five p.N342D carriers (5/18, aged between 21-30 years) ...",151,620,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...dependent) penetrance of the cardiac phenotype of p.N342D cannot be excluded,151,867,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... the mutation. Mutations in the 2B domain such as p.N342D are predominantly involved when patients h...,153,168,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... the mutation. Mutations in the 2B domain such as p.N342D are predominantly involved when patients h...,153,168,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...nds. Our estimation of the number of unidentified p.S13F carriers is several hundreds, taking into a...",159,165,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...nds. Our estimation of the number of unidentified p.S13F carriers is several hundreds, taking into a...",159,165,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.Asp620Asn,...the identification of the same missense mutation (p.Asp620Asn) in the vacuolar protein sorting 35 (V...,100,80,Neurogenetics_2015_May_16_16_245-263.txt
p.V394L,"...1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P)...",342,659,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.V394L,"...1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P)...",342,659,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.D409H,"...226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C)...",342,680,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.D409H,"...226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C)...",342,680,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.D409H,"...226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C)...",342,680,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.R463C,"...342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C), and c.1604G>A (p.R496H)) and 2 recombina...",342,722,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.R496H,"...>C (p.L444P), c.1504C>T (p.R463C), and c.1604G>A (p.R496H)) and 2 recombinant alleles (RecNci-l and ...",342,747,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.Ala239Thr,...LD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant . Acta Neuropathol,1577,94,Neuropathol_Appl_Neurobiol_2015_Aug_30_41(5)_601-612.txt
p.Lys695Arg,"...(p.Arg761His, c.2282G>A, rs104895097), and K695R (p.Lys695Arg, c.2084A>G, rs104895094) in exon 10; P...",22,788,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Lys695Arg,"...(p.Arg761His, c.2282G>A, rs104895097), and K695R (p.Lys695Arg, c.2084A>G, rs104895094) in exon 10; P...",22,788,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Pro369Ser,"...95Arg, c.2084A>G, rs104895094) in exon 10; P369S (p.Pro369Ser, c.1105C>T, rs11466023) in exon 3; and...",22,844,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Glu148Gln,"...Ser, c.1105C>T, rs11466023) in exon 3; and E148Q (p.Glu148Gln, c.442G>C, rs3743930) in exon 2 of the...",22,902,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Glu148Gln,"...Ser, c.1105C>T, rs11466023) in exon 3; and E148Q (p.Glu148Gln, c.442G>C, rs3743930) in exon 2 of the...",22,902,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.N478D,The homozygous p.N478D missense mutation in MTPAP causes spastic ...,16,16,Nucleic_Acids_Res_2015_Oct_15_43(18)_9065-9075.txt
p.G12D,"5	79	M	L (desc)	3,5 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Synchr lung WT	Prostate Cancer",44,49,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,"8	69	M	L (desc)	5,5 cm	T3	NA	NRAS c.182A>T (p.Q61L)	Reg LN & synchr liver WT	None",50,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"... were noted: 3 cases of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>T (p.G12V) in KRAS codon...",57,312,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,"...tient, and a NRAS mutation in codon 61 (c.182A>T [p.Q61L]) detected in 1 patient. There were no muta...",57,516,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,...N and liver metastases had the same KRAS c.34G>A (p.G12S) mutation. See Table 1 for RAS mutational d...,61,520,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,...N and liver metastases had the same KRAS c.34G>A (p.G12S) mutation. See Table 1 for RAS mutational d...,61,520,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,...tumor model carrying an activating NRAS mutation (p.Q61L). SiRNA-based knockdown of hnRNP K induced ...,7,307,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"... cellular tumor model carrying an activating NRAS p.Q61L mutation (IPC-298). Finally, we examined th...",19,1690,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"...osequencing. The CAA to CTA transition leads to a p.Q61L amino acid substitution, comprising constit...",69,793,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"...or model. We could confirm a previously described p.Q61L mutation of the NRAS gene in IPC-298 cells,...",100,210,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"... activated MAPK-signaling upon an activating NRAS p.Q61L mutation, MEK inhibition significantly decr...",104,423,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.N323Mfs, 143	p.N323Mfs*21 (c.968delA)	delA of (A)6	8,79,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.K267Rfs, 218	p.K267Rfs*9 (c.800delA)	delA of (A)6	7,81,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.R234W, 240	p.R234W (c.700C > T)		7,82,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.I122N, 264	p.I122N (c.365T > A)		5,83,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.N323Mfs, 264	p.N323Mfs*21 (c.968delA)	delA of (A)6	8,85,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.N323Mfs,MSIH24	p.N323Mfs*21 (c.968delA)	delA of (A)6	8,90,8,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.R764H,"...utations in HRAS p.G13C, CASP8 p.R127* and PDGFRA p.R764H at all sub-sites in primary and metastatic...",25,320,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...m TP53 fragments spanning the amino acid residues p.I251N and p.Y236C were carried out. We observed ...,30,611,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...ents spanning the amino acid residues p.I251N and p.Y236C were carried out. We observed 21.86% alter...,30,623,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...ents spanning the amino acid residues p.I251N and p.Y236C were carried out. We observed 21.86% alter...,30,623,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...lteration (T replaced by C) at amino acid residue p.Y236C and 6.87% alteration (A replaced by T) at ...,30,719,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"...p.Y236C and 6.87% alteration (A replaced by T) at p.I251N in the sub-site A. Further, at the tumor s...",30,769,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"...p.Y236C and 6.87% alteration (A replaced by T) at p.I251N in the sub-site A. Further, at the tumor s...",30,769,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"... the tumor sub-site B, there was no alteration at p.Y236C and 59.23% alteration (A replaced by T) at...",30,857,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,....Y236C and 59.23% alteration (A replaced by T) at p.I251N. Thus the p.I251N alteration at sub-site A...,30,908,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...tion at sub-site A developed independently of the p.Y236C alteration at tumor sub-site B. The number...,30,990,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,Figure 2 TP53 mutations p.I251N and p.Y236C within the primary laryngeal t...,32,25,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...A had 6.87% alterations in the amino acid residue p.I251N and 21.86% alterations in p.Y236C. Tumor B...,33,312,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...no acid residue p.I251N and 21.86% alterations in p.Y236C. Tumor B had 59.23% alterations in the p.I...,33,346,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"...tions in the p.I251N residue and no alteration in p.Y236C. Thus, mutations in p.I251N and p.Y236C re...",33,430,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"... and no alteration in p.Y236C. Thus, mutations in p.I251N and p.Y236C residues emerged independently...",33,458,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.A934P,"...tinguishable from acrocallosal syndrome who has a p.A934P GLI3 mutation [21]. Second, patients with ...",57,949,Orphanet_J_Rare_Dis_2008_Apr_24_3_10.txt
p.A934P,"...tinguishable from acrocallosal syndrome who has a p.A934P GLI3 mutation [21]. Second, patients with ...",57,949,Orphanet_J_Rare_Dis_2008_Apr_24_3_10.txt
p.H454R,c.1361A>G (p.H454R)	c.571>A (p.E191K,166,12,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.E191K,c.1361A>G (p.H454R)	c.571>A (p.E191K,166,30,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.R184W,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,11,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.A176T,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,30,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.R71H,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,43,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.R71H,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,43,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.R71H,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,43,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.Lys62X,...lly always double heterozygous mutations) and the p.Lys62X/p.Cys84fs mutation is present in two-thir...,260,453,Orphanet_J_Rare_Dis_2011_May_19_6_26.txt
p.E1492X,"c.4474G > T	21	p.E1492X	+	2	Bernal et al., 2005",76,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,"c.4474G > T	21	p.E1492X	+	2	Bernal et al., 2005",76,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1549X,"c.4645C > T	22	p.R1549X	+	1	Baux et al., 2007",78,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1549X,"c.4645C > T	22	p.R1549X	+	1	Baux et al., 2007",78,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3251X,c.9753T > A	50	p.C3251X	+	2	Present study,82,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3587X,"c.10759C > T	55	p.Q3587X	+	2	Baux et al., 2007",86,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3716X,c.11146C > T	57	p.Q3716X	+	1	Present study,88,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.A125T,"c.373G > A	2	p.A125T	-	81	Dreyer et al., 2000",144,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,c.130G > A	2	p.G44R	+	1	Present Study,146,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V230M,"c.688G > A	4	p.V230M	-	3	Dreyer et al., 2000",148,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V230M,"c.688G > A	4	p.V230M	-	3	Dreyer et al., 2000",148,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.D644V,"c.1931A > T	11	p.D644V	-	6	Weston et al., 2000",158,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L1572F,"c.4714C > T	22	p.L1572F	-	7	Dreyer et al., 2008",168,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I2106T,"c.6317T > C	32	p.I2106T	-	117	Aller et al., 2006",174,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I2169T,"c.6506T > C	34	p.I2169T	-	85	Aller et al., 2006",176,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2196T,"c.6587G > C	34	p.S2196T	UV2	2	Jaijo et al., 2009",178,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V2562A,"c.7685T > C	41	p.V2562A	-	1	Dreyer et al., 2008",190,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L2886F,"c.8656C > T	43	p.L2886F	-	9	Aller et al., 2006",196,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T3115A,"c.9343A > G	47	p.T3115A	-	9	Dreyer et al., 2008",202,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3199D,"c.9595A > G	49	p.N3199D	-	9	Baux et al., 2007",206,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"c.10073G > A	51	p.C3358Y	+	1	McGee et al., 2010",210,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3411A,"c.10232A > C	52	p.E3411A	-	94	Aller et al., 2006",212,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T3835I,c.11504C > T	59	p.T3835I	-	30	Present Study,216,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P3893T,"c.11677C > A	60	p.P3893T	-	2	Dreyer et al., 2008",220,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P3893T,"c.11677C > A	60	p.P3893T	-	2	Dreyer et al., 2008",220,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R4115C,"c.12343C > T	63	p.R4115C	-	2	van Wijk et al., 2004",224,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R4848Q,"c.14543G > A	66	p.R4848Q	-	1	McGee et al., 2010",232,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,c.14761G > A	67	p.E4921K	UV2	1	Present Study,234,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,c.14761G > A	67	p.E4921K	UV2	1	Present Study,234,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R303H,e p.R303H and p.Y1992C were initially described as b...,247,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,e p.R303H and p.Y1992C were initially described as being pathoge...,247,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,e p.R303H and p.Y1992C were initially described as being pathoge...,247,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T473T,"c.1419C > T	8	p.T473T	-	36	Dreyer et al., 2000",258,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3912E,"c.11736G > A	61	p.E3912E	-	2	Dreyer et al., 2008",276,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3912E,"c.11736G > A	61	p.E3912E	-	2	Dreyer et al., 2008",276,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y4031Y,"c.12093C > T	62	p.Y4031Y	-	1	Dreyer et al., 2008",282,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4397E,"c.13191G > A	63	p.E4397E	-	23	Dreyer et al., 2008",288,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,RP1274*	p.E1492X/p.E1492X	1969	USH2		Moderate-severe and stable	Nor...,308,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,RP1607	p.G3546R/p.G3546R	1925	USH2	33	Mild-moderate	NormalA	16	25	...,312,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,RP1618	p.C3267R/c.6319_6324delinsTAAA	1964	USH2		Severe-p...,328,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,"RP1759	p.C3267R/p.Y1992C#	1945	USH2	62	Congenital, modera...",334,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3894D,"RP1539*	p.R1295X/p.N3894D#	1987	USH2	20	Congenital, moderate and st...",344,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3894D,"RP1539*	p.R1295X/p.N3894D#	1987	USH2	20	Congenital, moderate and st...",344,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,RP1641*	p.C759F/p.W4725X	1967	USHA		Moderate and progressi...,348,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y506X,RP532	p.Y506X/p.Q3587X	1968	USH2		Profound	NormalA	15	20...,354,7,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,RP1613	c.9260delT/p.G44R	1971	USH2	30	Severe	NormalA	20	20	Marked co...,358,19,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2196T,"... possibly non-pathologic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have alr...",426,93,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2639P,"...non-pathologic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been ...",426,103,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G4692R,"...ogic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been reported i...",426,113,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.K5026E,"....G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been reported in other works...",426,126,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.K5026E,"....G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been reported in other works...",426,126,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,"...umc.nl/LOVD2/Usher_montpellier, [35]]. Meanwhile, p.N2377S, p.N2394K and p.E4921K have not been desc...",426,317,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,p.G44R	Affect (Score 0.01)	Probably damaging	Patho...,431,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,p.G44R	Affect (Score 0.01)	Probably damaging	Patho...,431,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,p.N2377S	Tolerated (Score 0.44)	Possibly damaging	...,433,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2394K,p.N2394K	Tolerated (Score 0.23)	Possibly damaging	...,435,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R303H,...sified as possibly-pathogenic (UV3). The variants p.R303H and p.Y1992C were described previously [ht...,448,83,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,Figure 1 In vitro splicing assays for p.E2496E and p.V382M mutations. Gel electrophoresi...,450,39,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,...ations were considered as pathogenic. p.C759F and p.C3267R were already described by others authors ...,452,76,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...-pathogenic (UV3). However, in the present study, p.C3358Y was detected in a patient together with a...",452,346,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,...d that the mutations were not in the same allele. p.P4818L was detected in a patient together with t...,452,519,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,"...lyses support the damaging effect of p.C3358Y and p.P4818L, so we have considered them as pathogenic...",452,913,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,"...P4818L, so we have considered them as pathogenic. p.G44R and p.G3546R were novel; none of them was d...",452,965,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,"...P4818L, so we have considered them as pathogenic. p.G44R and p.G3546R were novel; none of them was d...",452,965,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,...we have considered them as pathogenic. p.G44R and p.G3546R were novel; none of them was detected in ...,452,976,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,...we have considered them as pathogenic. p.G44R and p.G3546R were novel; none of them was detected in ...,452,976,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,...riant p.G44R was detected in a single patient and p.G3546R in three cases (one homozygous and two co...,452,1103,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,... three were novel (See Table 3). Only the variant p.E2496E was categorized as pathogenic. It was not...,455,195,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G162D,I.1	He	c.485 G > A	p.G162D	4	SRCR	Le Quintrec M. et al. 2008 [17],71,20,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.W393Yfs,"I.1, I.2	He	c.1176_1177dupAT	p.W393Yfs*5	11	SP	Baracho et al. 2003 [19]",74,30,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.R474X,"III.1, III.3, III.4	He	c.1420 C > T	p.R474X	11	SP	Fremaux-Bacchi et al. 2004 [20]",75,37,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.N177I,"...reported molecular change in exon 4, c.738 A > T; p.N177I. Taking into account that patient III.2’s ...",79,721,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.D27Afs,...ing situation that causes a premature stop codon (p.D27Afs*18),87,337,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.Gly162Ser,p.Gly162Ser	 	 	GA: 12 (10.7%)	GA: 8 (4%),96,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Cys4Ser,"...ne patient had a missense variant (g.35295505G>C; p.Cys4Ser) in exon 1, three patients had the same ...",124,209,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Pro312His,...the same missense variant in ex 5 (g.35300142C>A; p.Pro312His) and one patient had another missense ...,124,300,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Arg332Pro,... another missense variant in ex 5 (g.35300202C>G; p.Arg332Pro) (Table 3). None of the variants are r...,124,382,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Pro312His,"...in control and patient 223, B) the g.35300142C>A (p.Pro312His) in control and patients 162, 237, and...",126,216,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Arg192Gln,"...ations (c.468_469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,156,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
p.R206H,...us for a recurrent activating mutation (c.617G>A; p.R206H) in the cytoplasmic GS (glycine-serine ric...,21,94,Orphanet_J_Rare_Dis_2013_Sep_18_8_145.txt
p.G833R,...ation t(X;12) (q24;q15)	Deletion	Missense variant p.G833R	Missense variant p.R631S	Missense variant ...,118,74,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G833R,...ation t(X;12) (q24;q15)	Deletion	Missense variant p.G833R	Missense variant p.R631S	Missense variant ...,118,74,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G630R,...f GRIA3	Missense variant p.G630R	Missense variant p.G630R	Missense variant p.G630R,118,257,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg441Trp,...ution of the amino acid arginine with tryptophan (p.Arg441Trp) and was absent in 100 Finnish anonymo...,219,462,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg445Cys,"...ied in a sporadic case (annotated as c.1333C > T, p.Arg445Cys using a different SLC16A2 isofor",243,311,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg445Cys,...uld speak some words. Based on the available data p.Arg445Cys mutation seems to be associated with v...,246,333,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg445Cys,...uld speak some words. Based on the available data p.Arg445Cys mutation seems to be associated with v...,246,333,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg631Ser,...d in GRIA3[34-38]. One of the missense mutations (p.Arg631Ser,252,161,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gln119Arg,...ense variant of unknown significance (c.356A > G (p.Gln119Arg)) in ZMYM3 was reported in the index p...,265,189,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg2068His,...opsy) only carried the p.Arg1834Gly mutation. The p.Arg2068His and p.Trp3238Arg mutations have been ...,268,1028,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.Trp3238Arg,...ound in 3 patients with PCD. The p.Arg2068His and p.Trp3238Arg mutations are therefore very likely t...,268,1129,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.Trp3238Arg,...ound in 3 patients with PCD. The p.Arg2068His and p.Trp3238Arg mutations are therefore very likely t...,268,1129,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.E191K,"...homozygous DHCR24 mutation (NM_014762.3:c.571G>A; p.E191K), a recognized cause of desmosterolosis (A...",26,121,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
p.Arg506Gly,...he chromosome 12 candidate region: The c.1516C>G (p.Arg506Gly) variant in SLC11A2 has been annotated...,115,243,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg506Gly,...he chromosome 12 candidate region: The c.1516C>G (p.Arg506Gly) variant in SLC11A2 has been annotated...,115,243,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg18His,"...ned essentiality of this gene [36]. Moreover, the p.Arg18His variant has an MAF of 0.28% which is no...",115,890,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Thr580Pro,"...h an MAF of 0.04%. A variant in DIDO1 (c.1738A>C; p.Thr580Pro), also affects a non-conserved residue...",117,310,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Pro97Ser,...9C>T heterozygous de novo (both parents wildtype)	p.Pro97Ser	Missense,36,66,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Glu321*,"4		31,8	2	0	c.961G>T heterozygous	p.Glu321",40,35,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Tyr731*,"11	II/1	3,4	4	0	c.2192dupA heterozygous maternal	p.Tyr731",49,50,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Tyr731*,"11	II/1	3,4	4	0	c.2192dupA heterozygous maternal	p.Tyr731",49,50,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1526*,"21		18,0			c.4576G>T heterozygous	p.Gly1526",68,35,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1896Arg,"30,7	1	0	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splice	Splice site mutation",76,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1896Arg,"28,9	3	1	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splice	Splice site mutation",78,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Ser2352*,"...38,2	2	3	c.7055_7070delCTTTTGCAGTCAGCCT mosaicism	p.Ser2352",87,59,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Arg2419*,"34		1,0	4	2	c.7255C>T heterozygous	p.Arg2419",97,36,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Val2572Ile,...	4	1	c.7714G>A heterozygous; unclassified variant	p.Val2572Ile - VUS3	Missense/splice site mutation?...,101,58,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Pro97Ser,... patients. For one of these two missense variants p.Pro97Ser (c.289C>T) the absence in both parental...,149,271,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Glu82Val,...vicinity additional pathogenic missense mutations p.Glu82Val and p.Met102Val have been described pre...,149,585,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Met102Val,"...onal pathogenic missense mutations p.Glu82Val and p.Met102Val have been described previously [21, 22...",149,600,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Val455Met,... caused by a spontaneous GCK activating mutation (p.Val455Met) suffered from epilepsy and showed neu...,8,97,Orphanet_J_Rare_Dis_2015_Sep_24_10_120.txt
p.Asn88Ser,(NM_032667.6)	2	c.263 A>G	p.Asn88Ser,147,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn88Ser,(NM_032667.6)	2	c.263 A>G	p.Asn88Ser,147,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn88Ser,(NM_032667.6)	2	c.263 A>G	p.Asn88Ser,147,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg598Cys,(NM_001376.4)	2	c.1792 C>T	p.Arg598Cys,156,29,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg373Cys,(NM_006329.3)	1	c.1117C>T	p.Arg373Cys,162,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ile30Phe,(NM_000166.5)	1	c.88A>T	p.Ile30Phe,174,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ile71Thr,(NM_000166.5)	1	c.212T>C	p.Ile71Thr,183,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg7Ser,(NM_006308.2)	1	c.21G>T	p.Arg7Ser,195,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu128Pro,(NM_022489.3)	1	c.383T>C	p.Leu128Pro,198,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu128Pro,(NM_022489.3)	1	c.383T>C	p.Leu128Pro,198,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg94Trp,(NM_014874.3)	1	c.280 C>T	p.Arg94Trp,210,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.His361Tyr,(NM_014874.3)	1	c.1081C>T	p.His361Tyr,228,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.His361Tyr,(NM_014874.3)	1	c.1081C>T	p.His361Tyr,228,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg364Trp,(NM_014874.3)	1	c.1090 C>T	p.Arg364Trp,231,29,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Cys42Arg,(NM_153322.1)	1	c.124T>C	p.Cys42Arg,246,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Cys42Arg,(NM_153322.1)	1	c.124T>C	p.Cys42Arg,246,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg329His,Mutation p.Arg329His (c.986G>A) was found in three families...,290,10,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg329His,Mutation p.Arg329His (c.986G>A) was found in three families...,290,10,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg598Cys,A mutation p.Arg598Cys (c.1792 C>T) in DYNC1H1 gene was found...,297,12,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg598Cys,A mutation p.Arg598Cys (c.1792 C>T) in DYNC1H1 gene was found...,297,12,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly514Ser,(NM_001003800.1)	c.1540G>A	p.Gly514Ser	SIFT:,326,29,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ala163Thr,(NM_004082.4)	c.487G>A	p.Ala163Thr	SIFT:,332,25,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg42Gln,(NM_021629.3)	c.125G>A	p.Arg42Gln	SIFT:,350,25,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly694Glu,...A5: c.989_991delCAA; p.Thr330del and c.2081G > A; p.Gly694Glu was identified based on their compound...,33,979,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.L227X,...sideration are p.C78W (TNFRSF9; CD137; 4-1BB) and p.L227X (TNFAIP3;A20). Haplotype analysis showed t...,15,571,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.C78W,...27X (TNFAIP3;A20). Haplotype analysis showed that p.C78W occurred de novo on the haplotype inherited...,15,625,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.V1316A,"...f recovery from inactivation. In this regard, the p.V1316A mutation makes hyperpolarization shift in...",35,1273,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...eration, the most important changes caused by the p.V1316A mutation are both acceleration of the tra...",35,1528,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e genesis of resurgent currents. We show that the p.V1316A mutation chiefly accelerates the I to O t...,40,708,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...3020) [6–13]. Recently, two sporadic cases of the p.V1316A (located in the DIII/S4–5 linker) mutatio...",46,725,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Accordingly, these mutati...",48,948,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Accordingly, these mutati...",48,948,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...istent only in the presence of Navβ4 peptide. The p.V1316A mutation markedly increases both the sust...,48,2377,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...15]. Genetic analysis showed a missense mutation (p.V1316A) of human Nav1.7 (SCN9A) gene. The excruc...,52,203,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...15]. Genetic analysis showed a missense mutation (p.V1316A) of human Nav1.7 (SCN9A) gene. The excruc...,52,203,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...vestigate the molecular functional changes of the p.V1316A mutant Nav1.7 channel, we first character...",58,56,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,Larger Sustained Na+ Currents in the p.V1316A Mutant than in the WT Channe,66,38,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,Fig 4 compares the basic gating behaviors of the p.V1316A mutant with the WT Nav1.7 channel. The ac...,67,50,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...hannel. The activation and inactivation curves of p.V1316A mutant channel are negatively and positiv...,67,136,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...he mutation (Fig 4B). These results indicate that p.V1316A mutant channel can be more activated but ...,67,391,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...he mutation (Fig 4B). These results indicate that p.V1316A mutant channel can be more activated but ...,67,391,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...tently, the increase in sustained currents in the p.V1316A mutant channel could be demonstrated with...",67,738,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...tently, the increase in sustained currents in the p.V1316A mutant channel could be demonstrated with...",67,738,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...the open state) or both. Fig 4E shows that in the p.V1316A mutant channel, the decay of transient cu...",67,1228,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...oscopic inactivation rates are ~50% slowed by the p.V1316A mutation. In other words, the Navβ4 pepti...",67,1518,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...oscopic inactivation rates are ~50% slowed by the p.V1316A mutation. In other words, the Navβ4 pepti...",67,1518,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... currents in the p.V1316A mutant channel, and the p.V1316A mutation slows the macroscopic inactivati...",67,1669,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... substantiate that both the Navβ4 peptide and the p.V1316A mutation are gating modifiers of the Nav1...,67,1998,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...gle Boltzmann fits to the mean values are for the p.V1316A mutant channel: Vh and k are ~–30.7 mV an...,70,911,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...nnels (n = 15 for the WT channels; n = 12 for the p.V1316A mutant channels). The ratio between the s...,70,1372,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...olarization of +40 mV but not 0 mV in both WT and p.V1316A mutant channels, again demonstrating the ...",73,422,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...61.g005Fig 5 Larger resurgent Na+ currents in the p.V1316A mutant than that in the WT channels,75,77,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... Single Boltzmann fits to the mean values are for p.V1316A mutant channel: Vh = ~59.5 mV and k = ~21...,79,2037,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...the activation curve of resurgent currents in the p.V1316A mutant channel is very similar to or even...,82,1343,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the kinetics of resurgent currents caused by the p.V1316A mutation (Fig 7A and 7B). The kinetics of...,85,112,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...rents by membrane hyperpolarization in the WT and p.V1316A mutant channels,87,141,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...~+160 mV for ~10 ms in 20 mV increment for WT and p.V1316A mutant channels. Note that the inverse de...,88,259,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...time to peak of the resurgent Na+ currents in the p.V1316A mutant channel is always slower than that...,88,538,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...time to peak of the resurgent Na+ currents in the p.V1316A mutant channel is always slower than that...,88,538,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...voltage in semi-logarithmic scales for the WT and p.V1316A mutant channels. The lines are linear reg...,88,1405,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...annel and 1/tau(V) = 0.04×exp(–0.97V/25) ms-1 for p.V1316A mutant channel, respectively, where V is ...",88,1576,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...for ~20 ms (the deactivation pulse) in the WT and p.V1316A mutant channels. The tail currents show f...,88,2002,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...r different deactivating potentials in the WT and p.V1316A mutant channels. The inverses of time con...,88,2258,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nnel, and 1/tau(V) = 1.25×exp(–0.71V/25) ms-1 for p.V1316A mutant channel, respectively, where V is ...",88,2599,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the tail currents are very similar in the WT and p.V1316A mutant channels. Individual data is shown...,88,2796,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...epolarization prepulse 3 ms in length, the WT and p.V1316A mutant channels have not yet reached a st...",91,471,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...surgent currents are quite the same in the WT and p.V1316A mutant channels, although the absolute sp...",91,993,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...l, and 1/tau(V) = 0.07×exp(–0.8V/25) ms–1 for the p.V1316A mutant channel, respectively, where V is ...",94,1384,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ntials (e.g., +20, +40, and +60 mV) in the WT and p.V1316A mutant channels. Note that there is no si...",94,1622,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ntials (e.g., +20, +40, and +60 mV) in the WT and p.V1316A mutant channels. Note that there is no si...",94,1622,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ntials (e.g., +20, +40, and +60 mV) in the WT and p.V1316A mutant channels. Note that there is no si...",94,1622,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e is no significant difference between the WT and p.V1316A mutant channels at each voltage (n = 7; N...,94,1712,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...II and IV) of the homology model of WT Nav1.7 and p.V1316A mutant channels are shown in the ribbon p...,101,3777,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...II and IV) of the homology model of WT Nav1.7 and p.V1316A mutant channels are shown in the ribbon p...,101,3777,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...II and IV) of the homology model of WT Nav1.7 and p.V1316A mutant channels are shown in the ribbon p...,101,3777,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ue distances (from side chain tip to tip) between p.V1316A and L1610, and p.V1316A and R1611 are ~11...",101,4310,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...(tip to tip) distances between residues V1316 (or p.V1316A) and L1610, R1611, V1722, and G1723 in th...",101,4505,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...evidently increased distances in all cases in the p.V1316A mutant than in the WT channels (see also ...,101,4635,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...T channels, the main gating changes caused by the p.V1316A mutation include larger rate constants fo...",104,706,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nd 0.54 for +60 mV prepulse, respectively, in the p.V1316A mutant channel. (E) The inverses of time ...",104,1605,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,The p.V1316A mutant Nav1.7 channel is characterized by...,129,5,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...y that the conformational changes associated with p.V1316A mutation may well involve the pivotal poi...,129,2748,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... in presence or absence of the Navβ4 peptide, and p.V1316A mutant channels in presence of Navβ4 pept...",154,285,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...(D) The activation and inactivation curves in the p.V1316A mutant channels are simulated with the sa...,166,1617,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...chain tip to tip) between p.V1316A and V1722, and p.V1316A and G1723 are ~6.4 Å, and ~6.9 Å, respect...",173,633,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.Val2300Gly,"... second ATR mutation identified was c.6897+464C>G;p.Val2300Gly fs75*, which, surprisingly, was also ...",189,54,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Val2300Gly,"... second ATR mutation identified was c.6897+464C>G;p.Val2300Gly fs75*, which, surprisingly, was also ...",189,54,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Met1159Ile,"...both patients causing an amino acid substitution, p.Met1159Ile, which lies within a conserved UME (N...",275,261,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Met1159Ile,"...both patients causing an amino acid substitution, p.Met1159Ile, which lies within a conserved UME (N...",275,261,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Ser1012Pro,"...und to carry a de novo USP9X mutation (c.3034T>C, p.Ser1012Pro) at a highly conserved residue (GERP ...",131,286,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
p.R216H,...he promoter region and the non-synonymous variant p.R216H in exon8 were chosen for further genotypin...,57,530,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...he promoter region and the non-synonymous variant p.R216H in exon8 were chosen for further genotypin...,57,530,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...C>G, −276C>T, and the non-synonymous substitution p.R216H in exon8 were genotyped. LDs of the five C...",60,120,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...C>G, −276C>T, and the non-synonymous substitution p.R216H in exon8 were genotyped. LDs of the five C...",60,120,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...t001Table 1 Distribution of COLEC11—rs7567833G/A (p.R216H) genotypes and allele(s),67,80,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...s (median values) with investigated rs7567833G/A (p.R216H) variant,142,123,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...s (median values) with investigated rs7567833G/A (p.R216H) variant,142,123,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...study suggests that a non-synonymous substitution p.R216H in the exon8 of COLEC11 contributes to sus...,154,315,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...216H genotypes. It has been hypothesized that the p.R216H substitution increases the alpha helical p...,154,656,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...tability and protein folding properties [41]. The p.R216H substitution is located in the carbohydrat...,154,799,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...n addition, this particular variant rs7567833G/A (p.R216H) was reported to be under selective pressu...",154,1015,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...n addition, this particular variant rs7567833G/A (p.R216H) was reported to be under selective pressu...",154,1015,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...ficantly elevated [44]. The COLEC11 rs7567833G/A (p.R216H) variant was observed to correlate with in...,158,660,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...ed by S. haematobium. Furthermore, the variant in p.R216H in exon8 of the COLEC11 gene is a host gen...",162,194,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.K45E,...15 and MMP3 (rs2273535 (p.Phe31Ile) and rs679620 (p.K45E) respectively) were also analysed,15,1803,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.K45E,The rs679620 A MMP3 p.K45E polymorphism in the matrix metalloproteinas...,93,21,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,"...sformation [46]. Previously the STK15 (rs2273535, p.Phe31Ile) variant was found to alter the potency...",95,1070,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,"... not detect a significant association between the p.Phe31Ile variant and RCC, the patient and contro...",95,1387,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,"... not detect a significant association between the p.Phe31Ile variant and RCC, the patient and contro...",95,1387,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,"... not detect a significant association between the p.Phe31Ile variant and RCC, the patient and contro...",95,1387,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.D170D,"...N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G (1)(2), c.769-7_769-6dup...",110,71,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.D170D,"...N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G (1)(2), c.769-7_769-6dup...",110,71,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.V377I,"...pT(1)*,c.885+24G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1), p.E296GfsX14(1)		MVK (N...",110,170,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R388X,"...G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1), p.E296GfsX14(1)		MVK (N = 1)	Chr12q24....",110,185,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T219T,"...78−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L...",111,71,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.P340P,"...R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(...",111,99,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.L344L,"...8M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1),...",111,114,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.H463H,"...1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),...",111,141,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T587I,"...40P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T...",111,153,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Y859C,"....A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3)...",111,180,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...7I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)	...",111,208,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...7I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)	...",111,208,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.L411L,"...3K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = ...",111,220,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T436P,"...+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = 1)	p.T348M artificial delet...",111,247,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C30R,"TNFRSF1A (N = 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54...",112,20,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C73W,"TNFRSF1A (N = 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46L(1), p.R92...",112,42,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.P46L,"...(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46L(1), p.R92Q(1)		ITGB5 (N = 1)	Chr3q21.2dup		...",112,76,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R92Q,"...(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46L(1), p.R92Q(1)		ITGB5 (N = 1)	Chr3q21.2dup",112,87,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.A242A,"...nly 3 polymorphisms (c.769-7_769-6dupT in MVK and p.A242A, p.Y141Y in NLRP3) went undetected (not sh...",144,376,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C70R,"...37S]; one with CAPS, p.T348M; and two with TRAPS, p.C70R and p.R92Q. Representative HRM difference p...",152,443,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R92Q,"...ith CAPS, p.T348M; and two with TRAPS, p.C70R and p.R92Q. Representative HRM difference plots are sh...",152,454,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.K722X,p.Q2980X	p.S1142X	p.S1142X	p.K722X+D3771fsX3790,28,29,PLoS_One_2011_Apr_26_6(4)_e19081.txt
p.Q1069R,"...bols, unaffected individuals; Mut/Mut, homozygous p.Q1069R mutation; Mut/WT, heterozygous Q1069R mut...",24,387,PLoS_One_2011_Jun_9_6(6)_e20854.txt
p.Q1069R,"...bols, unaffected individuals; Mut/Mut, homozygous p.Q1069R mutation; Mut/WT, heterozygous Q1069R mut...",24,387,PLoS_One_2011_Jun_9_6(6)_e20854.txt
p.R2065S,"... of the protein containing the missense mutation, p.R2065S, was identified as highly conserved in va...",56,505,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.L2444X,2	Atypical	c.7331T>A	p.L2444X	Nonsense			Novel,61,22,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.R2065S,3	Atypical	c.6193C>A	p.R2065S	Missense			Novel,62,22,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.R2065S,"...he region containing the novel missense mutation, p.R2065S (indicated as an asterisk), is highly con...",164,263,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.Pro253Arg,"...755C>G encoding p.Ser252Trp and c.758C>G encoding p.Pro253Arg, both causing Apert syndrome) and a mu...",26,450,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.E542K,(a) The heterozygous p.E542K (c.G1624A) PIK3CA hotspot mutation was det...,109,22,PLoS_One_2012_Feb_17_7(2)_e31255.txt
p.L1341P,...or our experimental design: DYSF p.G299R and DYSF p.L1341P. The consequences of these mutations at t...,18,100,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...or our experimental design: DYSF p.G299R and DYSF p.L1341P. The consequences of these mutations at t...,18,100,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...or our experimental design: DYSF p.G299R and DYSF p.L1341P. The consequences of these mutations at t...,18,100,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...r missense-mutated dysferlin cDNA DYSF p.G299R or p.L1341P. Transfected cells were treated with TAT-...,21,134,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...using an anti-dysferlin ab. (C) merge. (D–F) DYSF p.G299R-GFP tagged. Experiment performed 14×. (D) ...,21,415,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...) Peptide A2 (10-mer) added corresponding to DYSF p.G299R. GFP-dysferlin relocalizes to sarcolemmal ...,21,591,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...r but not expressed at the sarcolemma. (G–I) DYSF p.L1341P-GFP tagged. Experiment performed 12×. (G)...,21,786,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...ma. (I) Peptide B4 (15-mer) corresponding to DYSF p.L1341P. 10mer peptides carrying the correspondin...,21,1011,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...y human myotubes obtained from patients with DYSF p.G299R and DYSF p.L1341P. Missense mutated dysfer...,39,144,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...y human myotubes obtained from patients with DYSF p.G299R and DYSF p.L1341P. Missense mutated dysfer...,39,144,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ect. (A–C) Primary human myotubes expressing DYSF p.G299R. Experiment performed 9x. (A) No peptides ...,42,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ect. (A–C) Primary human myotubes expressing DYSF p.G299R. Experiment performed 9x. (A) No peptides ...,42,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ect. (A–C) Primary human myotubes expressing DYSF p.G299R. Experiment performed 9x. (A) No peptides ...,42,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ect. (A–C) Primary human myotubes expressing DYSF p.G299R. Experiment performed 9x. (A) No peptides ...,42,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ect. (A–C) Primary human myotubes expressing DYSF p.G299R. Experiment performed 9x. (A) No peptides ...,42,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ect. (A–C) Primary human myotubes expressing DYSF p.G299R. Experiment performed 9x. (A) No peptides ...,42,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...µm boundary area of the plasma membrane. (A) DYSF p.G299R, no peptide. (B) DYSF p.G299R, nonsense pe...",48,289,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...B) DYSF p.G299R, nonsense peptide added. (C) DYSF p.G299R, corresponding mutant peptide A2 added. (D...",48,361,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptide FM1-43 dye rapidly spreads within the DYSF p.G299R human myotubes. After treatment with speci...,48,551,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptide FM1-43 dye rapidly spreads within the DYSF p.G299R human myotubes. After treatment with speci...,48,551,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... normal and dysferlin-mutant human myotubes. DYSF p.L1341P myotubes, untreated and treated with TAT-...",50,209,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... normal and dysferlin-mutant human myotubes. DYSF p.L1341P myotubes, untreated and treated with TAT-...",50,209,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...lesion continuously increases in size. (G–I) DYSF p.L1341P primary human myotube treated with corres...,53,473,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...t C2E domain of dysferlin that contained the DYSF p.L1341P mutation and the corresponding wildtype o...,56,845,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Peptide B2 corresponding to DYSF p.L1341P was labeled with ATTO-495-ME fluorescent ...,59,34,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...TO-495-ME fluorescent dye (red) and added to DYSF p.L1341P human myotubes. (A) DYSF p.L1341P human m...,59,112,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...d added to DYSF p.L1341P human myotubes. (A) DYSF p.L1341P human myotube immediately after addition ...,59,146,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... after addition of ATTO-495-ME-peptide B2 to DYSF p.L1341P human myotubes, (B) after 8 minutes and (...",59,230,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,ER Stress is Reduced by Treating DYSF p.G299R Expressing myotubes with TAT-Labeled Mutan...,61,39,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,ER Stress is Reduced by Treating DYSF p.G299R Expressing myotubes with TAT-Labeled Mutan...,61,39,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...t peptides decrease HSPA5 gene expression in DYSF p.G299R human myotubes most effectively (RT-PCR). ...,65,196,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...o wildtype dysferlin and dysferlin mutations DYSF p.G299R and DYSF p.L1341P 10 and 15mer peptides we...,94,66,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...lin and dysferlin mutations DYSF p.G299R and DYSF p.L1341P 10 and 15mer peptides were synthesized an...,94,83,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...tle Upon Tyne, UK). DYSF c.895G>A leading to DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431...",97,218,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...tle Upon Tyne, UK). DYSF c.895G>A leading to DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431...",97,218,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1431P,...o DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431P were cloned into the vector by site-direc...,97,261,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1431P,...o DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431P were cloned into the vector by site-direc...,97,261,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...and immortalized human myotubes carrying the DYSF p.L1341P mutation in (B) were treated with the dys...,137,193,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...and immortalized human myotubes carrying the DYSF p.L1341P mutation in (B) were treated with the dys...,137,193,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Figure S4 DYSF p.L1341P does not stably bind corresponding dysfer...,143,17,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptides. (A) In human myotubes harboring the DYSF p.G299R mutation specific peptides reduce the rela...,149,109,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... FM1-43 uptake after laser induced damage in DYSF p.G299R primary human myotubes. No peptides added,161,60,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... FM1-43 uptake after laser induced damage in DYSF p.G299R primary human myotubes. Nonsense peptide a...,167,60,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... FM1-43 uptake after laser induced damage in DYSF p.G299R primary human myotubes. Corresponding pept...,173,60,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.A350V,"...ogyMedicineNeurologyParkinson DiseaseSubstitution p.A350V in Na+/Mg2+ Exchanger SLC41A1, Potentially...",3,481,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ogyMedicineNeurologyParkinson DiseaseSubstitution p.A350V in Na+/Mg2+ Exchanger SLC41A1, Potentially...",3,481,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...t of SLC41A1 carrying the amino acid substitution p.A350V (c.1049C>T) in one PD patient of Caucasian...,19,315,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...or tet-inducible expression of the wt or mutated (p.A350V) HA-strep-tagged SLC41A1. Protein expressi...,27,782,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...s, over-expressing flag- or HA-strep-tagged wt or p.A350V, and the respective uninduced controls wer...",40,62,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...eins from HEK293 cell lines over-expressing wt or p.A350V according to the manufacturer's protocol. ...,43,167,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...rmination of the phosphorylation status of wt and p.A350V varian,48,55,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...rmination of the phosphorylation status of wt and p.A350V varian,48,55,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... strep- or flag-tagged wt or strep-tagged variant p.A350V (HA-Strep-tagged) were used as starting ma...,49,219,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...and Western blot analysis of SLC41A1- and SLC41A1 p.A350V-protein complexe,51,79,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...teins were transferred to a PVDF membrane. Wt and p.A350V protein complexes were immuno-detected as ...,52,299,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... goat serum. For detection of strep-tagged wt and p.A350V, we used a primary anti-strep antibody (di...",55,224,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... of tet-induced over-expression of SLC41A1 wt and p.A350V variants in HEK293 cell,70,67,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...rep-SLC41A1-p.A350V); referred to further only as p.A350V cells). Thus, the basic characteristics of...",71,324,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...rep-SLC41A1-p.A350V); referred to further only as p.A350V cells). Thus, the basic characteristics of...",71,324,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ability of the cells over-expressing either wt or p.A350V. Viability of uninduced (-tet) wt or -tet ...,73,482,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in total protein isolate from -tet and +te...,75,665,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in soluble and membrane-protein-enriched f...,75,1064,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...s in cytosolic (C) protein fractions and also for p.A350V in traces in the nuclear (N) protein fract...,75,1849,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...and 1B). Therefore, we concluded that both wt and p.A350V cells produced similar amounts of transcri...",76,557,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...of SLC41A2 and/or SLC41A3 in +tet and -tet wt and p.A350V cells, respectively. Indeed, we did not de...",76,805,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...s [27], [37]. Therefore, we tested whether wt and p.A350V over-expressing cell lines exhibited consi...",78,130,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...perimentation. Next, we determined whether wt and p.A350V cells expressed comparable amounts of SLC4...",78,725,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...perimentation. Next, we determined whether wt and p.A350V cells expressed comparable amounts of SLC4...",78,725,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... p.A350V cells, we calculated that the density of p.A350V-specific bands was ∼1% lower compared with...",78,941,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,SLC41A1 p.A350V localizes within the cytoplasmic membran,80,9,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...s of MF and SF isolated from -tet and +tet wt and p.A350V cells. The ∼56 kDa bands corresponding to ...,81,473,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...almost exclusive detection of both the wt and the p.A350V variants in the fraction enriched in plasm...,81,1106,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...mbrane localization of the potentially PD-related p.A350V variant of SLC41A1. Thus, we conclude that...",81,2255,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,(wt) and HA-strep-SLC41A1-p.A350V in +tet (2,84,27,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,h) cells. Strep-tagged wt and p.A350V were immunolabeled with primary mouse anti...,85,31,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...th blue native electrophoresis [27], [33]. Wt and p.A350V variants showed identical separation patte...",89,282,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...18%) and Western blot analysis of SLC41A1(wt) and p.A350V (M) complexes. Both wt and p.A350V variant...,92,54,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,Amino acid substitution p.A350V in human SLC41A1 induces increased Mg2+ ef...,94,25,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... of +tet cells was increased by 25% (wt) and 33% (p.A350V) when incubated in 10 mM Mg2+ solution. Af...,95,546,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...93-(HA-strep-SLC41A1) or HEK293-(HA-strep-SLC41A1-p.A350V) cells,102,362,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...rusion of 81.2±4.7 µM/10 min (Np.A350V  = 113) in p.A350V cells compared with 48.2±7.0 µM/10 min (Nw...,104,282,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...y 73.6±16.4 µM/10 min and 103.2±21.5 µM/10 min in p.A350V cells (Np.A350V; [Mg2+]e (5 mM)  = 13 & Np...,109,439,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"In both wt- and p.A350V-over-expressing cells, the observed [Mg2+]...",112,17,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...es, cell adhesion, and cell proliferation in +tet p.A350V cells and wt cells",114,188,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...es that the ∼56 kDa bands corresponding to wt and p.A350V were detected in the P fractions. The spec...,117,463,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...es that the ∼56 kDa bands corresponding to wt and p.A350V were detected in the P fractions. The spec...,117,463,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...g-tag. A signal specific for phosphorylated wt or p.A350V was detected in all three cell lines. The ...,120,337,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...he SLC41A1-dependent Mg2+ efflux from +tet wt and p.A350V cells could be further stimulated by the a...,122,75,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...th +tet wt cells, the normalized CI (nCI) of +tet p.A350V cells was reduced (2.03±0.03 vs. 2.26±0.08...",125,235,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...creases and increases the 48-h nCI of +tet wt and p.A350V cells compared with control values (Fig. 5...,125,486,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...much stronger in +tet wt cells compared with +tet p.A350V cells (2.81±0.08 vs. 2.55±0.08; P<0.001),125,802,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...much stronger in +tet wt cells compared with +tet p.A350V cells (2.81±0.08 vs. 2.55±0.08; P<0.001),125,802,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... coding variant of SLC41A1, carrying substitution p.A350V. Here, we have investigated if this potent...",132,118,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... media containing 1.2 mM Mg2+, the effects of the p.A350V mutation seem to be of relevance also unde...",132,1043,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... media containing 1.2 mM Mg2+, the effects of the p.A350V mutation seem to be of relevance also unde...",132,1043,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... growth-promoting effect of dB-cAMP is reduced in p.A350V-over-expressing cells compared with wt cel...,137,753,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ty [53], is similar (0.44±0.01 mM) between wt and p.A350V cells. Therefore, one can speculate that t...",137,1143,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... block SLC41A1-related Mg2+ efflux in both wt and p.A350V cells. Increasing the extracellular Mg2+ c...,140,139,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ion of HA-strep-SLC41A1 (wt) and HA-strep-SLC41A1-p.A350V in -tet (24 h) cells. Strep-tagged wt and ...,148,85,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.Tyr1957Ter,"...to identify a novel nonsense mutation of CACNA1A (p.Tyr1957Ter, NP_001120693.1) resulting in truncat...",7,849,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...s mutation in CACNA1A (c.6107C>A, NM_001127221.1, p.Tyr1957Ter, NP_001120693.1) by Sanger sequencing...",59,373,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...in is caused by “dominant negative effect” of the p.Tyr1957Ter. However, abdominal pain and episodic...",66,1403,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Cys64X,...form	r.[191_212del]	mono-allelic	stop at codon 64	p.Cys64X	5,92,98,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Lys2950Asn,...2 DBD wild-type and BRCA2 DBD carrying a variant (p.Lys2950Asn) classified as clinically neutral [7]...,144,505,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Lys2950Asn,...ained with Coomassie dye. The BRCA2 wild-type and p.Lys2950Asn polypeptides were both recovered in t...,149,490,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gly1366Asp,... were intronic and 3 introduced missense changes (p.Gly1366Asp and p.Asp1778Gly in BRCA1 and p.Pro30...,183,88,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Pro992Leu,"... founder effects for four mutations (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val) existe...",7,1510,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...cts for four mutations (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val) existed in these fa...",7,1523,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...tions (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val) existed in these families. Transfect...",7,1540,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Leu1325Leu,"...p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu), IVS8+26A>...",73,167,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ser105X,"...Twenty mutations, including 3 nonsense mutations (p.Ser105X, p.Gln388X and p.Gly837X), one deletion ...",73,400,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...ng 3 nonsense mutations (p.Ser105X, p.Gln388X and p.Gly837X), one deletion mutation (c.2659delG), on...",73,425,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val145Phe,"...mutation (c.1708-1G>C) and 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu...",73,534,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val145Phe,"...mutation (c.1708-1G>C) and 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu...",73,534,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr498Ser,"...708-1G>C) and 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu...",73,547,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro840Leu,"...Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro...",73,586,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly869Arg,"...Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met...",73,599,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...hr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg...",73,678,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg1320Ser) were identified by ...",73,706,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg1320Ser,"...Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg1320Ser) were identified by further analysis ...",73,723,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gln388X,"... S2–4). Among these mutations, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X) of them are ...",73,955,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...ns, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X) of them are novel ATP7B gene mutations ...",73,982,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...ns, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X) of them are novel ATP7B gene mutations ...",73,982,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"... mutation revealed that clear founder effects for p.Arg778Leu (Families M1279, M1524, M1841, M2621 a...",76,105,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"... mutation revealed that clear founder effects for p.Arg778Leu (Families M1279, M1524, M1841, M2621 a...",76,105,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"... mutation revealed that clear founder effects for p.Arg778Leu (Families M1279, M1524, M1841, M2621 a...",76,105,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1295Val (Families M41 and M1407) mutations ex...",76,292,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1295Val (Families M41 and M1407) mutations ex...",76,292,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr498Ser,...fected mother was in heterozygous status (M1279). p.Thr498Ser was found in a 20-year female WD patie...,101,1723,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,... Compound heterozygous ATP7B mutations (p.Gly837X/p.Pro992Leu) were found in an 18-year WD female (M...,101,1977,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"...e different pedigrees existed founder effects for p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala12...",101,4097,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Y83Y,"... of the family (Table 1). These SNPs, rs73415876 (p.Y83Y) and rs139884 (p.H309H) have a global Minor...",67,255,PLoS_One_2013_Jun_26_8(6)_e66631.txt
p.I1521K,"...Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W, p.I1521K) [23], [44], [45], [46], [47] as a result...",158,1116,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.S532L,T77	Clear cell	Unstable	c.C1595T	p.S532L	Missense	Low	Tolerated	Probably damaging,97,35,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.S532L,T77	Clear cell	Unstable	c.C1595T	p.S532L	Missense	Low	Tolerated	Probably damaging,97,35,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.R786C,T88	Endometrioid	Unstable	c.C2356T	p.R786C	Missense	Medium	Affects function	Probably ...,98,37,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.D679N,CHTF18	T79	Serous	Stable	c.G2035A	p.D679N	Missense	Low	Tolerated	Probably damaging,99,35,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.V910L,rs34587013	10	88686602	MMRN2	NM_024756	c.G2728C	p.V910L	0.91	neutral	NA	NA,123,49,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.I82V,rs2641563	10	88758233	AGAP11	NM_133447	c.A244G	p.I82V	1.00	neutral	NA	NA,125,48,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.I82V,rs2641563	10	88758233	AGAP11	NM_133447	c.A244G	p.I82V	1.00	neutral	NA	NA,125,48,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.S3588P,Pathogenicity of the bfb p.S3588P mutation was estimated using Polyphen (ht...,34,26,PLoS_One_2013_Oct_15_8(10)_e76342.txt
p.S3588P,Pathogenicity of the bfb p.S3588P mutation was estimated using Polyphen (ht...,34,26,PLoS_One_2013_Oct_15_8(10)_e76342.txt
p.Ala461Val,"... p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val were evaluated in parallel with 11 age...",99,443,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Leu73Phe,"...e clinical data, the p.Ala461Val, p.Ala270Ser and p.Leu73Phe variants did not affect the ability of ...",106,503,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.L90P,"...34	IV, mild, Hy	FLG R501X/wt; GJB2−/− (p.G11fsX59/p.L90P)",40,64,PLoS_One_2013_Oct_9_8(10)_e75355.txt
p.Cys356Gly,I-2	57	M	5.20	0.93	1.09	3.10	p.Cys356Gly (c.1129T>G),107,30,PLoS_One_2014_Apr_10_9(4)_e94697.txt
p.Cys356Gly,II-1	28	F	4.47	1.47	1.26	4.02	p.Cys356Gly (c.1129T>G),109,31,PLoS_One_2014_Apr_10_9(4)_e94697.txt
p.N247S,"... , Ainsworth JR , Shah S , et al (2007 ) Study of p.N247S KERA mutation in a British family with cor...",145,86,PLoS_One_2014_Apr_23_9(4)_e95037.txt
p.V600E,"...reditary origin, the mutation hotspot (c.1779T>A, p.V600E) of BRAF was scanned via HRM followed by d...",55,122,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Thr553X,MLH1/Exon 14	c.1657delACCAAGCTTAG	p.Thr553X	Malay	1	1	No record	No record	Novel path...,83,35,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gln681X,MSH2/Exon 13	c.2041C>T	p.Gln681X	Eurasian	1	1	No record	No record	Novel p...,90,24,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Thr553X,"136	MLH1/Exon 14, c.1657delACCAAGCTTAG, p.Thr553X	Novel Pathogenic	Lost	Normal	Normal	Lost...",113,41,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Thr553X,"136	MLH1/Exon 14, c.1657delACCAAGCTTAG, p.Thr553X	Novel Pathogenic	Lost	Normal	Normal	Lost...",113,41,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.R268Q,"...e identified a novel missense mutation (c.803G>A, p.R268Q) in the plasma membrane calcium ATPase (PM...",7,589,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,...m 1% to 3%. All the other variants were rare. The p.R268Q variant that was identified in the symptom...,84,743,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,...m 1% to 3%. All the other variants were rare. The p.R268Q variant that was identified in the symptom...,84,743,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,...m 1% to 3%. All the other variants were rare. The p.R268Q variant that was identified in the symptom...,84,743,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,...database. There was perfect co-segregation of the p.R268Q mutation with disease status in our family...,84,935,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.P297S,"...ransactivation in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P...",11,513,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,c.565A>T	p.I189F	40	P	—	—	—	—,54,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A291V,c.872C>T	p.A291V	73	P	0.2	—	—	rs200459003,55,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P195A,FOXC2	exon 1	c.583C>G	p.P195A	78	P	0.2	—	—	rs200751941,62,23,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,c.1331A>G	p.Q444R	34	—	0.2	0.14	—	rs147258453,63,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,exon 3	c.338G>C	p.S113T	500	—	0.8	0.66	0.2	rs144830740,69,18,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,exon 3	c.338G>C	p.S113T	500	—	0.8	0.66	0.2	rs144830740,69,18,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.T233T,GATA4	exon 2	c.699G>A	p.T233T	323	—	—	0.3	0.1	rs55788387,70,23,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...CC, p.A25_A26insAA (maternal) and FOXA2 c.280G>C, p.A94P (maternal). The second patient carried GATA...",98,1197,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,"...Six variants (HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and FOXC1 p.G378_G380delGGG a...",101,255,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"... silico tools predicted FOXA2 p.A94P, p.I189F and p.Y445C to be damaging (with PolyPhen scores of 0....",101,498,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,... we studied the transcriptional activity of TBX20 p.I122V as variation of the neighbouring amino aci...,101,892,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...three non-synonymous FOXA2 variants investigated (p.A94P, p.I189F, and p.Y445C) affected transcripti...",110,173,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,...gulation observed between wild-type TBX20 and the p.I122V variant (data not shown),113,222,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,"...er transactivation capacity: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPR...",124,403,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,"...ion capacity: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPRYDPCAAAAPGAPGP ...",124,418,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,500	FOXH1	p.S113T	Tetralogy of Fallot with severe valvar and...,136,11,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,...in Axenfeld Rieger syndrome (ARS) patients. FOXC1 p.P297S has been reported in two patients with thi...,137,392,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,...in Axenfeld Rieger syndrome (ARS) patients. FOXC1 p.P297S has been reported in two patients with thi...,137,392,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.G149V,"...oding region of NOTCH3, a novel missense mutation p.G149V (c.446G>T) was found. This mutation was no...",7,1451,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,"...oding region of NOTCH3, a novel missense mutation p.G149V (c.446G>T) was found. This mutation was no...",7,1451,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,"...By genetic testing, we revealed a novel c.446G>T (p.G149V) mutation located in exon 4 of the NOTCH3 ...",91,871,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.V44A,...(c.131T>C) in exon 2. E: Conservation analysis of p.V44A of the Cx50 gene,73,617,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...e residue for alanine at codon 44 of connexin 50 (p.V44A), which is located in the first extracellul...",76,412,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...ary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chinese or...",116,58,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...ary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chinese or...",116,58,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.Arg355Gln,"...lix of citrin protein (Fig. 4B), and the mutation p.Arg355Gln shortened the distance of the H-bond b...",109,291,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,...g. 6B). These results indicated that the mutation p.Arg355Gln caused complete loss of the AGC functi...,124,687,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,...g. 6B). These results indicated that the mutation p.Arg355Gln caused complete loss of the AGC functi...,124,687,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.G56R,"...have a recessive mode of inheritance, a c.166G>A (p.G56R) mutation in the NR2E3 gene is associated w...",14,1343,PLoS_One_2014_Jan_31_9(1)_e87942.txt
p.G56R,"...have a recessive mode of inheritance, a c.166G>A (p.G56R) mutation in the NR2E3 gene is associated w...",14,1343,PLoS_One_2014_Jan_31_9(1)_e87942.txt
p.Thr296Thr,...s144891994	C	C/T	0 ∧	0.005	NA	0.008	NA	G	c.888G>A	p.Thr296Thr	synonymous	2	CCD,95,65,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Thr296Thr,...s144891994	C	C/T	0 ∧	0.005	NA	0.008	NA	G	c.888G>A	p.Thr296Thr	synonymous	2	CCD,95,65,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Thr296Thr,...s144891994	C	C/T	0 ∧	0.005	NA	0.008	NA	G	c.888G>A	p.Thr296Thr	synonymous	2	CCD,95,65,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Asn561Asn,...4	A	A/G	0.250**	0.292	0.20	0.347	0.02	T	c.1683T>C	p.Asn561Asn	synonymous	6	linker region between TMD...,98,73,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Thr714Thr,...4891994	C	C/A	0.008	0.005	0.66	0	0.32	G	c.2142G>T	p.Thr714Thr	synonymous	8	TMD 6,100,68,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Phe843Phe,...209	G	G/A	0.077	0.054	0.28	0.081	0.87	C	c.2529C>T	p.Phe843Phe	synonymous	11,102,71,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.P140S,"...e found five potential disease-causing mutations, p.P140S, p.S183L, p.S196G, p.Ser161delAGC and p. S...",7,784,PLoS_One_2014_May_21_9(5)_e98157.txt
p.P140S,...). All other mutations were located in SRJ except p.P140S,119,444,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S196G,"...ction of VP16-P300 and the four mutants (p.S183L, p.S196G, p.Ser161delAGC, p.Ser192_Gly193delAGCGGC)...",122,530,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S196G,"...ction of VP16-P300 and the four mutants (p.S183L, p.S196G, p.Ser161delAGC, p.Ser192_Gly193delAGCGGC)...",122,530,PLoS_One_2014_May_21_9(5)_e98157.txt
p.P140S,"...ctivity of mutants increased obviously except the p.P140S mutant. In conclusion, CITED2 mutations we...",127,371,PLoS_One_2014_May_21_9(5)_e98157.txt
p.P140S,"...ctivity of mutants increased obviously except the p.P140S mutant. In conclusion, CITED2 mutations we...",127,371,PLoS_One_2014_May_21_9(5)_e98157.txt
p.H279D,"... four novel cytochrome P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary congenit...",152,118,PLoS_One_2014_Oct_16_9(10)_e110473.txt
p.K433K,"... P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary congenital glaucoma patients ....",152,140,PLoS_One_2014_Oct_16_9(10)_e110473.txt
p.R534Q,"... the genetic factors, factor V Leiden (c.1601G>A, p.R534Q) and prothrombin G20210A mutations are wel...",17,157,PLoS_One_2015_Jul_17_10(7)_e0133196.txt
p.L160H,"...with other CYP2A6 SNPs, e.g., rs1801272 (c.479T>A/p.L160H), with effect size of 0.68 CPD (N = 66,380...",176,516,PLoS_One_2015_Jul_1_10(7)_e0126113.txt
p.L160H,"...with other CYP2A6 SNPs, e.g., rs1801272 (c.479T>A/p.L160H), with effect size of 0.68 CPD (N = 66,380...",176,516,PLoS_One_2015_Jul_1_10(7)_e0126113.txt
p.Ser163Arg,"...45.3: c.489C>A), leading to the missense mutation p.Ser163Arg previously associated with Late-Onset ...",97,691,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Asp186Asn,RP-0107	adRP	adCRD	PRPH2 c556G>A; p.Asp186Asn (NM_000322.4)	Kohl et al. 2012 [33],103,35,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Asp186Asn,RP-0107	adRP	adCRD	PRPH2 c556G>A; p.Asp186Asn (NM_000322.4)	Kohl et al. 2012 [33],103,35,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Ser163Arg,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al. 2003 [3...,106,44,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Ser163Arg,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al. 2003 [3...,106,44,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Ser163Arg,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al. 2003 [3...,106,44,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Ser163Arg,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al. 2003 [3...,106,44,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.P174T,"c.521C>G, p.P174T	c.949_950insC	-",18,11,PLoS_One_2015_Jul_29_10(7)_e0134748.txt
p.R132H,"6	39	F	+++	p.R132H	WT	3,5",130,12,PLoS_One_2015_Jul_9_10(7)_e0130596.txt
p.R132H,"6	39	F	+++	p.R132H	WT	3,5",130,12,PLoS_One_2015_Jul_9_10(7)_e0130596.txt
p.D150H,"MIP: c.448G>C, p.D150H		1.628	1.718	1.797	1.806",77,16,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"MIP: c.448G>C, p.D150H		1.628	1.718	1.797	1.806",77,16,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,In order to evaluate the impact of p.D150H mutation on the structure and function of ...,82,36,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,In order to evaluate the impact of p.D150H mutation on the structure and function of ...,82,36,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...on was damaging. These results together indicated p.D150H mutation is likely to be deleterious to th...,82,535,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...ids individually. These data demonstrate that the p.D150H mutation would damage the trafficking mech...,91,852,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...ids individually. These data demonstrate that the p.D150H mutation would damage the trafficking mech...,91,852,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.M1T,"...autosomal dominant congenital cataract in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16...",97,1235,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R33C,"...minant congenital cataract in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [...",97,1247,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R113X,"...ital cataract in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [16], p.G165D ...",97,1260,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.T138R,"...ations in transmembrane domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water p...",99,800,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.T138R,"...ations in transmembrane domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water p...",99,800,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G165D,"... transmembrane domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water permeabili...",99,809,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R33C,"...rafficking [26]. In contrast, the cataract-linked p.R33C mutation, which locates at the extracellula...",99,1512,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...gressive cortical punctate cataract caused by the p.D150H mutation of MIP. It is a new missense muta...,105,99,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...gressive cortical punctate cataract caused by the p.D150H mutation of MIP. It is a new missense muta...,105,99,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...gressive cortical punctate cataract caused by the p.D150H mutation of MIP. It is a new missense muta...,105,99,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...dies focusing on the biological changes caused by p.D150H are needed,105,570,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.T2538R,"...eletion) or point mutations p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q42...",31,368,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.L4115F,"...tions p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p....",31,390,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.Q4201R,"...>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mu...",31,413,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.Leu412Phe,...prising 1116 matching donors and recipients. TLR3 p.Leu412Phe and SIGIRR p.Gln312Arg significantly d...,7,921,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Leu412Phe,...prising 1116 matching donors and recipients. TLR3 p.Leu412Phe and SIGIRR p.Gln312Arg significantly d...,7,921,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Leu412Phe,...prising 1116 matching donors and recipients. TLR3 p.Leu412Phe and SIGIRR p.Gln312Arg significantly d...,7,921,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,...onors and recipients. TLR3 p.Leu412Phe and SIGIRR p.Gln312Arg significantly deviated from Hardy-Wein...,7,944,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,...onors and recipients. TLR3 p.Leu412Phe and SIGIRR p.Gln312Arg significantly deviated from Hardy-Wein...,7,944,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...e (Illumina). Of the chosen SNPs, rs4986790 (TLR4 p.Asp299Gly) and rs4986791 (TLR4 p.Thr399Ile) are ...",20,937,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,... rs4986790 (TLR4 p.Asp299Gly) and rs4986791 (TLR4 p.Thr399Ile) are in linkage disequilibrium (LD) (r...,20,970,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,... rs4986790 (TLR4 p.Asp299Gly) and rs4986791 (TLR4 p.Thr399Ile) are in linkage disequilibrium (LD) (r...,20,970,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,"... testing, TLR3 p.Leu412Phe (P = 0.046) and SIGIRR p.Gln312Arg (P < 0.0001) appeared in Hardy-Weinber...",33,634,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	4	p.Asn248Ser (rs4833095)	LOF [25–27]	C/t	53.7	36.6	...,72,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	4	p.Arg753Gln (rs5743708)	LOF [28–30]	G/a	95.2	4.8	0...,73,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Leu412Phe,"TLR3	4	p.Leu412Phe (rs3775291)	LOF [31,32] GOF [33]	C/t	4...",74,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"TLR4	9	p.Thr399Ile (rs4986791)	LOF [34,35]	C/t	89.1	10.3	...",76,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	1	p.Arg392Ter (rs5744168)	LOF [36–38]	G/a	88.1	11.7	...,77,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"TLR8	X	p.Met1Val(rs3764880)	GOF [44,45]	A/g	66.4	15.0	18....",81,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"TLR8	X	p.Met1Val(rs3764880)	GOF [44,45]	A/g	66.4	15.0	18....",81,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,SIGIRR	11	p.Gln312Arg (rs3210908)	ND	C/t	60.8	34.2	5.0	22.1	...,82,11,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"...he carrier frequency of the minor allele for TLR1 p.His305Leu (OR = 4.79, 95% CI = 2.35–9.75, P = 0....",86,366,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	9.6	5.1	0.73	0.22–2.43	1,92,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	9.6	5.1	0.73	0.22–2.43	1,92,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,TLR4	p.Asp299Gly	5.8	5.4	1.27	0.52–3.12	1,93,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	8.2	7.1	2.93	1.03–8.33	0.4,95,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	21.7	21.1	1.05	0.85–1.30	1,98,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	21.7	21.1	1.05	0.85–1.30	1,98,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	Congenital	216	10.4	2.6	4.94	2.26–10.8...,108,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	Congenital	216	25.9	25.9	1.02	0.76–1.3...,112,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	Congenital	216	24.6	22.6	1.18	0.86–1.64	...,116,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	C/t	1.28	0.85–1.90	1	0.85	0.56–1.28	1,140,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	A/g	0.92	0.69–1.24	1	0.78	0.59–1.05	1,144,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	A/t	0.88	0.63–1.23	1	0.83	0.57–1.19	1,148,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	A/g	0.96	0.68–1.34	1	1.09	0.77–1.55	1,150,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,TLR4	p.Asp299Gly	A/g	0.85	0.60–1.20	1	0.90	0.65–1.25	1,170,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	A/g	1.08	0.85–1.36	1	0.92	0.74–1.16	1,176,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	T/a	1.02	0.52–2.00	1	1.01	0.65–1.56	1,196,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	T/a	1.02	0.52–2.00	1	1.01	0.65–1.56	1,196,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	C/t	1.13	0.84–1.52	1	1.11	0.82–1.50	1,198,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	G/a	1.13	0.72–1.77	1	1.29	0.93–1.80	1,200,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	G/a	1.13	0.72–1.77	1	1.29	0.93–1.80	1,200,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	G/a	1.31	0.90–1.90	1	0.84	0.55–1.27	1,206,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	A/g	1.03	0.75–1.43	1	1.20	0.87–1.64	1,208,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	A/g	1.03	0.75–1.43	1	1.20	0.87–1.64	1,208,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	1.19	0.87–1.64	1	0.85	0.62–1.17	1,210,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	1.19	0.87–1.64	1	0.85	0.62–1.17	1,210,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"...l transplant recipients, we observed that 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val s...",223,495,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"...l transplant recipients, we observed that 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val s...",223,495,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...ients, we observed that 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val significantly assoc...",223,513,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...at 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val significantly associated with the preval...",223,534,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,...d a higher frequency of the minor allele for TLR1 p.Asn248Ser in pediatric patients with IgA nephrop...,225,455,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...disease in our cohort, was not investigated. TLR4 p.Asp299Gly and p.Thr399Ile are by far the most st...",225,888,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...tion, which is in line with our study and because p.Asp299Gly and p.Thr399Ile are in high linkage di...",225,1277,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"TLR4	p.Asp299Gly	Nogueira, 2007	[12]	Brazil	Native	CKD	...",238,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"TLR4	p.Thr399Ile	Nogueira, 2007	[12]	Brazil	Native	CKD	...",258,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	-	-	-	-	-	-	-,277,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	-	-	-	-	-	-	-,278,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...es. In the context of renal transplantation, TLR4 p.Asp299Gly and p.Thr399Ile are also among the mos...",286,609,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,"...th our study, did not find an association of TLR5 p.Arg392Ter with renal transplant outcomes. Even t...",286,2198,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.A1066V,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,9,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
p.Gly371Arg,"...; a novel homozygous missense mutation c.1111C>G (p.Gly371Arg) in gene OTOF (otoferlin, MIM 603681) ...",44,373,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...cid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,77,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,Variant c.5254G>A (p.Gly1752Arg) in the RAI1 gen,78,20,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,Variant c.1111C>G (p.Gly371Arg) in the OTOF gen,92,20,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...153841.g002Fig 2 Identification of the c.1111C>G (p.Gly371Arg) mutation in the OTOF gene and the c.2...,95,73,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...153841.g002Fig 2 Identification of the c.1111C>G (p.Gly371Arg) mutation in the OTOF gene and the c.2...,95,73,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,...ee of the WES family F53 with mutation c.2168A>G (p.His723Arg) in the SLC26A4 gene which is denoted ...,96,259,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Q1389R,"...ein with missense mutations p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S...",116,1326,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Q1562R,"...tions p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all...",116,1348,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.S1808N,"...), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all are in C-terminal half o...",116,1373,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...evolutionarily conserved amino acid position 371 (p.Gly371Arg) in the region between domains C2B and...,124,195,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.R152W,...ardiac phenotype associated with homozygosity for p.R152W mutation in the ARSB gene . Am J Med Genet...,196,197,PLoS_One_2016_Apr_19_11(4)_e0153543.txt
p.Asn98Ser,...estive of a possible underlying CPVT phenotype. A p.Asn98Ser mutation in CALM2 was detected in both ...,17,252,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,...0.1371/journal.pone.0153851.g002Fig 2 View of the p.Asn98Ser mutation,45,52,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,...0.1371/journal.pone.0153851.g002Fig 2 View of the p.Asn98Ser mutation,45,52,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,... pathogenic variant found in probands A and B was p.Asn98Ser in CALM2. p.Asn98Ser is not listed in p...,54,98,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.G110Efs,"...YP21A2 deletion, large gene conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M23...",57,364,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.G110Efs,"...YP21A2 deletion, large gene conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M23...",57,364,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.V237E,"...on, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p...",57,400,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.M239K,"...A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p.G424S, p...",57,409,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.R356W,"... cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p.G424S, p.Arg483fs or the IVS2-...",57,431,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.I172N,"... A/C>G (I2 splice) mutations. B alleles carry the p.I172N mutation, resulting in 3 ± 7% residual enz...",57,533,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.P30L,"...idual enzymatic activity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in...",57,624,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.V281L,"...zymatic activity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in 20 ± 60...",57,632,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.V281L,"...zymatic activity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in 20 ± 60...",57,632,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.A467T,...cleotide position (np) 1399 in exon 7 (c.1399G>A; p.A467T) in all four individuals,93,543,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.Ala467Thr,...f the common homozygous polymerase-gamma mutation p.Ala467Thr?,226,86,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.Trp152Arg,...gregation of a novel missense mutation (c.454T>C; p.Trp152Arg) in the FOXC1 gene. (B). Systemic and ...,57,70,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,...amino-acid FHD [27]. The novel missense mutation (p.Trp152Arg) identified in this study affects a co...,75,620,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Gly,...ts the same amino acid as the previously reported p.Trp152Gly mutation in a patient with aniridia [2...,75,807,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Try152Gly,...Gly mutation in a patient with aniridia [28]. The p.Try152Gly mutation has a severe effect on FOXC1 ...,75,865,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,"...nding ability, and nuclear localization [28]. The p.Trp152Arg mutation may have a similar consequenc...",75,1029,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,"...phenotypes of the patients with these mutation as p.Trp152Arg mutation leads to ARS, while the previ...",75,1226,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.L22F,1 p.L22F,220,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.D61N,2 p.D61N,222,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.L139X,2 p.L139X,312,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.Gly316Ser,"...nalyzed with the Swiss PDV Viewer, SPDBV 4.1. The p.Gly316Ser mutation was introduced into human ATP...",25,258,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...ession studies were performed to test whether the p.Gly316Ser ATP1A3 mutation impairs the activity o...,73,64,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...ession studies were performed to test whether the p.Gly316Ser ATP1A3 mutation impairs the activity o...,73,64,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...her lanes show transient expression of WT ATP1A3, p.Gly316Ser, and p.Glu815Lys, an inactive mutation...",76,1284,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Glu815Lys,"...ansient expression of WT ATP1A3, p.Gly316Ser, and p.Glu815Lys, an inactive mutation found in AHC [28...",76,1301,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly358Val,...[17]. In an infant with catastrophic epilepsy and p.Gly358Val ATP1A3 mutation that severely inhibite...,82,422,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...e critical role of the Na,K-ATPase, our patient’s p.Gly316Ser ATP1A3 mutation may be sufficient to c...",84,635,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...e critical role of the Na,K-ATPase, our patient’s p.Gly316Ser ATP1A3 mutation may be sufficient to c...",84,635,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Thr467Ile,"...quilins, is a homozygous UBQLN2 missense variant, p.Thr467Ile, found in a female FTD patient [41]. I...",87,1227,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Arg225X,"...ected) identified a novel LMNA nonsense mutation (p.Arg225X) in a Japanese family [16], and WES of f...",142,384,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...orts, our study does not support the role of TMPO p.Arg690Cys [22], MYBPC3 p.Val895Met [23,24], and ...",148,78,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...ly penetrant, primary mutations. We excluded TMPO p.Arg690Cys as the primary mutation in our family ...",148,208,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,... cohort was screened for TMPO mutations. The TMPO p.Arg690Cys variant was found in two brothers with...,148,494,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,... cohort was screened for TMPO mutations. The TMPO p.Arg690Cys variant was found in two brothers with...,148,494,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,...y that showed reduced lamin A binding of the TMPO p.Arg690Cys protein in vitro [22]. Our family stud...,148,648,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,...y that showed reduced lamin A binding of the TMPO p.Arg690Cys protein in vitro [22]. Our family stud...,148,648,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...ad the variant; therefore, we concluded that TMPO p.Arg690Cys variant was not the primary mutation i...",148,884,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...ad the variant; therefore, we concluded that TMPO p.Arg690Cys variant was not the primary mutation i...",148,884,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Val895Met,"...ur study also does not support the role of MYBPC3 p.Val895Met as a highly penetrant, primary mutatio...",150,52,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,"...lished HCN4 mutation and two subjects had the HCN p.M1113V variant [25]. In our family, we found the...",152,336,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,"...ily, we found the lack of segregation for the HCN p.M1113V and heart disease; only one affected sibl...",152,419,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg321Ter,"...li A , Hansen J , et al (2013 ) The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy...",277,114,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.L811P,"...in sensation, a de novo missense SCN11A mutation (p.L811P; we have abbreviated the prefix “p” in thi...",15,584,PLoS_One_2016_May_25_11(5)_e0154827.txt
p.R222S,"...CN11A p.R222H (Family 1, 2, 4, 5 and 6) or SCN11A p.R222S (Family 3) for each individual is illustra...",35,528,PLoS_One_2016_May_25_11(5)_e0154827.txt
p.W57C,"p.W57C[44, 45],[4]	Homo	-			221.71±16.19	337.84 ± ...",89,1,PLoS_One_2016_May_31_11(5)_e0156252.txt
p.W57C,"p.W57C[44, 45],[4]	Homo	-			221.71±16.19	337.84 ± ...",89,1,PLoS_One_2016_May_31_11(5)_e0156252.txt
p.Y81N,Comp. Het.	Comp. Het		p.Y81N* in POAG			0 for both	5for Y81N; 0 for fs	J...,93,23,PLoS_One_2016_May_31_11(5)_e0156252.txt
p.Arg23Lys,c.68G>A (p.Arg23Lys)	rs6190		2.98% (ss1317539290)	2.85%	2.4...,130,10,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
p.V368I,...; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p.V368I)] of CPT II and mitochondrial energy crisi...,56,974,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
p.Glu376Asp,...> A; p.Arg101His) and PI*M3 (rs1303; c.1200A > C; p.Glu376Asp). The allelic frequency of these polym...,28,496,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Y110C,...g detected a homozygous novel mutation (c.329A>G; p.Y110C) in the MUT gene in patient 1 and a hetero...,3,1725,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.Q734X,... a novel homozygous nonsense mutation (c.2200C>T; p.Q734X) and a heterozygous in parents. This mutat...,3,1961,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.Q734X,...etected a homozygous nonsense mutation (c.2200C>T;p.Q734X) in the patient and heterozygous in both h...,25,69,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.Y110C,"...nted in both patients. In patient 1, the c.329A>G;p.Y110C mutation is located in the alpha/beta chai...",30,804,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.P753S," 	EGFR c.2257C > T, p.P753S	Yes	98%	Yes	99%",170,21,Sci_Rep_2013_Dec_13_3_3494.txt
p.P388S," 	c.1162 G > A, p.P388S (MeWo)",191,17,Sci_Rep_2013_Dec_13_3_3494.txt
p.D498E,"...ied a novel missense sequence variant (c.1494C>A, p.D498E) in the CNNM4 gene which is located in the...",25,777,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,...nd identified a novel homozygous missense change (p.V734M) in the CDH3 gene. The p.V734M change was ...,27,675,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,"...s missense change (p.V734M) in the CDH3 gene. The p.V734M change was absent in WES databases, fully ...",27,706,Sci_Rep_2015_Aug_26_5_13187.txt
p.C363S,ADAM9	c.1087T>A	p.C363S	0	arRP	Iraqi Jew	MOL0827 MOL0838	—	Homozyg...,85,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.C363S,ADAM9	c.1087T>A	p.C363S	0	arRP	Iraqi Jew	MOL0827 MOL0838	—	Homozyg...,85,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.D696Afs,CDHR1	c.2087_2090delACAA	p.D696Afs	0	arRD	Arab Muslim	MOL0835	—	Homozygous	...,88,26,Sci_Rep_2015_Aug_26_5_13187.txt
p.T452Sfs,FAM161A	c.1355_6delCA	p.T452Sfs	4*10−5	arRP	Moroccan Jew	MOL0228	26	Homo...,97,23,Sci_Rep_2015_Aug_26_5_13187.txt
p.T494M,PRPF3	c.1481C>T	p.T494M	0	adRP	Yemenite Jew	MOL0108	—	Heterozygous...,102,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.A126V,RDH12	c.377C>T	p.A126V	8*10−6	arRP	Arab Muslim	MOL1389	—	Homozygo...,106,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.G2313C,USH2A	c.6937G>T	p.G2313C	1*10−4	arRP	Arab Muslim	MOL1234	—	Heteroz...,113,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.G2313C,USH2A	c.6937G>T	p.G2313C	1*10−4	arRP	Arab Muslim	MOL1234	—	Heteroz...,113,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,CDH3	c.2200G>A	p.V734M	Disease causing	1	0.06 Tolerated	0	0	3*10−...,132,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.D498E,CNNM4	c.1494C>A	p.D498E	Disease causing	1	0.00 Damaging	0	0	0,134,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.D110G,RPE65	c.329A>G	p.D110G	Disease causing	0.998	0.31 Tolerated	0	0	0...,136,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.D110G,RPE65	c.329A>G	p.D110G	Disease causing	0.998	0.31 Tolerated	0	0	0...,136,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.I591T,"...gous state with unknown function for patients O1 (p.I591T, rs11466045, MAF 0.07) and R1 (p.F425Y, rs...",27,381,Sci_Rep_2015_May_19_5_10200.txt
p.E148Q,"...Conversely, in family A, we identified a variant (p.E148Q, rs3732930, MAF 0.06) shared among the two...",27,575,Sci_Rep_2015_May_19_5_10200.txt
p.Q703K,"...d a heterozygous change in NLRP3 related to CAPS (p.Q703K, rs35829419, MAF 0.04). In family B, we id...",27,750,Sci_Rep_2015_May_19_5_10200.txt
p.R121Q,"...A, usually associated with milder forms of TRAPS (p.R121Q, rs4149584, MAF 0.018). This change cosegr...",27,893,Sci_Rep_2015_May_19_5_10200.txt
p.R211C,"... cold autoinflammatory syndrome-2, in patient R1 (p.R211C). This change, located in a well-conserved...",27,1096,Sci_Rep_2015_May_19_5_10200.txt
p.R274Q,"...tated changes in NLRP5, for patients 2940 and F1 (p.R274Q, and p.N255S, respectively). Again, patien...",33,423,Sci_Rep_2015_May_19_5_10200.txt
p.N255S,"... in NLRP5, for patients 2940 and F1 (p.R274Q, and p.N255S, respectively). Again, patient 2940 presen...",33,436,Sci_Rep_2015_May_19_5_10200.txt
p.S4L,"...her common in the control CoLaus Lausanne cohort (p.S4L, rs142463014, for 2492, MAF 0.09; p.I331V, r...",33,857,Sci_Rep_2015_May_19_5_10200.txt
p.I384T,"...R families we identified a rare change in NLRP10, p.I384T (rs150112481, MAF 0.01) although only in p...",33,1214,Sci_Rep_2015_May_19_5_10200.txt
p.S1025L,"...0.01) although only in patient O1, and the change p.S1025L (rs11671248, MAF 0.08) in NLRP11 in patie...",33,1290,Sci_Rep_2015_May_19_5_10200.txt
p.R352C,...n function. Recently a similar missense mutation (p.R352C) in the same NACHT domain of this gene was...,44,215,Sci_Rep_2015_May_19_5_10200.txt
p.R352C,...n function. Recently a similar missense mutation (p.R352C) in the same NACHT domain of this gene was...,44,215,Sci_Rep_2015_May_19_5_10200.txt
p.E148Q,"...fically, we identified a change in the MEFV gene (p.E148Q) and in NLRP3 (p.Q703K), both common polym...",44,1011,Sci_Rep_2015_May_19_5_10200.txt
p.Q703K,"...ctional effect on the protein. In particular, for p.Q703K, functional impairment of NLRP3 has been c...",44,1139,Sci_Rep_2015_May_19_5_10200.txt
p.G504D, 	novel	B7	p.G504D	0	NACHT,127,12,Sci_Rep_2015_May_19_5_10200.txt
p.L607P, 	182098487	2940	p.L607P	0.005	between NACHT and LRR1,128,18,Sci_Rep_2015_May_19_5_10200.txt
p.I384T,NLRP10	150112481	O1	p.I384T	0.001	NACHT,134,21,Sci_Rep_2015_May_19_5_10200.txt
p.R1005Q,NOD3 (NLRC3)	novel	2940	p.R1005Q	0	LRR15,138,25,Sci_Rep_2015_May_19_5_10200.txt
p.L193V,NOD5 (NLRX1)	150153921	B7	p.L193V	0.007	NACHT,140,27,Sci_Rep_2015_May_19_5_10200.txt
p.L193V,NOD5 (NLRX1)	150153921	B7	p.L193V	0.007	NACHT,140,27,Sci_Rep_2015_May_19_5_10200.txt
p.R547W," 	145779362	O1,O5	p.R547W	0.007	between NACHT and LRR1",141,19,Sci_Rep_2015_May_19_5_10200.txt
p.R547W," 	145779362	O1,O5	p.R547W	0.007	between NACHT and LRR1",141,19,Sci_Rep_2015_May_19_5_10200.txt
p.Arg18Leu,rs139293	22q13.1	39496336	G/T	0.17	APOBEC3H	p.Arg18Leu	exon 2	D	T,124,45,Sci_Rep_2015_Oct_13_5_14969.txt
p.Arg18Leu,rs139293	22q13.1	39496336	G/T	0.17	APOBEC3H	p.Arg18Leu	exon 2	D	T,124,45,Sci_Rep_2015_Oct_13_5_14969.txt
p.A2808T,...ir of compound heterozygous mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Table 2) in t...,36,1199,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,"...he parents were unaffected carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A2808T, mother)...",36,1648,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,"....A2808T, mother) in family ARRP-49 and c.1871G>A (p.S624L, father) in family ARRP-206. The inheritan...",36,1732,Sci_Rep_2016_Jan_20_6_19432.txt
p.T657Afs,"...ntified in EYS include p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, p.E1836* and others5918. Mo...",48,116,Sci_Rep_2016_Jan_20_6_19432.txt
p.T657Afs,"...ntified in EYS include p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, p.E1836* and others5918. Mo...",48,116,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,"...us mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in EYS in family ARRP-49. Both mutation...",48,421,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,...ARRP-49. The novel homozygous mutation c.1871G>A (p.S624L) in EYS is likely the causative mutation f...,48,1291,Sci_Rep_2016_Jan_20_6_19432.txt
p.Q1536E,"...10, the compound heterozygous mutations c.C4060G (p.Q1536E) and c.A5038G (p.N1680D) were found, and ...",50,296,Sci_Rep_2016_Jan_20_6_19432.txt
p.G473V,"...18, the compound heterozygous mutations c.G1418T (p.G473V) and c.C2971T (p.L991F) were found, and th...",50,504,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,"...in mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), respectively, and these mutations resul...",52,130,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,"...in mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), respectively, and these mutations resul...",52,130,Sci_Rep_2016_Jan_20_6_19432.txt
p.A2808T,ARRP-49	43	c.8422G>A	het	p.A2808T	missense	rs111991705	LamG	Tolerated (0.05...,104,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.A2808T,ARRP-49	43	c.8422G>A	het	p.A2808T	missense	rs111991705	LamG	Tolerated (0.05...,104,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,ARRP-206	12	c.1871G>A	hom	p.S624L	missense	novel	Unknown region	Tolerated (0...,106,27,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,ARRP-206	12	c.1871G>A	hom	p.S624L	missense	novel	Unknown region	Tolerated (0...,106,27,Sci_Rep_2016_Jan_20_6_19432.txt
p.L991F,RP:S-18	19	c.2971C>T	het	p.L991F	missense	novel	EGF	Tolerated (0.541)/Neutr...,112,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.L991F,RP:S-18	19	c.2971C>T	het	p.L991F	missense	novel	EGF	Tolerated (0.541)/Neutr...,112,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.L991F,RP:S-18	19	c.2971C>T	het	p.L991F	missense	novel	EGF	Tolerated (0.541)/Neutr...,112,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.C2396S,RP:S-34	36	c.7187G>C	hom	p.C2396S	missense	novel	EGF	Damaging (0.000)/Delet...,114,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,RP:S-48	20	c.3024C>A	hom	p.C1008X	stopgain	novel	EGF-CA	NA/N,116,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,RP:S-48	20	c.3024C>A	hom	p.C1008X	stopgain	novel	EGF-CA	NA/N,116,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.S323P,"...(p.A191V) in individuals 1 and 2, and c.967T > C (p.S323P) and c.1243 A > G (p.M415V) in individual ...",7,1100,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"...cing validated the c.279 + 1G > C and c.572C > T (p.A191V) variants in two siblings, which were tran...",19,603,Sci_Rep_2016_Jul_20_6_30072.txt
p.W318S,"...pound heterozygous SLC12A5 mutations [c.953G > C (p.W318S) and c.2242_2244del (p.S748del)], who was ...",21,474,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,"...V), and the large extracellular loop (p.W318S and p.S323P) adjacent to four conserved cysteines (C28...",23,622,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,...nces in Cl− extrusion function especially between p.A191V and p.S323P mutants and WT KCC2. The surfa...,45,385,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"...nal domain (p.E50_Q93del), transmembrane domains (p.A191V and p.M415V) and the large extracellular l...",45,727,Sci_Rep_2016_Jul_20_6_30072.txt
p.L426P,"...ound heterozygous missense mutations c.1277T > C (p.L426P) and c.1652G > A (p.G551D), and the other ...",49,190,Sci_Rep_2016_Jul_20_6_30072.txt
p.L426P,"...ound heterozygous missense mutations c.1277T > C (p.L426P) and c.1652G > A (p.G551D), and the other ...",49,190,Sci_Rep_2016_Jul_20_6_30072.txt
p.G551D,"... mutations c.1277T > C (p.L426P) and c.1652G > A (p.G551D), and the other two (one deceased) possess...",49,216,Sci_Rep_2016_Jul_20_6_30072.txt
p.Met415Val,"...p.Ala191Val	c.967T > C, p.Ser323Pro; c.1243A > G, p.Met415Val	c.953G > C, p.Trp318Ser; c.2242_2244de...",109,165,Sci_Rep_2016_Jul_20_6_30072.txt
p.Trp318Ser,"...p.Ser323Pro; c.1243A > G, p.Met415Val	c.953G > C, p.Trp318Ser; c.2242_2244del, p.Ser748del",109,189,Sci_Rep_2016_Jul_20_6_30072.txt
p.Trp318Ser,"...p.Ser323Pro; c.1243A > G, p.Met415Val	c.953G > C, p.Trp318Ser; c.2242_2244del, p.Ser748del",109,189,Sci_Rep_2016_Jul_20_6_30072.txt
p.Gly245Ser,"...ns; however, certain mutants such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln and p.Arg273...",7,1234,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Gln,"...ts such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln and p.Arg273His have been shown to act...",7,1260,Sci_Rep_2016_May_18_6_26191.txt
p.Arg175His,"...Furthermore, a number of GOF mutations, including p.Arg175His and p.Arg273His have been linked to th...",7,1404,Sci_Rep_2016_May_18_6_26191.txt
p.Leu344Gln,"...e missense mutation occurring outside of the DBD, p.Leu344Gln, was located in exon 10 of TP53. All m...",19,727,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Gln,"... acid, with approximately 9% (6/68) of mutations (p.Arg248Gln and p.Arg248Trp) occurring at this cod...",21,110,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Gln,"... acid, with approximately 9% (6/68) of mutations (p.Arg248Gln and p.Arg248Trp) occurring at this cod...",21,110,Sci_Rep_2016_May_18_6_26191.txt
p.Leu344Gln,...ll occurring in the p53 DBD with the exception of p.Leu344Gln in exon 10. All tumours with missense ...,47,119,Sci_Rep_2016_May_18_6_26191.txt
p.Leu344Gln,...ll occurring in the p53 DBD with the exception of p.Leu344Gln in exon 10. All tumours with missense ...,47,119,Sci_Rep_2016_May_18_6_26191.txt
p.S267F,... is encoded by the SLC10A1 gene. Variation of the p.S267F (rs2296651) in SLC10A1 gene results in los...,11,172,Sci_Rep_2016_May_23_6_26465.txt
p.Y856X,...troduction of a premature stop codon (p.R572X and p.Y856X). In silico predictions supported a pathog...,34,265,Sci_Rep_2016_Oct_14_6_35414.txt
p.A2064T,"...emplate to predict the likely structure impact of p.A2064T substitution on ABCA4 protein with PyMOL,...",39,486,Sci_Rep_2016_Oct_14_6_35414.txt
p.A2064T,...with the residue ALA-2064 located at chain B. The p.A2064T mutation would induce an additional hydro...,39,1185,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,...ional structure. The other two missense mutations p.N965S and p.G1977S were respectively first descr...,39,1524,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,...ional structure. The other two missense mutations p.N965S and p.G1977S were respectively first descr...,39,1524,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,...ure. The other two missense mutations p.N965S and p.G1977S were respectively first described in Dani...,39,1536,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,...ure. The other two missense mutations p.N965S and p.G1977S were respectively first described in Dani...,39,1536,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,...tations: two were nonsense mutations (p.R572X and p.Y856X); two were splice-site mutations (c.6479 +...,41,107,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,...tations: two were nonsense mutations (p.R572X and p.Y856X); two were splice-site mutations (c.6479 +...,41,107,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,16	c.2568C > A	p.Y856X	Het	Nonsense	—	—	—	Novel	This study,74,16,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,43	c.5929G > A	p.G1977S	Het	Missense	PD(1.000)	DC(0.999)	D(0.000)...,78,16,Sci_Rep_2016_Oct_14_6_35414.txt
p.D38A,Exon 4	rs5035	c.113A > C for eAE1	p.D38A for eAE1	1 incomplete dRTA,152,35,Sci_Rep_2016_Oct_21_6_35841.txt
p.Ile157Thr,... DNA damage3435. The missense variant rs17879961 (p.Ile157Thr) changes Isoleucine to Threonine at po...,28,367,Sci_Rep_2016_Sep_16_6_33542.txt
p.Lys3326Ter,...ation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context ...,299,58,Sci_Rep_2016_Sep_16_6_33542.txt
p.Thr400Pro,"...G > A, which resulted in following substitutions: p.Thr400Pro (p.T400P) and p.Arg516His (p.R516H), r...",91,277,Sci_Rep_2016_Sep_20_6_33742.txt
p.T158M,"...). In comparison with wild-type MECP2, MECP2 with p.T158M or p.R168X mutation failed to enhance the ...",45,1080,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R270X,...s in the transcription repressor domain of MeCP2 (p.R270X and p.R306C) did not significantly alter M...,45,1425,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R306C,...nscription repressor domain of MeCP2 (p.R270X and p.R306C) did not significantly alter MET transcrip...,45,1437,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R306C,...nscription repressor domain of MeCP2 (p.R270X and p.R306C) did not significantly alter MET transcrip...,45,1437,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R257X,"...zličnih mutacij gena AIRE, najpogostejša mutacija p.R257X je bila opredeljena pri 63,3 % mutiranih a...",22,461,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
